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ABSTRACT
Cardiovascular disease (CVD) is the leading cause of death worldwide. Atherosclerosis, one of
the primary CVDs, is characterized as a chronic inflammatory disease. In the initial stages of
atherosclerosis, there is a buildup of cholesterol and lipoproteins that triggers monocytes to enter
the arterial wall and begin accumulating lipids. Vascular smooth muscle cells (VSMCs) begin to
detach and migrate from the media toward the intima in a process known as phenotypic
switching. Phenotypic switching transitions VSMCs from a contractile to synthetic phenotype
and they gain the capacity for migration, proliferation, and secretion of extracellular matrix
(ECM) proteins. Synthetic VSMCs experience a variety of microenvironments of differing
stiffness and composition within the atherosclerotic plaque which elicit different biomechanical
responses. The growth of atherosclerotic plaques can cause stenosis and reduced blood flow. One
treatment for this is revascularization surgery using vascular grafts to bypass blockages. In this
dissertation, we examine how VSMC biomechanics change in response to substrate stiffness and
composition. Then we developed an electrospun polycaprolactone (PCL)-silk fibroin (SF)
electrospun scaffold for use in vascular tissue engineering. In specific aim 1, the effect of
substrate stiffness and collagen or fibronectin coatings on VSMC migration and cytoskeletal
organization was analyzed. Protein coatings and substrate stiffness were found to synergistically
regulate migration and cortical actin organization in the opposite manner. In specific aim 2, the
differences in biomechanics of atherosclerotic ApoE-/- and wild type (WT) VSMCs was
analyzed. ApoE-/- VSMCs were found to have lower adhesion forces but increased migration
capacity, cytoskeletal alignment, and stiffness, with the latter two being enhanced by increasing
substrate stiffness. In specific aim 3, an exploration into the use of electrospun PCL-SF scaffolds
as vascular grafts was conducted. The addition of SF improved the mechanical properties of the
graft, making them more similar to those of native arteries, as well as increasing the diameter of
the nanofibers. Furthermore, the PCL-SF scaffolds supported the differentiation of mesenchymal
stem cells into VSMC-like cells. Therefore, this dissertation provides further insights in the
alteration of VSMC biomechanics during atherosclerosis and a promising material for the
development a tissue engineered vascular graft.
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Dr. Zhongkui Hong

ii

ACKNOWLEDGEMENTS

First and foremost, I would like to thank my advisor Dr. Zhongkui Hong. I am forever grateful
for the day he let me join his lab and begin this journey. His kindness and mentorship have been
much appreciated and I have learned a great deal in my time with him, becoming a better
researcher and person. Without Dr. Hong’s guidance, none of this would have been possible.
I would also like to thank my committee members. Dr. Daniel Engebretson accepted me
into this program and has provided guidance at every step of my journey. His love of
entrepreneurship has opened my eyes to countless opportunities beyond academic research. Dr.
Erin Harmon has been amazing in his help around the lab, training me on how to use a variety of
instruments and always being available to answer question or discuss random topics. Dr. Aaron
Harmon allowed me to join GMP where I gained valuable skills outside of my day-to-day
research. His insights into how to best approach problems has been quite useful and was always
available to discuss anything. Dr. Jingwei Xie was willing to join my committee late and without
previously knowing me to which I am quite grateful. His insights at my final committee meeting
helped to create a more realistic end goal to my final research aim.
I am forever grateful to the members of Dr. Hong’s lab, Dr. Hanna “Johnny” Sanyour,
Courtney Kinser, Dr. Na Li, Josh Childs, Nisha Khatiwada, and Xiajun “Jamie” Deng. Johnny is
a good friend and great researcher. His commitment to his work is inspiring as is the countless
hours he spent in the lab. His AFM work is present throughout this work, without which this
dissertation would be much different. Courtney was my partner at tissue harvesting, gathering
countless aortas from rats and mice, and was a significant help in optimizing lab protocols. To
Nisha and Jamie, I hope my brief time with them was helpful and that I provided decent

iii

mentorship. I would also like to thank my two former summer students, Neil Leyda and Hayley
Vogel for their help during the summer months and their eagerness to learn. I would also like to
thank all the faculty, students, and staff of the Biomedical Engineering Department and Gear
Center for their support of this program.
Finally, I want to thank my parents and sisters for their continuous support and helpful
advice. I would not be where I am today without them.

iv

DEDICATION

To my dogs Wendall and Augie,
Though they will not understand or know how much they have helped,
Their unconditional love and unbridled joy have been immeasurably appreciated.

v

Table of Contents
COMMITTEE SIGNATURE PAGE............................................................................................... i
ABSTRACT.................................................................................................................................... ii
ACKNOWLEDGEMENTS ........................................................................................................... iii
DEDICATION................................................................................................................................ v
List of Tables ................................................................................................................................ xii
List of Figures .............................................................................................................................. xiii
Chapter 1: Introduction ................................................................................................................... 1
1. Background ............................................................................................................................. 1
1.1. Statistics ........................................................................................................................... 1
1.2. Vascular Structure and Composition ............................................................................... 3
2. Atherosclerosis........................................................................................................................ 5
2.1. Pathogenesis..................................................................................................................... 5
2.2. Role of VSMCs in Atherosclerosis and Phenotypic Switching ....................................... 8
2.3 ECM Proteins.................................................................................................................. 11
3. Cellular Biomechanics .......................................................................................................... 13
3.1. Cytoskeleton Organization............................................................................................. 13
3.2. Cell Migration ................................................................................................................ 14
3.3. Mechanotransduction ..................................................................................................... 15
3.4. Importance of Cellular Biomechanics to the Study of Atherosclerosis ......................... 17
4. Electrospinning Vascular Grafts ........................................................................................... 17
4.1. Statistics ......................................................................................................................... 17
vi

4.2. Current Vascular Grafts ................................................................................................. 18
4.3. Properties of an Ideal Tissue Engineered Vascular Graft .............................................. 19
4.4. Techniques to Produce TEVGs...................................................................................... 19
4.4. Electrospinning .............................................................................................................. 20
4.5. Synthetic Polymers for the Fabrication of Vessel Grafts by Electrospinning ............... 21
4.5.1. Polylactic acid ......................................................................................................... 21
4.5.2. Polyglycolic Acid.................................................................................................... 22
4.5.3. Poly(lactic-co-glycolic) acid ................................................................................... 24
4.5.4. Polycaprolactone..................................................................................................... 26
4.5.5. Poly(L-lactide-co-𝜀-caprolactone) .......................................................................... 27
4.5.6. Polyurethanes .......................................................................................................... 29
4.6. Natural polymers for the Fabrication of Vessel Grafts by Electrospinning................... 31
4.6.1. Collagen .................................................................................................................. 31
4.6.2. Silk Fibroin ............................................................................................................. 32
4.6.3. Polysaccharides....................................................................................................... 34
4.7. Polymer Summary ......................................................................................................... 36
4.8. Polymer Blends .............................................................................................................. 38
4.9. Modified Electrospinning Techniques for Vascular Tissue Engineering ...................... 42
4.9.1. Multilayered Electrospun Vascular Grafts.............................................................. 42
4.9.2. Fiber morphology and alignment............................................................................ 45
4.9.3. Increasing Porosity.................................................................................................. 50
4.10. Reducing Thrombogenicity by Including an Anticoagulant Molecule........................ 54
4.11. Improving Endothelialization by Incorporating Endothelial Growth Compounds...... 57

vii

4.12. Modulation of the VSMC Layer Formation on TEVG by VSMC Regulating
Compounds ........................................................................................................................... 62
5. Main Goal, Specific Aims, and Hypotheses ......................................................................... 66
Chapter 2: Extracellular Matrix Proteins and Substrate Stiffness Synergistically Regulate
Vascular Smooth Muscle Cell Migration and Cortical Cytoskeleton Organization ..................... 67
Abstract ..................................................................................................................................... 67
1. Introduction........................................................................................................................... 68
2. Materials and Methods.......................................................................................................... 70
2.1. Vascular Smooth Muscle Cell Isolation ........................................................................ 70
2.2. ECM Protein-Coated Polyacrylamide Gel Substrate Preparation ................................. 71
2.3. ECM Protein Coating Evaluation .................................................................................. 72
2.4. Cell Migration Studies ................................................................................................... 72
2.5. Confocal Imaging and Image Processing ...................................................................... 73
2.6. Live VSMCs AFM Imaging and Cytoskeletal Orientation Processing. ........................ 74
2.6. Statistical Analysis......................................................................................................... 74
3. Results................................................................................................................................... 74
3.1. Effect of Substrate Stiffness and Extracellular Matrix Proteins on Vascular Smooth
Muscle Cell Migration Distance. .......................................................................................... 74
3.2. Effect of Substrate Stiffness and Extracellular Matrix Proteins on Vascular Smooth
Muscle Cell Migration Dynamics ......................................................................................... 75
3.3. ECM Composition did not Alter Global VSMC Cytoskeletal Architecture in Response
to Changes in Substrate Stiffness.......................................................................................... 77

viii

3.4. Live AFM imaging Revealed ECM Composition Induces Differential Effects of
Substrate Stiffness on VSMC Cytoskeletal Orientation. ...................................................... 78
4. Discussion ............................................................................................................................. 79
5. Conclusion ............................................................................................................................ 83
Chapter 3: Exploring the difference in the mechanics of vascular smooth muscle cells from wild
type and apolipoprotein-E knockout mice .................................................................................. 101
Abstract ................................................................................................................................... 101
1. Introduction......................................................................................................................... 102
2. Materials and Methods........................................................................................................ 104
2.1. Mouse vascular smooth muscle cell isolation.............................................................. 104
2.2. Elastically tunable ECM protein coated polyacrylamide gel preparation ................... 104
2.3. Cell migration studies .................................................................................................. 105
2.4. VSMC biomechanical characterization using AFM .................................................... 106
2.5. VSMC adhesion rate using MTT assay ....................................................................... 107
2.6. VSMC adhesion rate using manual cell count ............................................................. 107
2.7. Real time VSMC cytoskeletal imaging using AFM and image processing................. 107
2.8. Confocal Imaging and Image Processing .................................................................... 108
2.8. Statistical testing .......................................................................................................... 109
3. Results................................................................................................................................. 109
3.1. ApoE-/- and WT VSMCs stiffness and submembranous stress fibers orientation
measurement using AFM .................................................................................................... 109

ix

3.2. Stiffness, cell-cell adhesion, and cell-ECM adhesion of WT and ApoE-/- VSMCs on
COL1-coated gel substrates. ............................................................................................... 110
3.3. ApoE-/- and WT VSMC migration dynamics on COL1-coated gel substrates. ........... 111
3.4. ApoE-/- and WT VSMC global cytoskeleton architecture ........................................... 111
3.5. Statistical testing .......................................................................................................... 112
4. Discussion ........................................................................................................................... 112
5. Conclusion .......................................................................................................................... 115
Chapter 4: Electrospun Nanofiber Scaffold for Vascular Tissue Engineering ........................... 125
Abstract ................................................................................................................................... 125
1. Introduction......................................................................................................................... 126
2. Materials and Methods........................................................................................................ 127
2.1. Silk Fibroin Extraction................................................................................................. 127
2.2. Electrospinning ............................................................................................................ 128
2.3. Mechanical Testing ...................................................................................................... 129
2.4. Scanning Electron Microscopy .................................................................................... 129
2.5. Cell Culture .................................................................................................................. 129
2.6. VSMC Differentiation ................................................................................................. 130
2.7. Confocal Imaging......................................................................................................... 130
2.8. Statistical Analysis....................................................................................................... 131
3. Results................................................................................................................................. 131
3.1. Scaffold Characterization............................................................................................. 131
3.2. VSMC Marker Expression........................................................................................... 132
x

4. Discussion ........................................................................................................................... 133
5. Conclusion .......................................................................................................................... 136
Chapter 5: Overall Conclusions and Future Directions .............................................................. 145
1. Conclusions......................................................................................................................... 145
2. Future Directions ................................................................................................................ 146
References................................................................................................................................... 149

xi

List of Tables
Chapter 1

Table 1. Brief summary of the advantages and disadvantages of selected synthetic polymers. 37

Chapter 4

Table 1. Electrospinning parameters for PCL-SF scaffolds. 137

Table 2. Mechanical testing results and fiber diameter. 138

xii

List of Figures
Chapter 1

Figure 1. Projected prevalence of CVDs through 2035. 2

Figure 2. Comparative costs of various CVDs. 3

Figure 3. Diagram of an artery. An artery is composed of three layers: the intima, media, and
adventitia. The intima is composed of a monolayer of ECs surrounded by the elastic lamina. The
media contains several layers of VSMCs interspersed with an extensive ECM of collagen fibers
and elastin (not shown). The adventitia is composed of connective tissue and contains fibroblast
and macrophages. 5

Figure 4. Initiating steps in the formation of an atherosclerotic lesion. Lipoproteins accumulate
within the intima triggering the release of proinflammatory cytokines. ECs begin expressing
leukocyte adhesion molecules that causes monocytes to adhere to the endothelium and eventually
enter the intima. In the intima, monocytes transform into macrophages and begin accumulating
lipids, forming foam cells. VSMCs from the media begin migrating into the intima, joining
resident VSMCs and proliferate, secrete ECM, and form additional foam cells. 6

Figure 5. Phenotypic switching of VSMCs in an atherosclerotic plaque. Early in atherosclerosis,
VSMCs switch from a contractile to synthetic phenotype. Synthetic VSMCs migrate into the
plaque, proliferating and secreting ECM to form the fibrous cap. In addition, VSMCs are now

xiii

known to undergo metaplasia and become macrophage-like. Macrophage-like VSMCs reside in
the lipid rich core, ingesting lipids and forming foam cells that eventually contribute to the
formation of a necrotic core. 9

Figure 6. VSMCs can undergo phenotypic switching to become a variety of cells with different
effects on plaque stability. 11

Figure 7. Wang et al. rolled PLGA mats with fibrin glue to create a multilayered scaffold. Cells
seeded in the scaffolds demonstrated good viability and proliferation. In addition, the cell-seeded
scaffolds also showed reduced leakage. 25

Figure 8. Han F. et al. made a three-layered graft composed of an outer PCL/gelatin layer,
middle PLGA/gelatin + PDGF layer, and inner PLCL/gelatin + VEGF layer. The gelatin fibers
on the inner layer support rapid EC attachment and once degraded increased the porosity of the
outer and middle layers allowing for VSMC ingrowth. 42

Figure 9. Schematic used by Wu T. et al. to create a three-layered graft. (A) Aligned
PLCL/collagen fibers were collected on a rotating mandrel. (B) A customized electrospinning set
up was used to generate PLGA/SF yarns that comprised the middle layer by twining on the inner
layer. (C) A thin outer layer of random electrospun PLCL/collagen nanofibers was used to bind
the construct together. 44

xiv

Figure 10. (A) Electrospinning schematic used by Tan et al. (B) Electrospun PCL nanofibers
were collected between two parallel rods and (C, D) collected on a mandrel resulting in
longitudinally aligned fibers. (E) PCL and PEG were co-electrospun to create the outer layer and
(F) finished scaffold. 48

Figure 11. Schematic used by Mi et al. The set up was composed of a hollow metal mandrel
surrounded by satellite rods. When rotating, the metal rods deform and fibers are collected. As
the fibers are deposited the rods contract with the fibers forming a wavy structure. 50

Figure 12. Schematic used by Norouzi and Shamloo. A crosslinked gelatin hydrogel was cast
around an inner electrospun PCL/gelatin layer. After freeze drying, the hydrogel formed a porous
outer layer. 54

Chapter 2

Figure 1. VSMC migration on the different ECM protein-coated gel substrates with varying
stiffness. (A) Schematic of VSMC migration experiments. The descending thoracic aorta was
harvested from 8-week-old male Sprague-Dawley rats and VSMCs were enzymatically isolated.
After 6-10 days of culture, VSMCs were trypsinized and seeded on ECM protein-coated PA gels
for 24 h imaging and VSMC positions were tracked. Distance (in red) covers the path the cell
took. Displacement (yellow) is the straight-line path from the start point to the end point. Mean
Square Displacement (MSD, cyan) is the square of the displacement, essentially a box covering
the area traversed by the cell. (B) Position plot of VSMC nucleus mapped to a common origin.

xv

Top Row: VSMCs on COL1-coated substrates displayed little visual change in migration.
Bottom Row: VSMCs on FN-coated substrates show an apparent increase in migration with
increasing substrate stiffness. For each stiffness and protein combination, 30 to 50 cells were
tracked per independent trial, with three independent replicates. 85

Figure 2. Distribution of the VSMC migration distance on different ECM protein coated gel
substrates with varying stiffness. (A-C) VSMCs on the COL1-coated gel substrates. 103 kPa
substrate histogram had a left-shifted, narrower peak than those on the 3.5 and 28 kPa substrates,
indicating lower migration distance. (D-F) VSMCs on the FN-coated gel substrates. VSMC
migration distances became more dispersed on the stiffer substrates, with the peak shifting to the
right indicating a higher average migration distance. 87

Figure 3. Substrate stiffness and ECM composition alter VSMC migration. (A, B) Migration
distance vs. time plots demonstrated VSMC migration distance decreased on COL1-coated gels
as stiffness increased, while migration distance increased on FN-coated gels with increasing
stiffness. (C) Increasing substrate stiffness resulted in a significant decrease in migration distance
for COL1-coated substrates. (D) FN-coated substrates showed a significant increase in migration
distance with increasing substrate stiffness. Data in panels A and B are presented as mean
migration distance (mid-line) at each time point ± SEM. Data were presented in panels C and D
as mean migration distance at end point ± SEM. **P ≤ 0.01 and ***P ≤ 0.001. 88

Figure 4. The combinatorial effect of ECM proteins and substrate stiffness on VSMC migration
dynamics. (A) A representative migration distance vs. time plot shows an apparent stepwise

xvi

migration behavior. (B) Instantaneous migration speeds were determined by the first derivative
of the migration distance at each time point. A clear pattern of speed peaks and stops was seen in
migration speed vs. time plot. (C, F) VSMC migration speed significantly decreased on COL1
(C) with increasing substrate stiffness. VSMCs on 103 kPa FN-coated (F) substrates displayed
significantly higher migration speed than the 28 kPa and 3.5 kPa FN-coated substrates. (D, G)
The number of migration stops significantly increased on COL1-coated (D) substrates with
increasing substrate stiffness. On FN-coated substrates (G), VSMCs experienced significantly
fewer stops on the stiffer gels. (E, H) VSMCs on stiffer COL1-coated substrates (E) stopped for
a longer resting time. Conversely, the total resting time significantly decreased on the stiffer FNcoated substrates (H). Data were presented as mean ± SEM. **P ≤ 0.01 and ***P ≤ 0.001. 89

Figure 5. The combinatorial effect of ECM proteins and substrate stiffness on VSMC migration
displacement. (A) Despite having the lowest migration distance, VSMCs on the 103 kPa COL1coated substrate had the highest MSD across all time points, indicating a more persistent
migration. (B) VSMCs on the 103 kPa FN-coated substrate also had the highest MSD. (C)
Substrate stiffness had no significant effect on the RMC of VSMCs on COL1-coated substrate.
However, VSMCs on the 103 kPa substrate did have the highest RMC. (D) On FN-coated
substrate, substrate stiffness was found to have a significant effect on the RMC. Data were
presented as mean ± SEM. **P ≤ 0.01. 91

Figure 6. Confocal images of VSMC actin cytoskeleton. (A, B) The top row of each panel shows
a representative confocal image of VSMC actin fibers culture on the 3.5 kPa (left), 28 kPa
(middle) and 103 kPa (right) substrates for COL1 and FN-coatings, respectively. The bottom row

xvii

of each panel shows the corresponding color map of stress fiber orientation computed from the
confocal images. (C, D) Stress fiber orientation histograms for COL1 and FN-coating
respectively, where the dominant orientation angle was normalized to zero for each cell. (E, F) A
significant difference in the frequency of the dominant orientation angle (−10° ~ +10°) was
observed for COL1-coated PA gels, with VSMCs on the 3.5 kPa substrate having a more
disorganized actin cytoskeleton. No significant difference in the dominant orientation was
observed for VSMCs cultured on the FN-coatings. Actin (green) was stained with phalloidin and
the nuclei (blue) were counterstained with Hoechst. At least 20 confocal images were analyzed
for each condition. Data were presented as mean ± SEM. 92

Figure 7. AFM height images of the cortical cytoskeleton and the area fraction of cortical stress
fiber. (A, B) Representative AFM height images for VSMCs cultured on COL1 and FN-coated
28 kPa (left) and 103 kPa (right) substrates (top row of panel A and B, respectively). The color
changes from blue to red indicate the increasing height of the stress fibers. The bottom row of
each panel shows the threshold applied to the height image to separate the areas occupied by
stress fibers (red) from the empty background (blue). (C, D) Substrate stiffness did not have a
significant effect on the area occupied by stress fibers for the cells cultured on the COL1 or FNcoated substrate. (E, F) Substrate stiffness did not have a significant effect on the average
roughness of cell surface cultured on COL1 or FN-coated substrate. For AFM imaging, 20 cells
cultured on COL1 for each stiffness and 14 cells on FN for each stiffness were imaged. Data
were presented as mean ± SEM. 94

xviii

Figure 8. Substrate stiffness and ECM coating alter VSMC’s cytoskeleton organization. (A, B)
Representative 30 μm × 30 μm AFM deflection images for VSMCs cultured on 28 kPa (left) and
103 kPa (right) are seen in the top row of each panel. The bottom row of each panel displays
circular histogram showing the normalized stress fiber orientation of each corresponding
deflection image. (C) The VSMCs cultured on the 103 kPa COL1-coated substrate displayed a
more aligned stress fiber organization than those on the 28 kPa substrate. (D) On FN-coated
substrates, VSMCs on the softer 28 kPa substrate displayed the more aligned stress fiber
architecture. (E) Summarized percent frequency of dominant fiber orientation (-20 ~ 20) showed
a significantly more orientated stress fiber architecture on the 103 kPa COL1-coated substrate.
(F) The summarized percentage frequency of dominant fiber orientation (-20 ~ 20) showed the
opposite trend for FN-coated substrate, with VSMCs on the 28 kPa substrate having a more
aligned stress fiber orientation. Data were presented as mean ± SEM. *P ≤ 0.05. 95

Figure 9. ECM protein-coated gels. (A) Protein-coatings appeared visually uniform for COL1
(top row) and FN (bottom row) for the 3.5 kPa (left), 28 kPa (middle), and 103 kPa (right)
substrates. (B, C) Intensity quantification showed no significant difference in coating on the
substrate of different stiffness for both COL1 and FN-coated substrates. Images were taken of
three different spots on each gel with three replicates for each group. 97

Figure 10: AFM height image flattening. (A) A representative raw AFM height image of cortical
cytoskeleton. (B) Representative flattened AFM height image. A higher contrast between the
stress fiber and the background is visualized in the flattened height image. 99

xix

Figure 11: Calculation of x- and y-gradients of the AFM deflection image. (A) Representative
raw AFM deflection image of cortical cytoskeleton (same cell as Figure 10). (B, C) x- and ygradients calculated by convolving of x- and y- directional masks with the original AFM
deflection image, respectively. 100

Chapter 3

Figure 1. Live WT and ApoE-/- VSMC stiffness maps. (A) 30 × 30 μm cell surface areas were
automatically scanned and indented at 6×6 positions with a glass bead. Created with
Biorender.com. (B) Average stiffness for normal diet fed ApoE-/- and WT VSMCs. (C, D)
Stiffness force maps for WT and ApoE-/- VSMCs, respectively. (E) Average stiffness for
Western diet fed WT and ApoE-/- VSMCs. No significant difference in E-modulus was observed
between normal diet fed ApoE-/- and WT VSMCs. Western diet fed ApoE-/- VSMCs had a
significantly higher E-modulus compared to WT VSMCs. All data are presented as the mean ±
SEM (n ≥ 60 cells across six different mice). Scale bar in lower right corner represents 10 μm.
116

Figure 2. Live WT and ApoE-/- VSMC submembranous stress fibers orientation measurement.
(A) 30 × 30μm areas were scanned for overall VSMCs stiffness measurement. Created with
Biorender.com. (B, C) Representative 30 × 30 μm three-dimensional stress fiber topography of a
WT and ApoE-/- VSMC used for live VSMCs stress fiber orientation and area fraction analysis.
(D) Average area fraction of VSMC submembranous actin stress fibers. (E, F) Circular
histogram, showing the normalized stress fiber orientation of WT and ApoE-/- deflection images,

xx

respectively. (G) The average stress fiber orientation percentage histogram for WT and ApoE -/VSMCs, in which the dominant stress fiber orientation angle was set as zero degrees for each
cell. (H) The summarized percentage frequency of dominant fiber orientation (−20°~+20°). (I)
Average stress fiber surface roughness average. ApoE-/- VSMCs have significantly greater stress
fiber alignment and surface roughness compared to WT VSMCs. All data are presented as the
mean ± SEM (n= 16 cells for imaging both across 6 different mice). 117

Figure 3. Measuring stiffness of WT and ApoE-/- VSMCs on COL1-coated gel substrates. (A)
WT or ApoE-/- VSMCs were cultured on elastically tunable COL1-coated PA gels and indented
with a glass bead at a single point. Created with Biorender.com (B) Average VSMC E-modulus
on 28 and 103 kPa substrates. ApoE-/- VSMCs cultured on 28 and 103 kPa substrates had a
significantly higher E-modulus compared to WT VSMCs and demonstrated an increase Emodulus when cultured on stiffer substrates. All data are presented as the mean ± SEM (n ≥ 60
cells across 6 different mice for each group). 119

Figure 4. Measuring cell-cell adhesion and cell-ECM adhesion of WT and ApoE-/- VSMC on
COL1-coated gel substrates. (A) AFM tips were coated in ECM proteins or cadherin and used to
measure adhesion forces. Created with Biorender.com. (B) Total average adhesion force to cellECM adhesion protein COL1. (C) Average adhesion force to N-cadherin. ApoE-/- VSMCs
demonstrated a significant lower adhesion force to COL1 and N-Cad compared to WT cells.
Interestingly, a slight decreasing trend of adhesion force was observed for both WT and ApoE-/cells on the 103 kPa compared to the 28 kPa substrate. All data are presented as the mean ± SEM
(n ≥ 60 cells across 6 different mice for each group). 120

xxi

Figure 5. Measuring cell adhesion of ApoE-/- and WT VSMCs to plastic and COL1-coated
surfaces. (A, B) MTT assay measuring percent cell count relative to control at three different
time points on plastic and COL1 coated surfaces, respectively. (C) Manual cell count of ApoE-/and WT cells at 30 minutes on plastic and COL1 coated surfaces. No statistical significance
between ApoE-/- and WT cell counts were observed from either the MTT assay or manual cell
count. All data are presented as the mean ± SEM (n ≥ 3 different mice). 121

Figure 6. WT and ApoE-/- VSMCs migration dynamics on COL1-coated gel substrates. (A)
VSMCs isolated from WT and ApoE-/- mice were seeded onto COL1-coated PA gel to track cell
migration. (B, C) Average distance vs time for WT and ApoE-/- VSMCs on the 28 and 103 kPa
COL1-coated substrates, respectively. (D) Migration distance of VSMCs on different substrate
stiffnesses. ApoE-/- VSMCs demonstrated a higher migration capacity compared to WT cells. All
data are presented as the mean ± SEM (n = 90 cells across 3 different mice for each group). 122

Figure 7. Confocal imaging of WT and ApoE-/- VSMC cytoskeleton orientation. (A, B, C, D)
Representative fluorescent z-stack images of the actin cytoskeleton for WT and ApoE-/- VSMCs
on the 28 and 103 kPa COL1-coated substrates. (E, F, G, H) The corresponding segmented color
maps showing cytoskeleton orientation computed from the confocal images. (I, J, K, L)
Corresponding circular histograms showing the normalized F-actin fiber orientation. (M, O)
Average normalized fiber orientation where the dominant angle is set as zero degrees on the 28
and 103 kPa substrate, respectively. (N, P) Summarized percentage frequency of fibers
orientated around the dominant angle. ApoE-/- VSMCs on the 103 kPa substrate demonstrated a
greater cytoskeletal alignment compared to WT cells. All data are presented as the mean ± SEM

xxii

(n > 60 cells from at least 25 images across 3 different mice for each group). Scale bars in lower
right corner represent 50 μm. 123

Chapter 4

Figure 1. Mechanical characterization of PCL-SF nanofibrous scaffolds. (A) 10% PCL scaffolds
had significantly higher elastic modulus compared to the PCL/SF blend scaffolds. (B) 10% PCL
scaffolds had significantly higher ultimate tensile strength compared to the PCL/SF blend
scaffolds. (C) 10% PCL scaffolds had significantly lower percent elongation compared to the
PCL/SF blend scaffolds. All data are presented as the mean ± SEM (n = 12 or 16 with
measurements taken on 3 or 4 samples from each polymer blend with 4 replicates per sample).
*P ≤ 0.05. 139

Figure 2. SEM imaging of fiber morphology. (A) SEM images showing the microstructure of the
scaffolds (top row) and morphology of the nanofibers (bottom row). Scale indicated by the white
bar showing 100 µm for the 1000x images and 5 µm for the 20000x images. (B) 10% PCL
scaffolds had significantly smaller average fiber diameter. Data are presented as the mean ±
SEM (n ≥ 56 with measurements taken on 3 or 4 samples from each polymer blend). *P ≤ 0.05.
141

Figure 3. Immunostaining for VSMC marker MHC. Scale bar in the bottom right indicates 100
µm. 142

xxiii

Figure 4. Immunostaining for VSMC marker calponin. Scale bar in the bottom right indicates
100 µm. 143

Figure 5. Immunostaining for VSMC marker smoothelin. Scale bar in the bottom right indicates
100 µm. 144

xxiv

Chapter 1: Introduction
1. Background
1.1. Statistics
Cardiovascular diseases (CVDs) remain the leading cause of mortality, accounting for
approximately 19 million deaths worldwide in 2020. This represents an 18.7% increase in deaths
attributable to CVDs compared to 2010 [1]. While the number of deaths attributable to CVDs
increased from 2007 to 2017, the death rate from CVDs dropped by 10% over the same time
frame [2]. Despite the decrease in death rate, the years of life lost increased for coronary heart
disease (CHD) and stroke over that time ranking first and third, respectively [2]. In 2015, 41.5%
of the United States population had at least one CVD condition lead by hypertension (96.1
million), CHD (16.8 million), stroke (7.5 million), congestive heart failure (CHF) (5.8 million),
and atrial fibrillation (AFib) (5.2 million). This burden is expected to rise to 45% of the United
States population by 2035 (Figure 1) [3]. CVDs represent a sizable portion of healthcare
spending with average annual direct and indirect costs estimated at $378.0 billion from 2017 to
2018, accounting for 12% of total health expenditures in the United States. Direct and indirect
costs for CHD alone is estimated at $228.7 billion (Figure 2). Costs are rising too, with direct
costs estimated to have increased from $103.5 billion in 1996-1997 to $226.2 billion in 20172018 [1]. These costs are expected to grow, reaching $749 billion in 2035 [3].
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Figure 1. Projected prevalence of CVDs through 2035 [3].
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Figure 2. Comparative costs of various CVDs [1].

1.2. Vascular Structure and Composition
The cardiovascular system is composed of the heart and blood vessels and has two distinct
divisions: the pulmonary circulation, directing blood flow between the heart and lungs, and the
systemic circulation, directing blood flow between the heart and the rest of the body. The
vasculature contains five types of blood vessels: arteries, arterioles, veins, venules, and
capillaries. Arteries are the largest of the vessels, carrying blood away from the heart and have
the highest internal pressure. Arteries branch off into smaller arterioles which have the greatest
influence on blood pressure and blood flow to various tissue and organs. Arteries and arterioles
are composed of three distinct layers: the tunica intima, tunica media, and adventitia. The
innermost layer is the tunica intima and is composed of a single layer of endothelial cells that lay
a top the elastic lamina, providing for smooth laminar flow of blood. Endothelial cells (ECs) are
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responsible for the release of numerous bioactive substances, modulation of vascular tone, and
the selective diffusion of various substances [4, 5]. The middle layer is the tunica media and is
composed of concentric layers of circumferentially aligned vascular smooth muscle cells
(VSMCs), with the number of layers depending on the size of the artery. VSMCs are contractile
cells and the primary regulator of blood pressure. Interspersed amongst the VSMCs is an
extensive extracellular matrix (ECM) of collagen fibers and elastin. The collagen fibers have
high tensile strength and elastic modulus and bear most of the force on the artery. Elastin is a
distensible protein that acts as an elastic reservoir allowing the artery to expand and contract to
maintain blood pressure [6]. The amount of VSMCs and elastic tissue vary between arteries with
muscular arteries such as the femoral and radial arteries having more VSMCs while elastic
arteries, such as the aorta, have more elastic tissue allowing them to maintain a relatively
constant pressure gradient despite their proximity to the heart [1]. Finally, the outermost layer of
an artery is the adventitia. The adventitia is primarily composed of connective tissue, with nerve
fibers and lymphatic vessels dispersed throughout. Fibroblasts are the main cell type found in the
adventitia and regulate inflammatory responses. Immune cells such as macrophages are also
present in the adventitia [7].
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Figure 3. Diagram of an artery. An artery is composed of three layers: the intima, media, and
adventitia. The intima is composed of a monolayer of ECs surrounded by the elastic lamina. The
media contains several layers of VSMCs interspersed with an extensive ECM of collagen fibers
and elastin (not shown). The adventitia is composed of connective tissue and contains fibroblast
and macrophages.

2. Atherosclerosis
2.1. Pathogenesis
Atherosclerosis is a chronic inflammatory disease of the arteries. Several risk factors contribute
to atherosclerosis including lifestyle, hypertension, and smoking. However, the most prominent
cause is increased concentration of low-density lipoprotein (LDL) to the extent that people with
low LDL levels seldomly develop atherosclerosis despite having other risk factors [8, 9]. The
accumulation of LDLs in the arterial intima is the initiating step in atherosclerosis. In the intima,
LDLs are modified by oxidization and aggregation which causes an inflammatory response [8].
5

ECs are activated by proinflammatory cytokines and begin to express leukocyte adhesion
molecules which allows the rolling and adhesion of monocytes and lymphocytes. Monocytes
then migrate into the intima due to the release of chemoattractant cytokines, transform into
macrophages, and begin to uptake lipids forming foam cells [10, 11]. T lymphocytes are also
attracted to the area, helping to further stimulate an immune response. Both resident intimal
VSMCs and those beginning to migrate from the media start secreting ECM protein, causing
intimal thickening (Figure 3) [11]. At this point the lesion is known as a xanthoma and is still
fully reversible [8].

Figure 4. Initiating steps in the formation of an atherosclerotic lesion. Lipoproteins accumulate
within the intima triggering the release of proinflammatory cytokines. ECs begin expressing
leukocyte adhesion molecules that causes monocytes to adhere to the endothelium and eventually
enter the intima. In the intima, monocytes transform into macrophages and begin accumulating
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lipids, forming foam cells. VSMCs from the media begin migrating into the intima, joining
resident VSMCs and proliferate, secrete ECM, and form additional foam cells [11].

If the xanthoma does not heal, further progression into an atherosclerotic lesion will
occur. Lipid accumulation continues and as macrophages internalize excessive amounts of lipids,
they switch from having a protective role–removing excess cytotoxic lipids–to a more
detrimental one, becoming foam cells. Since the scavenger receptor proteins responsible for the
uptake of lipoproteins are not down regulated by the accumulation of cellular cholesterol,
macrophages eat until they die. This contributes to the formation of a lipid-rich necrotic core
which destabilizes the plaque. Furthermore, these macrophages begin to express matrix
metalloproteinases (MMPs) and tissue factor, which destabilize the plaque and promote
thrombosis, respectively [10]. VSMCs continue to proliferate and migrate into the intima
secreting ECM and forming a protective fibrous cap [12]. At this point the lesion is known as a
fibroatheroma [8].
In the traditional dogma of atherosclerosis progression, myocardial infarction (MI) occurs
due to vulnerable plaques. In these advanced lesions, the fibrous cap is thinned due to the
degradative action of MMPs on the collagen rich fibrous cap and the loss of VSMCs [8]. Various
triggers can cause plaque rupture, which exposes blood coagulation factors to the thrombogenic
plaque (particularly the procoagulant tissue factor). This results in the formation of a thrombosis,
blocking blood flow and causing ischemia [8, 11]. The vulnerable plaque mechanism has
commonly been associated with ST-segment elevation MI (STEMI) and higher mortality [13].
However, in recent decades there has been a notable decline in acute MI age-adjusted mortality
and hospitalizations. This has been associated with the rise of antihypertension drugs, lipid
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lowering medication, and changes in smoking policies [13]. Instead, a growing proportion of
acute coronary syndrome is due to non-STEMI (NSTEMI). NSTEMI tends to have higher
survivability and is not associated with the vulnerable plaque model. Superficial erosion, where
there is a loss of ECs on the plaque surface, appears to be the predominant cause of NSTEMI but
the mechanism behind it remains unresolved [8, 11, 13].

2.2. Role of VSMCs in Atherosclerosis and Phenotypic Switching
VSMCs typically reside within the medial layer of arteries. In their normal state, VSMCs have a
quiescent contractile phenotype. Contractile VSMCs express several smooth muscle cell markers
including smooth muscle myosin heavy chain (MYH11), smooth muscle cell actin (ACTA2),
and smoothelin [12]. A key hallmark of atherosclerosis is the process known as phenotypic
switching, where VSMCs transition from their normal contractile phenotype to a synthetic
phenotype. With the synthetic phenotype, expression of contractile markers is reduced and
VSMCs gain an increased capacity for proliferation, cell migration, and ECM protein secretion
(Figure 5) [12]. Synthetic VSMCs also have a large rough endoplasmic reticulum and Golgi
apparatus and few myofibrils [8]. This gain of function is commonly viewed as having a
protective role by forming the fibrous cap on an atherosclerotic lesion and helping to stabilize the
plaque. In the small mammals typically used in in vivo studies, VSMCs reside exclusively in the
medial layer of a healthy artery while humans are known to have synthetic VSMCs that reside in
the normal intima. This, combined with the loss of contractile VSMC markers, makes lineage
tracing and thus the relative contribution of intimal and medial VSMCs to atherosclerotic
progress difficult to ascertain [8].
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Figure 5. Phenotypic switching of VSMCs in an atherosclerotic plaque. Early in atherosclerosis,
VSMCs switch from a contractile to synthetic phenotype. Synthetic VSMCs migrate into the
plaque proliferating and secreting ECM to form the fibrous cap. In addition, VSMCs are now
known to undergo metaplasia and become macrophage-like. Macrophage-like VSMCs reside in
the lipid rich core, ingesting lipids and forming foam cells that eventually contribute to formation
of a necrotic core [14].
In addition to switching to a synthetic phenotype, VSMCs are now known to undergo
metaplasia and become macrophage-like [11]. This is denoted by the up regulation of
9

macrophage markers such as CD68 and LGALS3 and pro-inflammatory cytokines. The loss of
myocardin appears to be key to triggering pro-inflammatory pathways and the formation of
macrophage-like cells [12]. Macrophage-like VSMCs’ gene expression is different from that of
macrophages and reduce macrophage functionality. In particular, these cells have less
phagocytotic capacity and may be ineffectual at clearing apoptotic cells, contributing to the
formation of the necrotic core in advanced atherosclerotic plaques (Figure 5) [12]. VSMCderived foam cells have been found to comprise up to 40% of the total foam cells [15]. This
transformation is suspected to be due to excess loading of cholesterol into VSMCs. The receptor
P2RY12 has been demonstrated to be an important regulator of lipid accumulation in VSMCs
through the autophagy pathway and VSMC-derived foam cell formation [16]. Contrary to the
protective role synthetic VSMCs are viewed as having, macrophage-like and VSMC-derived
foam cells likely contribute to plaque instability [14]. Furthermore, VSMCs exhibit a high degree
of plasticity in atherosclerosis and are known to transform into myofibroblast-like, mesenchymal
stem cell-like, and osteochondrogenic cells with some evidence of differentiation into adipocytelike and EC-like cells. The numerous phenotypes VSMCs can mimic contribute to plaque
stability or instability to a varying degree, highlighting the critical roles VSMCs play in
atherosclerosis progression (Figure 6) [14].
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Figure 6. VSMCs can undergo phenotypic switching to become a variety of cells with different
effects on plaque stability [14].
2.3 ECM Proteins
A healthy artery contains a substantial number and amount of different proteins that comprise the
ECM. 50% of the weight of large arteries is ECM and provide much of the strength of healthy
arteries with decellularized arteries having the same static mechanical properties as cellularized
arteries [17]. The intimal layer contains collagens, laminins, nidogens, proteoglycans, fibronectin
(FN), and von Willebrand factor in the basement membrane. Among the collagens expressed in
the artery, collagens I, III, IV, V, and VI have the highest expression. The intimal layer is
predominantly composed of fenestrated sheets of elastin interspersed with collagen fibers and
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thin layers of proteoglycans [17]. The most prominent collagens in the media are collagens I and
III, with collagen I (COL1) comprising 70% of collagen in a blood vessel [18]. The adventitia
has a large amount of collagen fibrils, providing tensile strength to the artery, and the
proteoglycan versican, which maintains the elastic properties of blood vessels and connects to
the surrounding connective tissue [17, 18].
Like the numerous changes in cell behavior seen in the progression of atherosclerosis, the
ECM undergoes a host of changes with the abundance of nearly ECM protein present in the
artery changing. Most notable is the increased expression of collagens I and III as well as
fibronectin whereas elastin expression is decreased [17, 18]. Synthetic VSMCs have been shown
to secrete 25-35 times more collagen that contractile cells [19]. This contributes to the high
abundance of collagen within the plaque, comprising as much as 60% of the total protein in an
atherosclerotic plaque [18]. COL1 is highly abundant within the fibrous cap having a protective
role by stabilizing the plaque [20]. Increased FN deposition appears to promote the early
formation of the atherosclerotic lesion, acting as adhesion sites for monocytes, but later switches
to a more protective role by controlling the formation of the fibrous cap and promoting the
proliferation of VSMCs [18, 21].
In a healthy artery, ECM homeostasis is maintained by regular turnover of ECM proteins.
While elastin is essentially stable over a person’s lifetime, COL1 is regularly turned over with a
half-life of 60-70 days [22, 23]. Collagen degradation occurs through the action of MMPs, which
are stored within ECM and activated when needed [18]. Degraded and monomeric collagen
produced by MMPs have been shown to stimulate VSMC migration [24]. Macrophages within a
developing atherosclerotic lesion secrete MMPs which breakdown the existing ECM helping the
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initial migration of VSMCs. However, continued action of MMPs in late-stage plaques promote
plaque instability, making it more vulnerable to rupture [18].
3. Cellular Biomechanics
3.1. Cytoskeleton Organization
Collectively, the cytoskeleton is composed of three types of protein filaments: actin filaments,
microtubules, and intermediate filaments. The most prominent of these cytoskeletal elements in
VSMCs is actin filaments. Three isoforms of actin are present in VSMCs. Alpha smooth muscle
actin is present in contractile filaments and interacts with myosin in contractile VSMCs. Gamma
nonmuscle actin is located in the cell cortex. Beta nonmuscle actin acts as a linker between alpha
and gamma actin, helping to transmit contractile forces from the contractile filaments to focal
adhesions and the gamma actin cortex. All three of the actin isoforms contribute some degree to
VSMC stiffness [25]. Monomeric actin, known as G-actin, has 375 amino acids and folds into a
globular protein with an α and 𝛽 domain. When G-actin binds to ATP it is able to form F-actin
filaments. F-actin undergoes continuous polymerization and depolymerization in a process
known as treadmilling [26]. The actin cytoskeleton undergoes constant assembly, disassembly,
and reorganization allowing cells to change shape and enabling cell motility. Actin
polymerization at the leading edge of cells is responsible for the formation of filopodia and
lamellipodia which are responsible for cell mobility.
In a recent study, Sanyour et al. studied the effects of substrate stiffness and cholesterol
on actin organization. Softer substrates resulted in a more disorganize cytoskeleton.
Cyclodextrin-mediated cholesterol depletion resulted in a disorganized cytoskeleton, however on
the softest substrate this effect was eliminated. On the other hand, cholesterol enrichment
resulted enhanced organization of actin fibers. These indicate that substrate stiffness and
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cholesterol may work together to regulate cytoskeletal organization [27]. Cholesterol depletion
from treatment with Fluvastatin has also been demonstrated to disrupt actin fiber organization
[28]. The Rho signaling pathway appears critical to actin organization and polymerization. Rho
activation following stretching or tension results in cytoskeleton tension and increased cell
stiffness through the YAP and serum response myocardin pathway. Other members of the
myocardin family bind to G-actin and induce actin polymerization following Rho activation [17].
Angiotensin II, which promotes proliferation and migration of VSMCs, has also been shown to
regulate actin polymerization through the RhoA/ROCK pathway [29].
3.2. Cell Migration
VSMC migration from the media to the intima is a key step in the progression of atherosclerosis.
Migration is driven by the formation of protrusions at the leading edge of a cell and retraction of
the posterior end due to the polymerization and depolymerization of actin, respectively. The
actin filaments that are formed at the leading edge of the cell move toward the rear of the cell as
actin polymerization continues, a process known as treadmilling [30]. Thus, actin filaments flow
backwards relative to the substrate in a process termed retrograde flow. The actin cortex is
tightly linked to the ventral and dorsal membrane, driving migration. Furthermore, retrograde
flow can still be observed on cells detached from the substrate, indicating that cortical actin
generates forces rather than simply flowing to the rear of the cell [31]. Known as the molecular
clutch, the proteins connecting the ECM-bound integrins to actin filaments harness the
retrograde motion of actin to generate tension along the substrate to induce movement [32].
RhoA, as a prominent regulator of actin filament dynamics, is also a key regulator of migration
[33]. Two other protein groups are key to actin polymerization nucleation–the formins mDia1
and mDia2 and the Arp2/3 complex. mDia1 and mDia2 polymerize actin linearly, key to the
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formation of filopodia, while Arp2/3 promotes branching of actin filaments to form lamellipodia
[33]. At the leading edge of cells, cofilin promotes filament branching and increases
polymerization by cleaving the ends of actin filaments. The Arp2/3 nucleated branching on these
recently cleaved ends is 10 times more stable than those on older filaments [33]. The ECM also
plays a key role in regulating the migration of VSMCs as degraded COL1, FN, MMPs, and
collagen type VIII have all been shown to stimulate migration [18].
3.3. Mechanotransduction
Cells can detect and react to mechanical forces from their environment, processes known as
mechanosensing and mechanoresponse, respectively. The process through which mechanical
ques are translated into biochemical responses is known as mechanotransduction [34]. The
components of the mechanotransduction system include the cytoskeleton, particularly actin
filaments, and focal adhesion complexes (FAs). Actin is linked to the ECM through FAs
containing various proteins including talin, vinculin, and various integrins [35]. At sufficiently
high forces, talin unfolds allowing vinculin to bind, stabilizing the FA and increasing force
transmission to actin [36, 37]. These mechanosensitive proteins likely have a role in cytoskeleton
organization as talin has been shown to mediate the co-alignment of integrins in FAs and F-actin
and the growth of FAs parallel to strain. Additionally, vinculin, through its link to actin, has
been shown to coordinate cell polarization in response to stretching forces [38].
FAs are also known to cluster with lipid rafts, which are membrane domains rich in
cholesterol and sphingolipids [39]. Lipid rafts themselves may be mechanosensitive with the
ganglioside GM1 having been shown to accumulate in lipid rafts in endothelial cells in response
to deformation, prior to talin accumulation [40]. Clustering of GM1 lipid rafts has also been
associated with enhanced β1 integrin adhesion, cortical F-actin polymerization, and shear
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resistance in T cells [41]. Cholesterol depletion from lipid rafts has been shown to inhibit
phosphorylation of Src and FAK and subsequent dislocation of FA components [42]. Actin
disruption following cholesterol depletion has also been associated with the reorganization of the
phospholipid phosphatidylinositol 4,5-bisphosphate, a key F-actin regulatory molecule [43].
Furthermore, the cholesterol metabolite 25-hydroxycholesterol has been implicated in activation
of integrin-FAK signaling [44].
Another class of proteins that play a key role in the mechanotransduction pathway is the
ezrin/radixin/moesin (ERM) protein family. ERMs structurally link the actin cytoskeleton to the
cell membrane and govern interactions between transmembrane proteins and associated
cytoplasmic proteins [45]. Regulation of ERMs is carried out by phosphorylation at numerous
serine, tyrosine, and threonine residues. One highly conserved threonine residue (Thr567,
Thr564, and Thr558 on ERM, respectively) is critical in the full activation of ERMs [46]. In the
cytoplasm, ERM exists in a closed state. In a proposed model, ERMs are recruited to membrane
domains rich in phosphatidylinositol 4,5-bisphosphate (PIP2). Upon interacting with PIP2, ERMs
partially unfold revealing the conserved threonine residues. When phosphorylated, ERMs switch
to an open conformation revealing the actin and membrane binding sites [45, 47]. NIH3T3
fibroblasts transfected with constitutively active ezrin had increased cell migration speed as well
as reduced cortical stiffness. Conversely, fibroblasts transfected with constitutively inactive ezrin
showed no alteration in cell migration or cell stiffness [48]. Moesin has been shown to be critical
to the transduction of cell shape signals through integrin 𝛽3 [49]. ERMs have also been shown to
critical to maintain cortical stiffness during mitosis and determining apical polarity [50].
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3.4. Importance of Cellular Biomechanics to the Study of Atherosclerosis
Atherosclerosis is primarily viewed as a disease of lipid dysfunction and the role of lipids in
disease progression is well understood. Given that, current methods for the prevention and
treatment of atherosclerosis focus primarily on reducing cholesterol and lipid levels through the
use of drugs such as statins as well as lifestyle changes [11]. However, a multitude of changes to
the ECM and concurrent changes to arterial stiffness are also known to occur, creating diverse
microenvironments within the artery and plaques. Furthermore, mechanosensitive proteins
including integrins have been shown to regulate proinflammatory pathways [51] and appear to be
important contributors to disease progression [52–56]. Cell mechanics, such as VSMC stiffness,
have also been demonstrated to contribute to vascular stiffness in hypertension [57]. Given these,
VSMC biomechanics may be a significant contributor to atherosclerosis and play a crucial role in
disease progression. Understanding altered VSMC biomechanics could provide novel insights
into the progression of atherosclerosis. In turn this could lead to the discovery of new pathways
to target with therapeutics or mechanics themselves may be a direct target. This could help to
modulate phenotypic switching for example, keeping VSMCs in a protective role or helping to
keep the fibrous cap intact.
4. Electrospinning Vascular Grafts
4.1. Statistics
Nearly 200 million people have CHD and 113 million people suffer from peripheral artery
disease (PAD) [58]. In the United States, an estimated 20 million people suffer from CHD and
6.5 million people have PAD, with 365,000 people dying from CHD and 70,000 from PAD in
2018 [59]. Graft bypass surgery is one of the most common treatments for CHD with an
estimated 371,000 surgeries performed in 2014 in the United States [59]. Open revascularization

17

surgery for the treatment of PAD is needed in cases of critical limb ischemia or where
endovascular intervention is unsuitable [60, 61]. The rise of these diseases has created an everpresent demand for suitable vascular grafts.
4.2. Current Vascular Grafts
Autologous vessel grafts are considered to be the gold standard for bypass and
revascularization surgeries, with the greater saphenous vein (GSV) considered the vessel of
choice by many [62]. However, between 20 and 40% of patients lack a suitable GSV due to it
being too small, previous removal, or disease [62–64]. Alternative vascular conduits include
internal mammary, radial, and internal thoracic arteries as well as the lesser saphenous and arm
veins [62, 65–68]. Many of the same availability issues seen with the GSV arise with these
vessels as well and the use of some of these vessels, such as the arm vein, results in reduced
patency of the graft [62]. Therefore, there is a need for an alternative to autologous vessel grafts.
Allograft and xenograft vessels prepared by cryopreservation or decellularization to reduce
immunogenicity have been used as an alternative to autologous vessels but generally suffer from
lower patency. This has attributed to increased thrombogenicity, host immune response, and
increased calcification [69–72]. Synthetic grafts composed of expanded polytetrafluoroethylene
(ePTFE) and polyethyleneterephthalate (Dacron) have been used clinically since the 1950s for
the replacement of medium to large diameter vessels. For small diameter vessels (<6mm in
diameter), however, these synthetic grafts are prone to failure due to rapid occlusion and acute
thrombogenicity. This has been attributed to a mismatch of mechanical properties and poor
endothelialization [73, 74]. Tissue engineering represents a promising approach to overcome the
shortcomings of currently available vessel grafts.
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4.3. Properties of an Ideal Tissue Engineered Vascular Graft
An ideal small diameter tissue engineered vascular graft (TEVG) would replicate the biological
and mechanical properties of autologous vessels and be able to function in the low flow, higher
resistance hemodynamic environment that exists in small diameter vessel [74, 75]. Several
design criteria would have to be met to develop a viable TEVG. The TEVG would have to be
biocompatible such that it is nonimmunogenic and nonthrombogenic, properties that are
associated with a fully developed and functional endothelium. It would have to have similar
mechanical properties as the native vessel, able to withstand hemodynamic forces immediately
upon implantation and over the long term while also not being susceptible to permanent
deformation that could lead to an aneurysm. In addition, a successful TEVG would need to elicit
a good healing response to minimize inflammation and avoid intimal hyperplasia and fibrosis. A
biologically active TEVG would also be beneficial to induce remodeling, allowing for the
growth of an endothelium and the infiltration of VSMCs to successfully integrate into the
vasculature. Finally, from a surgical perspective, the TEVG needs to compliant enough for
handling and strong enough to hold sutures for implantation [73, 76, 77].
4.4. Techniques to Produce TEVGs
Various techniques have been employed to create TEVGs such as casting [78], self-assembly
[79], 3D bioprinting [80], and decellularized scaffolds [81]. However, with the exception of
decellularized scaffolds, many of these methods fail to mimic the structure of natural ECM,
which is a key component to the regeneration and remodeling of tissue [82]. One promising
method for the production of TEVGs that addresses this concern is electrospinning.
Electrospinning a polymer solution results in the production of nanofibers that recreates the
natural structure of ECM. Fiber structure, diameter, topology, and mechanical properties are
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readily tunable by adjusting various operating parameters. Furthermore, electrospinning can
utilize a wide variety of polymers and blends to further tune the scaffold’s properties and various
bioactive compounds can be incorporated into the fibers to improve remodeling of the scaffold
into the native vasculature.
4.4. Electrospinning
Electrospinning was first discovered in 1887 and mathematically described in the 1960s in a
series of papers by Geoffrey Taylor [83–86]. In the simplest set-up, electrospinning involves a
high voltage DC power supply, syringe pump, spinneret (typically a blunt hypodermic needle),
and a collector. For vascular tissue engineering a rotating mandrel is generally used as the
collector to produce a tubular shaped graft. During electrospinning, a droplet of liquid is emitted
from the spinneret. This droplet becomes electrically charged and deforms due to electrostatic
repulsion forming a Taylor cone. A jet is emitted from the apex of the Taylor cone, forming a
long, thin strand of liquid. This strand initially travels straight as it is stretched and elongated
within the electric field. At various points the electrostatic repulsion within the strand is great
enough for bending instability to occur causing the strand to further stretch into a series of coils
and accounts for most of the reduction in diameter of the fiber [87]. At smaller diameters, the
solvent evaporates quickly allowing the fiber to solidify and accumulate on the collector.
All the set-up parameters (voltage, distance to collector, flow rate, and needle diameter)
are readily adjustable and allow for fine tuning to achieve the desired fiber diameter. In general,
higher voltage results in smaller fiber diameters although in some cases a higher voltage may
cause more liquid to be emitted and increase fiber diameter [88, 89]. Higher flow rates usually
result in increased fiber diameter. Increasing the distance between the spinneret and collector
generally results in thinner fibers up to a certain distance beyond which the fiber will have
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solidified and no further extension will occur [89]. However, there is a complex interplay
between each of these parameters that often requires numerous experiments to optimize the
operating parameters and achieve the desired fiber diameter [88]. Furthermore, additional factors
such as the polymer, solvent, and ambient conditions including temperature and humidity
influence the operating parameters and fiber diameter, requiring further optimization.
4.5. Synthetic Polymers for the Fabrication of Vessel Grafts by Electrospinning
4.5.1. Polylactic acid
Polylactic acid (PLA) is a renewable, bioresorbable, low-cost manufacturable synthetic material.
It has been wildly popular in different fields such as implantable biomedical devices, food
packaging, drug delivery systems and many more [90]. PLA is an aliphatic hydrophobic
polyester. There are three commonly used methods to synthesize PLA from the L, D lactic acid
monomers, including direct condensation, dehydration condensation, and ring-opening
polymerization (ROP) [91]. Lactide ROP pathway is the most practiced method in industrial
settings to produce high molecular weight PLA, and polymers can be customized to achieve
specific properties through the controlled ROP method [91]. PLA degrades naturally via
hydrolysis, and its by-product lactic acid is nontoxic to the human body. The degradation rate of
PLA is slow due to its hydrophobic methyl group [92]. The molecular weight and
stereochemistry determine the crystallinity of PLA, which then determines its mechanical
performance. Generally, higher crystallinity leads to higher PLA stiffness and toughness, and
vice versa [92, 93]. A few major disadvantages hinder the function and performance of PLA in
biomedical applications. Homopolymer PLA is very brittle, which limits its ability to withstand
high stress settings because it cannot undergo enough plastic deformation. Slow degradation rate
makes it unfit for shorter term implants. Hydrophobicity leads to low cell attachment and will
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further result in inflammation reactions [94]. To optimize PLA’s applicability in the biomedical
field, it can be blended with other polymers, such as polyglycolic acid, polyethylene glycol,
polycaprolactone, etc. to increase the hydrophilicity, flexibility, and elasticity, respectively [91].
In one study, Shalumon et al. [95] created a multilayered PLA tubular scaffold. Initially,
aligned PLA fibers were collected on a rotating mandrel after which the aligned mat was
wrapped around a tubular form and fused with a concentrated PLA in chloroform solution.
Multilayered scaffolds were generated by wrapping additional PLA mats around the form and
fusing them. An outer layer composed of a 50:50 PLA/polycaprolactone (PCL) blend was then
electrospun onto the tubular scaffold. The inner aligned PLA was selected to support ECs while
the more porous PLA/PCL layer was selected to support the growth and infiltration of VSMCs.
The bilayer graft composed of one inner PLA and one outer PLA/PCL layer had good
mechanical stability and the multilayered grafts with additional PLA layers showed enhanced
mechanical properties. Human umbilical vein endothelial cells (HUVECs) and human umbilical
artery smooth muscle cells (HUASMCs) were seeded onto the inner and outer layers,
respectively. After 48 h, HUVECs had aligned and elongated in the direction of the aligned PLA
fibers while the HUASMCs spread well and showed good actin organization. The scaffold
supported the proliferation of both cell types similarly over the course of 96 h. The functionality
of the HUVECs was assessed by measuring acetylated-low density lipoprotein uptake and nitric
oxide (NO) production and the HUVECs present were found to be functional, mimicking the
behavior of ECs in native vessels.
4.5.2. Polyglycolic Acid
Among many biodegradable biomaterials, polyglycolic acid (PGA) is considered to be the first
synthetic biodegradable polymer used for biomedical applications [96]. It was used in the first
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biodegradable synthetic sutures under the tradename “DEXON®” [97]. Although PGA is much
like PLA in terms of structure and degradation pathway, it lacks a methyl group thus making it
hydrophilic and degrade in the presence of water. PGA possesses great mechanical strength due
to its high crystallinity, and excellent controlled degradation while maintaining its shape in
organic solvents due to its low solubility. With a glass transitional temperature in the range
between 35°C and 40°C, PGA degrades under physiological conditions. However, rapid
degradation and a toxic by-product are two major limitations of PGA. The ability to degrade
within weeks (depending on specific molecular weight) is beneficial in some instances such as
for short-term implants but is also a significant drawback because the mechanical properties are
compromised [96]. Although PGA is considered to be non-toxic, its degradation by-product
glycolic acid can acidify the local environment and result in inflammation [98]. To resolve these
challenges, it is more common to copolymerize PGA with PLA to form poly(lactic-co-glycolic)
acid (PLGA) copolymer to optimize their mechanical properties and degradation rate.
Hodge and Quint took advantage of the rapid degradation of PGA, developing a TEVG
by electrospinning PGA while simultaneously electrospraying polyethylene oxide (PEO) [99].
After rinsing with deionized water, the PEO was removed resulting in a more porous scaffold.
The PGA grafts were seeded with human dermal fibroblasts to promote collagen deposition and
cultured under pulsative flow at 160 cycles per minute for 10 weeks. The PGA rapidly degraded,
allowing for rapid migration of the fibroblasts into the scaffold and formation of a collagen-rich
construct, with no residual PGA fibers being detected after 10 weeks. The cyclic mechanical
stretch provided by pulsative conditions resulted in significantly greater collagen content that
was evenly distributed throughout the wall of the graft compared to those cultured under static
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conditions. Likewise, the pulsative cultured grafts had much better mechanical properties, with
significantly higher ultimate tensile strength, elastic modulus, and burst pressure.

4.5.3. Poly(lactic-co-glycolic) acid
Poly(lactic-co-glycolic) acid (PLGA), the co-polymer of PLA and PGA, has been extensively
investigated since the 1970s to better tailor the properties of PLA and PGA [100]. PLGA is an
attractive polymer for use in tissue engineering as it is FDA approved and is already used in
absorbable sutures and meshes under the tradename “Vicryl®”. Furthermore, it has good
processibility, controllable degradation times, commercial availability, and excellent
biocompatibility [96]. In addition, PLGA is in an amorphous state up to 70% glycolide making it
less stiff than either of its co-polymers [100]. PLGA degrades through bulk erosion and
hydrolysis of the ester bonds. The degradation rate of PLGA is faster than either of its copolymers due to morphological changes that disrupt the more crystalline structure of its pure copolymers and can be adjusted by varying the lactide:glycolide ratio. The 50:50 co-polymer has
been shown to be relatively unstable, degrading in 1-2 months. Greater resistance to degradation
can be found at higher co-polymer ratios at either end of the spectrum, with the 75:25 copolymer degrading in 4-5 months and increasing to 5-6 months for the 85:15 blend [96, 101].
Wang et al. [102] developed a multilayered tubular PLGA graft by rolling an electrospun
PLGA sheet coated with fibrin glue around a 2 mm diameter mandrel (Figure 7). This method
allowed for the number of PLGA layers and thus wall thickness to be easily adjusted and allowed
for easy manipulation of mechanical properties, with a 5-layer graft having a burst pressure
similar to the GSV. Cells could be easily encapsulated within the scaffold by seeding cells on the
PLGA sheet prior to rolling the graft. C2C12 mouse myoblast cells seeded in the scaffolds
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demonstrated good viability and proliferation. Importantly, the cell-seeded scaffolds also showed
reduced leakage.

Figure 7. Wang et al. rolled PLGA mats with fibrin glue to create a multilayered scaffold. Cells
seeded in the scaffolds demonstrated good viability and proliferation. In addition, the cell-seeded
scaffolds also showed reduced leakage [102]. Reproduced with permission of MDPI.

The degradation properties of PLGA pose a potential issue in its use for a TEVG. In one
study, porcine smooth muscle cells grew on PLGA nanofibers for 30 days after which growth
slowed [103]. PLGA nanofibers have been shown to shrink in fluids including Dulbecco’s
Modified Eagle Medium (DMEM), simulated body fluid (SFB), and saliva [104]. This is due to
fluid-induced relaxation of the polymer chain and can increase hydrolytic and enzymatic
degradation. Any implantable medical device also must undergo sterilization, which has also
been shown to speed the degradation of PLGA. Chor et al. [104] found that gamma irradiated
electrospun PLGA scaffolds had low polymer molecular weight and enhanced hydrolytic
degradation in SBF and saliva compared to nonirradiated scaffolds. Since PLGA undergoes bulk
erosion, the mechanical properties of PLGA decrease as it degrades and may pose a problem for
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the long-term patency of a PLGA TEVG, especially, if it degrades before substantial remodeling
and integration can occur.
4.5.4. Polycaprolactone
PCL has many versatile properties including excellent biocompatibility, biodegradability, and
nontoxicity. It is a competitive biomaterial candidate for medical and clinical uses such as tissue
engineering scaffolds, drug delivery, surgical sutures, wound dressings, etc., attributed to these
merits [96]. There are two methods to synthesize PCL, including 6-hydroxyhexanoic acid
polycondensation, and epsilon-caprolactone ring-opening polymerization (ROP). ROP pathway
is more commonly practiced since it yields a more superior end product [105]. PCL has a semicrystalline structure. It has a low melting point at about 60°C and a glass transition temperature
at about -60°C. Therefore, under physiological conditions, it maintains great mechanical
properties such as high toughness, strength, and elasticity. A general degradation period for PCL
implants is about 2 to 3 years and the degradation mechanism is usually undergone by the
indwelling microorganism's digestion and through ester linkage hydrolysis [106]. Caproic acid,
one of the degradation products, is non-toxic to the local tissues and can be reabsorbed by
metabolic processes or excreted through the renal system [107]. Although PCL possesses many
talents as a biomaterial, its limitations in tissue engineering need to be addressed and overcome
with novel solutions. PCL alone as a tissue engineering scaffold exhibits a slow degradation rate,
low cell attachment, and poorly matched mechanical properties. Blending PCL with other
materials is a potential remedy to overcome these challenges [108].
In a long-term study in a rat model, de Valence et al. implanted PCL vascular grafts into
the infrarenal abdominal aorta for up to 18 months [109]. Over the time course of the study, the
compliance of the PCL grafts was hypothesized to improve due to degradation and remodeling.
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While the grafts did experience significant degradation, especially after 6 months, little change in
compliance was found. The lumen of the grafts was rapidly covered in ECs and a small amount
of intimal hyperplasia developed after 1.5 months and remained stable through 18 months.
However, by 12 months VSMCs began to regress and the intimal hyperplasia was primarily
composed of collagen layers. Furthermore, calcification was noted to begin at 1.5 months and by
12 to 18 months extensive calcification was noted with the presence of compact bone and
osteocytes. Within the graft wall, macrophages infiltrated for the first 6 months then retreated. A
similar process was noted with vascularization of the grafts with capillaries forming over the
course of the first 6 months and then regressing at 12 to 18 months. At 18 months, the interior of
the graft wall was observed to be devoid of cells and only contained collagen, which could
explain the lack of change in compliance. It was noted that this could be due to the lack of
stimulating cues to direct the remodeling of the graft wall. Despite these issues, all grafts
remained patent over the course of the study.
4.5.5. Poly(L-lactide-co-𝜀-caprolactone)
Poly(L-lactide-co-𝜀-caprolactone) (PLCL), a co-polymer of PLA and PCL, has been investigated
for its potential use in constructing TEVGs. PLCL, an amorphous polymer with the PCL
disrupting the more crystalline nature of PLA, exhibits better mechanical properties than PLA.
Similar to PLGA, the properties of PLCL can be tailored by adjusting the ratio of the copolymers. Increasing the caprolactone content increases the elastomeric properties of the
polymer with a 70:30 PLCL co-polymer having a Young’s modulus of 12 MPa, significantly
softer than PLA and comparable to the stiffness of native vessels [110, 111]. However, PLCL
co-polymers do have relatively low glass transition temperatures, making several blends
metastable at temperatures ranging from room temperature to body temperature and may
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undergo drastic change in mechanical properties. The 70:30 PLCL co-polymer has been shown
to undergo significant changes during storage at room temperature in as little as 3 weeks with its
elastic modulus increasing from 12 to 128 MPa [111]. Despite this, PLCL nanofibers have been
shown to support VSMC growth up to 3 months with the nanofibers having a half-life of 110
days [103].
In one study, Mun et al. [112] developed an electrospun vascular graft using 50:50 PLCL.
2D mats of electrospun PLCL were seeded on both sides with New Zealand white rabbit VSMCs
and then rolled on 4 mm diameter mandrels using fibrin to glue the layers together. The grafts
were then cultured under static or dynamic conditions. For the dynamic conditions, a peristaltic
pump was used with gradually increasing pressure over the first week after which the pump head
was switched to a pulsative one for the second week to better mimic in vivo conditions. Pressures
were gradually increased such that over the last 4 days of culture, the graft was subject to
systolic/diastolic pressures of 120/80 mmHg. After 2 weeks, dynamically cultured grafts had
significantly higher burst pressure and collagen content compared to the statically cultured grafts
indicating significant remodeling of the graft was occurring. A confluent layer of VSMCs was
observed on the outer surface and were present on all layers of the dynamically cultured graft
compared to just a few on the statically cultured one.
Horakova et al. [113] created a tubular graft from 70:30 PLCL. In vitro studies showed
that PLCL scaffolds better supported viability and proliferation of 3T3 mouse fibroblasts and
endothelial cells after 14 days in static culture compared to PCL scaffolds. This was attributed to
the more hydrophilic PLCL allowing for better cell adhesion. Long-term patency studies were
done in New Zealand white rabbits using an end-to-side coronary bypass procedure. Full cell
penetration was observed at 10 weeks and after 6 months a confluent endothelium and layers of
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VSMCs were found. After 10 weeks, however, 4 of 5 grafts remained patent, while after 6
months only 1 of 5 grafts maintained full patency. These were attributed to thrombotic events
(both at 10 weeks and 6 months) and the loss of mechanical properties from degradation of the
grafts (at 6 months). It was noted that the long-term mechanical properties could be improved
with a thicker graft as the graft wall was only 100 μm thick compared to 200-300 μm for the
coronary artery wall.
4.5.6. Polyurethanes
Polyurethanes (PUs) are a diverse group of polymers with a wide variety of mechanical
properties, good biocompatibility, and anti-thrombogenic properties. PUs are thermoplastics
composed of hard and soft segments. Under strain, the soft segments will deform and elongate
while the hard segments stabilize the structure and ultimately allow it to return to its original
shape. Electrospun PU has been shown to closely match the circumferential tensile strength of
human bloods vessels and a nonlinear stress-strain curve or J-shaped response mimicked those
seen in natural vessels that was maintained after cyclic loading. Specifically, the toe region (a
region of low slope prior to the linear region) that corresponds to the unfolding of elastin fibers
was reproduced by collecting PUs on a mandrel with a wavy cross section [114]. Adjusting the
length and type of the hard and soft segments allows PUs to achieve unique and desirable
properties. By utilizing polyesters such as PLA, PGA, and PCL or polyethers as the soft
segments, PUs can be made to be biodegradable. Typically, the hard segments of PUs are
composed of diisocyanates, the most common being 2,4-toluene diisocyanate and 4,4’methylenediphenyl diisocyanate and are toxic degradation products. To overcome this, non-toxic
diisocyanates such as lysine-diisocyanate, hexmethylene diisocyanate, and 1,4diisocyanatobutane have been used [96, 115]. A potential issue with the use of PUs is biostability
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for those containing polyesters and polyethers as soft segments, which undergo hydrolysis and
oxidation, thus reducing mechanical properties and can lead to graft failure [116]. The PUs
Tecoflex and Pellethane have been shown to maintain their mechanical properties for 6 months
after implantation into the abdominal aorta of Wistar rats [117]. Using next generation
sequencing gene expression profiling, HUVECs cultured on electrospun Tecoflex scaffolds
showed similar gene expression to HUVECs cultured on decellularized human umbilical vein
[118].
Several groups have created TEVGs from PUs. Bergmeister et al. [119] implanted
Pellethane electrospun grafts into the infrarenal aorta of male Sprague-Dawley rats. Across all
time points 95% of the grafts remained patent. One-week post-implantation, CD34+
hematopoietic stem cells were observed on the luminal surface and after 1 month, the luminal
surface was covered with endothelial cells. After 3 months, actin+ myofibroblasts and vimentin+
fibroblasts were observed throughout the graft wall while desmin+ SMCs were only found in the
outer third of the graft wall. However, at 6 months, the population of actin+, vimentin+, and
desmin+ cell decreased compared to 3 months and the proportion of cell-free voids also
increased. This was attributed to a mix of cell death and lack of cell penetration and was
hypothesized that larger voids could improve this. Another study compared HUVEC attachment
and proliferation on electrospun PU grafts to PTFE grafts and found HUVECs had better
attachment and proliferation on the electrospun PU grafts. Furthermore, the grafts had good
tensile strength (5.85 ± 0.62 MPa), flexibility (elongation 294.5 ± 19.4%), and porosity (50-60%)
[120].
One newer PU that has shown promise for vascular tissue engineering is degradable polar
hydrophobic ionic PU (D-PHI). The hydrophobic, ionic, and polar regions of D-PHI can be
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selected to optimize physical properties, while maintaining good cytocompatibility and
promoting cell adhesion [121]. D-PHI has been shown to have only a slight effect on blood
clotting over negative control albumin-coated substrates, with slightly higher whole blood
clotting and platelet activation. No activation of the intrinsic blood clotting pathway was
observed while there was mild activation of the extrinsic pathway, which may play a beneficial
role in the wound healing response rather than excessive blood clotting [122]. Chan et al. [123]
developed an electrospun scaffold containing D-PHI. To achieve the proper viscosity for
electrospinning, D-PHI was mixed with a polycarbonate PU (PCNU) and UV crosslinked in
midair before being collected on a rotating mandrel. The D-PHI/PCNU scaffolds were more
hydrophilic and significantly softer than PCNU films. Scaffolds implanted into Wistar rats
showed slow degradation over 90 days, maintaining their thickness while also having good
integration with the surrounding tissue. VSMCs showed good viability and proliferation on the
scaffolds and continued to express 𝛼-smooth muscle actin (α-SMA) after 7 days of culture.
4.6. Natural polymers for the Fabrication of Vessel Grafts by Electrospinning
4.6.1. Collagen
Collagen is the most abundant mammalian protein and is an excellent biomaterial for tissue
engineering applications. Collagen proteins have four structural hierarchies and at least 28
different types of collagen exist in vertebrate tissues varying in the length of the molecule and
the number and characteristics of the carbohydrates attached on the helix, but they all have the
triple helix structure in common [124]. There are six collagens found in the vascular wall with
collagen types I and III being the most prevalent, constituting a major portion of ECM, and types
IV, VI, XV, and XVIII found in basement membranes [125]. Having similar chemical
compositions as the native tissue, collagen scaffolds aid in cell attachment and migration,
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therefore they can interact and be integrated with the local tissues over time [126]. They also
have excellent biodegradability and can be degraded by enzymes within the human body,
particularly MMPs [124]. Regardless of these merits of collagen, major limitations prevent it
from being widely used for biomedical applications such as its poor mechanical properties and
rapid degradation rate [126]. A promising solution is to blend collagen with other materials such
as proteoglycans and glycosaminoglycans (GAGs) to reduce the degradation rate, and to improve
the mechanical behavior such as elasticity and fracture energy. Gelatin, a derivative of collagen,
is commonly used in polymer blends for electrospinning to improve the biocompatibility of
synthetic polymers, though it must be crosslinked to prevent rapid degradation [127].
4.6.2. Silk Fibroin
Silk is renowned for its strength and elasticity, often exceeding those of synthetic polymers,
making it of particular interest in the field of tissue engineering [128]. The most extensively used
silk in tissue engineering comes from the domesticated silkworm Bombyx mori. Raw silk
cocoons are composed of two proteins: the adhesive sericin and silk fibroin (SF). SF is extracted
through a multistep purification process involving degumming to remove sericin, dissolution,
and dialysis to remove impurities [129]. SF is composed of a light chain and heavy chain
polypeptide linked together by a disulfide bridge. The heavy chain polypeptide consists of
hydrophilic and hydrophobic domains. The hydrophobic domain form crystalline 𝛽-sheets while
the hydrophilic regions form interspersed semi-amorphous regions. The crystalline 𝛽-sheets give
SF its strength and stiffness while the semi-amorphous region lend SF its extensibility and
toughness. However, regenerated silk fibroin does lose a great deal of its mechanical properties
due to the degumming and dissolution processes [130]. Similar to synthetic co-polymers and
PUs, the mechanical properties and degradation of SF is tunable, particularly by modulating the
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formation of 𝛽-sheets via heating or solvent exposure. 𝛽-sheet formation essentially renders SF
immune to degradation in water or biological salt solutions and SF mainly degrades by surface
erosion through the action of proteases and immune cells. Increased 𝛽-sheet content slows
degradation as most proteases act outside of 𝛽-sheets [131]. Like all implantable polymers, SF
does elicit an immune response. The formation of fibrosis tissue has been noted early after
implantation and decreases with time and unlike synthetic polymers does not result in fibrotic
encapsulation [131]. The thrombogenic properties of SF are disputed. Studies of silk sutures and
vascular grafts from the 1980s demonstrated the thrombogenic potential of SF [132, 133].
However, like mechanical and degradation properties, the processing parameters of SF have been
shown to influence its thrombogenicity, with no single parameter successfully predicting blood
compatibility [134].
Electrospun TEVG were produced by Marelli et al. [135] using SF dissolved in formic
acid. After electrospinning, the grafts were treated with methanol which enhanced 𝛽-sheet
formation and the crystallinity of SF. The compliance at physiological pressures was 3.51 ±
0.42% radial deformation per mmHg × 10-2, slightly lower than the compliance of the saphenous
and umbilical veins. The SF graft was able to withstand pressures up to four times physiological
levels (575 ± 17 mm Hg), but much lower than the coronary artery (5000 mm Hg) and saphenous
vein (2250 mm Hg). Despite the somewhat lackluster mechanical properties, the SF tubes
showed good cytocompatibility when cultured with 3T3 fibroblasts. Importantly, 3T3 fibroblasts
were observed to pass through the graft wall after 5 days, indicating sufficient porosity to allow
cell migration.
In a novel manufacturing approach, Alessandrino et al. [136] created a three-layer SF
scaffold called SilkGraft composed of an inner and outer layer of electrospun SF with a braided
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degummed SF yarn layer in between, which lent strength to the scaffold. A burst pressure of
2308 mm Hg was close to that of the internal mammary artery (3196 ± 1264 mm Hg) and the
saphenous vein (1599 ± 877 mm Hg). The SilkGrafts were seeded with human endothelial cells
on the luminal surface and with human VSMCs and adventitial fibroblasts on the outer surface.
Cell adhesion on SilkGraft was two-fold better compared to polystyrene tissue culture plates and
after 20 days normalized cell number was significantly higher for VSMCs and fibroblasts on
SilkGraft. The SilkGraft did not induce biologically relevant compliment activation, nor did it
exert hemolytic activity or alter red and white blood cell counts. Long-term in vivo pilot studies
were performed in the carotid artery of minipigs and sheep. No thrombosis was observed after 4
weeks in either minipigs or sheep. SilkGrafts in minipigs did have slight neointimal hyperplasia
and endothelium lined the lumen. No hyperplasia was observed in sheep and endothelialization
was restricted to the ends of grafts which was attributed to the slower proliferation of endothelial
cells in sheep. SilkGrafts in both animals elicited a foreign body response similar to other SF
grafts.
4.6.3. Polysaccharides
Polysaccharide-based biomaterials have been investigated as a candidate for tissue engineering
applications because their biomimicry, non-toxicity, biodegradability and ease of manufacture
[137]. Common polysaccharides used in biomedical applications can be found in naturally
occurring plants and animals, such as cellulose and amylose from plants; chitin from insects and
crustaceans; and glycosaminoglycans from the mammalian connective tissues [137]. They are
generally high molecular weight carbohydrates composed of repeating or alternating units of
monosaccharides, linked by glycosidic linkages. Because polysaccharides have similar chemical
composition to human tissue, it is easier for cell attachment and integration with the surrounding
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tissue to occur. The biggest challenge of this type of biomaterial is weak mechanical strength,
and an effective solution is to blend it with other natural polymers to increase the mechanical
performance. Polysaccharide biomaterials are usually degraded by specific enzymes and the rate
of degradation depends on the type and molecular weight of the material [138]. Recent research
has found that cellulose-based scaffolds provide excellent mechanical strength for bone tissue
engineering [139]. Sulfated-polysaccharide-based scaffolds show great potential in orthopedic
tissue engineering scaffolds credited with its high porosity, biomimicry, competent mechanical
performance [140]. Li et al. demonstrated that oxidized pectin electrospun mats supported the
differentiation of mesenchymal stem cells into ECs and VSMCs, with the softer 25% oxidized
mats better supporting EC differentiation and the stiffer 50% oxidized mats supporting VSMC
differentiation [141].
Chitosan is a natural amino polysaccharide derived from chitin with a structure analogous
to GAGs found in the ECM [142]. Chitosan is generally used in blends for vascular tissue
engineering due to its lack of suitable mechanical properties. A particularly common blend is one
with chitosan and collagen due to their ability to form a complex with one another and mimic the
natural ECM [142–144]. Chen et al. demonstrated that ECs and VSMCs proliferated well on
chitosan/collagen electrospun mats, particularly at chitosan concentrations of 20% and 50%.
However, the addition of chitosan greatly reduced the ultimate tensile strength and elastic
modulus of the mats [142]. PLA has been added, as a blend and co-electrospun, to improve the
mechanical properties of the chitosan/collagen blend which has the added benefit of reducing the
hydrophobic nature of PLA [143, 144]. PCL has also been utilized to improve the mechanical
properties of chitosan for vascular grafts while also using chitosan to deliver the anti-thrombotic
drug heparin and vascular endothelial growth factor (VEGF) [145, 146].
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4.7. Polymer Summary
A wide variety of synthetic and natural polymers have seen use in the development of an
electrospun TEVG. A brief summary of the advantages and disadvantages of the discussed
synthetic polymers are listed in Table 1. These polymers share similar disadvantage namely
degradation/biostability (PGA, PLGA, PLCL, and PUs), hydrophobicity (PLA and PCL), and
mismatched mechanical properties (PLA and PCL). Furthermore, all of these benefit from the
addition of bioactive molecules to improve cell attachment and proliferation. On the other hand,
the main issue with natural polymers is lack of mechanical properties making the use of
unmodified natural polymers unlikely. PCL is by far the most commonly used polymer in
vascular grafts and its main drawback of hydrophobicity can be overcome by blending with
natural polymers or through the addition of bioactive molecules.
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Table 1. Brief summary of the advantages and disadvantages of selected synthetic polymers
Polymer Advantages
Disadvantages
Polylactic acid Slow degradation
Currently used in several
biomedical applications
Polyglycolic acid High strength and
crystallinity
Current use in biomedical
applications such as sutures
Poly(lactic-co-glycolic) acid Tunable mechanical
properties and degradation
rates by adjusting
lactide:glycolide ratio
Current use in biomedical
applications
Polycaprolactone Slow degradation
Great mechanical properties
including strength and
elasticity

Poly(L-lactide-co-𝜀- Tunable mechanical
caprolactone) properties by adjusting copolymer ratio

Hydrophobicity limits cell
attachment
Brittle
Rapid degradation (within
several weeks) severely limits
potential use in TEVG
without combining with other
polymers
Relatively fast degradation
(up to 6 months) which can
be sped up by sterilization
and enzymatic degradation
Undergoes bulk erosion
Hydrophobic character limits
cell attachment and
proliferation
Mismatched mechanical
properties poses a potential
issue
Several blends are metastable
and can undergo drastic
changes in mechanical
properties

Slow degradation
Stiffness comparable to
native vessels
More hydrophilic than its copolymers
Polyurethanes Tunable properties based on
chosen soft and hard
segments
Capable of replicating the Jshaped response seen in the
stress-strain curves of native
vessels
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In vivo studies showed a loss
of mechanical properties after
6 months which could be
improved with thicker grafts

Potential biostability issues
depending on PU used

4.8. Polymer Blends
Very few electrospun grafts are made using a single pure polymer without modification.
Synthetic polymers generally have great, tunable mechanical properties including stiffness and
elasticity but are typically hydrophobic and lack a suitable interface for cells to adhere to, spread,
and proliferate on. On the other hand, though they possess great biocompatibility and cell
affinity, natural polymers lack the mechanical strength needed for the dynamic environment
found in arteries. Thus, most research today focuses on combinations of polymers, typically a
mix of synthetic and natural, either mixed together in solution as a blend, co-electrospinning of
polymers simultaneously, or in a multilayer fashion, which will be discussed in the following
section. Here we discuss some promising polymer blends and co-electrospun polymers for use in
the construction of TEVGs.
One common polymer blend used in the development TEVGs is an elastic PU mixed with
a stiffer polymer to mimic the behavior of elastin and collagen, respectively. The goal of these
blends is to mimic the nonlinear mechanical behavior of natural vessels; in particular the region
of low strain referred to as the toe region or a J-shaped response. In the J-shaped response, low
strain produces low stress corresponding to the elastic response of elastin fibers. At higher
strains, stress is greatly increased due to the stretching of collagen fibers. In a study using
synthetic polymers, Montini-Ballarin et al. [147] developed electrospun TEVGs using segmented
PU and PLA. PLA and the PU PHD were chosen to mimic the mechanical behavior of elastin
and collagen, respectively, with the ultimate goal of creating a J-shaped mechanical response.
Two different ratios of PLA/PHD were chosen: a 50:50 and a 90:10 blend. The PLA/PHD grafts
had two layers, created by spinning different concentrations of polymer solution (20% wt/v for
the inner layer and 15% wt/v for the outer layer) and resulted in a layer separation of 100-200
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𝜇m. This was a desired outcome as the J-shaped response was hypothesized to result from the
response of the inner layer to low pressure ranges followed by support from the external layer
after a certain level of deformation is achieved. Anisotropy between the axial and circumferential
directions was found, similar to the behavior seen in natural vessels but to a lesser extent and a Jshaped mechanical response was noted at low strains (<10%). Young’s modulus, ultimate tensile
strength, and ultimate tensile strain were in the range of those seen in the coronary, mammary,
and radial arteries and the saphenous vein. A J-shaped response was more clearly seen in the
mechanical behavior in response to pressure though the response was more rigid (lower
compliance) than that seen in young vessels and more similar to older vessels. Burst pressures
were less than native vessels but exceeded physiological pressures. Mi et al. [148] used another
synthetic blend of PU and PCL. A 7:3 and 1:1 blend of PU/PCL had modulus and
circumferential strength closest to that of native vessels, particularly at lower electrospinning
volumes of 0.6 and 1.1 mL. The blends also showed good recovery from cyclic loads after initial
loading due to hysteresis. Compliance values of 1.5 to 5.4% per mmHg × 10-2 were similar to
that of veins but lower than that of arteries. In addition, the PU/PCL grafts showed sufficient
suture retention strength and burst pressure. Live/Dead stain and MTS proliferation assay on
HUVECs cultured on the 1.1 mL 1:1 PU/PCL showed high biocompatibility though proliferation
on pure PCL was greater. In another study, Yu et al. [149] utilized the PU Tecoflex blended with
the natural polymer SF at different ratios with a concentration of 12% wt/v in
hexafluoroisopropanol (HFIP). PU/SF ratios of 2:1, 1:1, and 1:2 were used in the study. The 1:1
PU/SF scaffolds had the highest ultimate tensile stress and strain and the lowest modulus of the
three ratios tested. The 2:1 and 1:2 blends had similar mechanical properties due to the greater
amount of the stiff SF in the 1:2 blend and conglutination of fibers in the 2:1 blend which
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increased stiffness and limited extensibility despite the presence of more PU. All blends
produced cyclic loading results similar to that of the coronary artery with the 1:1 PU/SF blend’s
behavior falling in the middle of the upper and lower bounds for the coronary artery. The 1:1
blend was chosen for cell studies due to its similar mechanical properties and decent suture
retention strength and surface wettability. Live/Dead staining showed good EC viability after 14
days in static culture. When seeded at a higher density, ECs were able to completely cover the
surface after 5 days and more cells were clearly present on the PU/SF blend graft compared to a
PU graft indicating that SF greatly enhanced the biocompatibility of PU.
Fibrin is a natural polymer that forms the protein scaffolding of blood clots and plays a
major role in the wound healing response and displays very favorable qualities for use in
vascular tissue engineering including high biocompatibility, non-immunogenic, tunable
biodegradability, and high affinity for biological surfaces [150, 151]. However, fibrin alone lacks
the mechanical strength needed for use in TEVGs [150]. To take advantage of the excellent
biological properties of fibrin, Yang L. et al. [152] constructed a TEVG using a blend of
electrospun fibrin and PU to provide mechanical support. PU was dissolved in a mix of
tetrahydrofuran (THF) and dimethylformamide (DMF) and fibrin was dissolved in formic acid to
prepare PU/fibrin blends of 5:95, 15:85, and 25:75. As the PU content of the graft increased so
too did the mechanical properties and hydrophobicity, though the elastic modulus did decrease,
and degradation rates also decreased. The suture retention strength and burst pressure of all three
were sufficient for implantation and all three showed good hemocompatibility. However, at 25%
PU in vitro proliferation of mesenchymal stromal cells was significantly reduced. Thus the 15:85
PU/fibrin graft was selected for animal studies in SD rats. At 3 months post-implantation the
PU/fibrin grafts were visually indistinguishable from the native artery. The mechanical strength
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and function were similar to native arteries and were better than a PU graft. Decent remodeling
of the PU/fibrin graft took place in vivo with deposition of ECM proteins similar to the native
artery and the formation of an endothelium and intima, all of which were greatly reduced on the
PU graft. The 15:85 PU/fibrin graft proved to be viable candidate for a TEVG with the addition
of fibrin greatly improving the biocompatibility of PU grafts. The same group also found that a
20:80 PCL/fibrin graft possessed good hemocompatibility and cytocompatibility as well as good
mechanical and degradation properties [153]. Nine months post-implantation in rats, the 20:80
PCL/fibrin grafts had undergone extensive remodeling and were virtually indistinguishable
visually from the native tissue. The PCL/fibrin graft showed an improved response to
vasoconstrictors compared to a PCL graft and similar response to vasodilators as the native
artery. In addition, a nearly continuous endothelium was observed on the luminal surface and
VSMC layer of comparable thickness to the native artery with similar expression of contractile
phenotype proteins. Similarly, the deposition and arrangement of ECM proteins including
collagen, elastin, and GAGs were not significantly different from the native tissue.
For one of the few preclinical large animal studies, Ju et al. [154] fabricated a TEVG
from a PCL/collagen type 1 blend. The graft was constructed as a bilayer with a 5% w/v
PCL/collagen blend for the inner layer and 18% PCL/collagen for the outer layer on a 4.75 mm
diameter mandrel. After electrospinning, the PCL/collagen grafts were crosslinked with 2.5%
glutaraldehyde. The grafts were then seeded with ECs and VSMCs and preconditioned in a
pulsatile bioreactor for 7 days. The pre-seeded grafts remained patent after 6 months in ovine
carotid artery while all 3 unseeded control grafts failed. The pre-seeded grafts underwent
extensive remodeling and had a well-organized ECM of collagen, elastin, and GAGs as well as a
full endothelial and VSMC layer. The seeded grafts had an improved contractility response
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compared to the unseeded grafts, though much lower than the native vessel. However, the
mechanical properties of the pre-seeded grafts were much improved after 6 months and quite
similar to the native artery.
4.9. Modified Electrospinning Techniques for Vascular Tissue Engineering
4.9.1. Multilayered Electrospun Vascular Grafts

Figure 8. Han F. et al. made a three-layered graft composed of an outer PCL/gelatin layer,
middle PLGA/gelatin + PDGF layer, and inner PLCL/gelatin + VEGF layer. The gelatin fibers
on the inner layer support rapid EC attachment and once degraded increased the porosity of the
outer and middle layers allowing for VSMC ingrowth [155]. Reproduced with permission of
Elsevier.

Multilayered electrospun vascular grafts are a promising choice as they can replicate the natural
multilayered structure of native vessels. A multilayered design allows for the tailoring of various
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properties through the choice of polymer, electrospinning parameters, or addition of bioactive
molecules to best suit the needs of the cell types found in each layer of the graft. Han F. et al.
[155] made a three-layered vascular graft designed for spatio-temporal delivery of VEGF and
platelet derived growth factor (PDGF) (Figure 8). An inner layer composed of 75:25 PLCL was
chosen for the quick release of VEGF to promote rapid endothelialization while a middle layer of
75:25 PLGA was selected for a slow release of PDGF for the formation of a VSMC layer. The
outer layer of PCL improved the mechanical strength of the graft, while also delaying the release
of PDGF. The mechanical properties of the three-layer graft were considerably higher than that
of the porcine coronary artery used for comparison (tensile strength 5.2 ± 0.7 MPa vs 2.6 MPa,
Young’s modulus 35.9 ± 7.7 MPa vs 1 MPa, elongation at break 146.7 ± 0.6% vs 100%,
respectively). However, burst pressure and suture retention strength were comparable to native
vessels. Though not seen in their 8-week in vivo study in New Zealand white rabbits, the
compliance mismatch could lead to intimal hyperplasia and restenosis.
Wu T. et al. [156] fabricated a three-layer graft with the inner two layers tailored to ECs
and VSMCs (Figure 9). The inner layer was composed of circumferentially aligned
PLCL/collagen nanofibers. HUVECs proliferated well on the aligned nanofibers but no
difference was observed between the aligned and random fibers. The HUVECs were observed to
orientate themselves along the nanofibers which may help promote the growth of an organized
endothelium and functioning ECs. The middle layer was composed of a PLGA/SF electrospun
yarn. PLGA/SF nanofibers were collected on a rotating funnel used to twist the fiber into yarn
and collected on a rod. The yarn was wrapped around the aligned PLCL layer. VSMCs
proliferated significantly better on the PLGA/SF yarns compared to PLGA/SF fibers due to its
more porous three-dimensional structure and were found to orientate themselves along the yarn.
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This would help VSMC function in the media wall. Finally, an outer layer of random
PLCL/collagen nanofibers was collected to keep the whole structure intact.

Figure 9. Schematic used by Wu T. et al. to create a three-layered graft. (A) Aligned
PLCL/collagen fibers were collected on a rotating mandrel. (B) A customized electrospinning set
up was used to generated PLGA/SF yarns comprised the middle layer by twining on the inner
layer. (C) A thin outer layer of random electrospun PLCL/collagen nanofibers was used to bind
the construct together [156]. Reproduced with permission of Elsevier.

In order to mimic the structure of a native artery, Wu C. et al [157] created a threelayered graft from PLGA and crosslinked gelatin. The inner and outer layers were comprised of
coaxial electrospun PLGA/gelatin, with a PLGA core for strength and a gelatin shell. HUVECs
proliferated well on the PLGA/gelatin fibers, nearly covering the surface after 5 days. The
middle layer had electrospun PLGA and served to enhance the mechanical strength of the graft.
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The radial tensile strength of the graft was comparable to the human aorta but much higher than
the coronary artery (5.13 MPa vs 5.49 vs 1.43 MPa, respectively). The axial tensile strength of
the graft was also higher than the aorta or coronary artery (3.14 MPa vs 1.47 MPa vs 1.30 MPa,
respectively). However, the three-layer graft did have sufficient suture retention strength.
Fiber orientation can also be used to delineate layers in a multilayered graft [158–160].
Elsayed et al. [158] orientated the syringe at 45˚ relative to the collector resulting in the collected
gelatin nanofibers having a 45˚ orientation. The syringe was flipped every 4 min resulting in
alternating layers with orientations of ±45˚ for a total of 16 layers after which the gelatin was
crosslinked. While the reported mechanical properties were lower than that of the coronary
artery, they were similar to those of the tunica media, the layer this method attempts to replicate.
Considering the additional 45˚ layers as well as axially orientated layers for the tunica intima are
intended to be added, the final version of this graft could have sufficient mechanical properties.
The alternating 45˚ orientation of the layers provided a highly porous structure for human
umbilical vein smooth muscle cell migration (HUVSMC), allowing them to migrate up to 240
µm into the scaffold after 9 nine days. The more porous structure also allowed increased
HUVSMC proliferation.
4.9.2. Fiber morphology and alignment
Electrospun fiber morphology and mechanics play a significant role in cell growth and
proliferation. Generally, bead-free fibers without conglutination are desired in electrospinning
applications. Fiber diameter in particular is known to have a strong influence on cell behavior.
3T3 fibroblasts have been shown to exhibit increased cell area and aspect ratio in response to
larger diameter fibers while no effect on proliferation was observed [161]. In one study, Han D.
et al. [162] reported the effect of increasing fiber diameter on VSMC proliferation, infiltration,
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and phenotype. PCL fibers with diameters ranging from 0.5 to 10 𝜇m were generated by varying
PCL concentration, solvent mix, and voltage. While increasing fiber diameter had no effect on
VSMC survival over the course of 10 days, slower proliferation was found with increasing
diameter. In contrast, infiltration of VSMCs into the PCL scaffold was noted to improve with
increasing fiber diameter, associated with the increased pore size found with the larger diameter
fibers. Somewhat quixotically, the ratio of VSMCs with a synthetic phenotype to total VSMCs
was observed to increase with larger fiber diameters after 10 days of culture. This same trend
was also observed in in vivo studies 7, 14, and 28 days after implantation into mice. These results
are intriguing as the synthetic phenotype is associated with VSMC proliferation and may have
been due to the greater infiltration of VSMCs in the larger fiber diameter scaffolds. Furthermore,
the number of activated macrophages was also observed to increase on scaffolds with larger fiber
diameters, which is important for the remodeling of the scaffold. In another study, Shen et al.
[163] analyzed the role of fiber diameter on cells ability to resist shear stress. Using electrospun
zein, the primary protein found in corn, aligned fibers with diameters of 112 ± 31 nm, 513 ± 80
nm, and 959 ± 147 nm were generated. While no difference in endothelial cell (EA.hy926 cells)
retention was observed on randomly orientated fibers of different diameter under 15 dynes cm-2
shear stress after 4 h, aligned medium diameter fibers had significantly higher cell retention at 1,
2, and 4 h under both parallel and perpendicular flow compared to the small and large diameter
fibers (the small diameter fibers also had significantly higher retention compared to the large
diameter fibers). When allowed to adhere on fibers for 2 days, EA.hy926 cells on medium
diameter fibers resisted shear stress under both parallel and perpendicular flow and under parallel
flow elongated in the direction of flow. Cells on the large diameter fibers, which were initially
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aligned along the fibers, changed to a more rounded morphology and eventually washed away
under both parallel and perpendicular shear stress.
Fiber morphology can also alter the mechanics of electrospun fibers. Within tissues,
collagen fibers have a crimped morphology that contributes to their elasticity. Chao et al. [164]
recreated this crimped morphology in PLA nanofibers. It was found that by heating PLA at 85ºC
for 15 minutes, PLA fibers developed a stable crimped morphology hypothesized to be due to
changes in its crystallinity, going from an amorphous to semi-crystalline state. A similar result
was achieved by soaking PLA nanofibers in 95% ethanol at 37ºC for two days and this method
could also be applied to PCL and PLGA nanofibers to achieve crimped fibers. There was a
decrease in elastic modulus for heat-treated (362.5 ± 110.8 MPa) and ethanol-soaked (441.6 ±
46.1 MPa) compared to as spun fibers (478.3 ± 77.8 MPa), though not significantly different. In
addition, a significant increase in transition state strain was observed. Importantly, the stressstrain curve showed a J-shaped response that is characteristic of native vessels. This behavior
was associated with a decrease in “crimpness” at higher strains. Crimpness of the fibers was also
maintained after dynamic loading. ACL fibroblasts aligned themselves with the crimped fibers
taking on an undulating morphology and had significantly increased collagen type 1 expression
which was further increased under dynamic loading conditions.
Nanofiber alignment has also been identified as a method to direct the behavior of cells
on electrospun scaffolds. Within a normal blood vessel different cell types align in different
ways, forming a key aspect of their function. ECs are aligned longitudinally with the direction of
blood flow while VSMCs are aligned circumferentially and thus able to contract the vessel.
When electrospinning tubular scaffolds, circumferentially aligned fibers can be obtained by
rotating the mandrel at a sufficient speed. The rotational speed depends on the exact set up as the
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surface velocity of the mandrel must exceed the velocity of the fibers being deposited. He et al.
[120] found that a 4 mm diameter mandrel rotated at 1000 rpm resulted in aligned nanofibers. At
higher and lower rotational speeds, random fiber orientation was observed. As this is set up
dependent, either mandrel diameter and rotation speed or linear velocity of the mandrel should
be reported. Fusaro et al. [165] found that EC proliferation and function was enhanced on
circumferentially aligned nanofibers. Longitudinally aligned fibers can be obtained by using two
parallel plates as a collector. The deposited fibers will bridge the gap between the plates,
orientated perpendicular to the plates and aligned parallel to each other. The fibers can then be
collected by rolling a mandrel over them such that they are orientated along the length of the
mandrel (Figure 10) [159, 160]. Tan et al. [159] showed that the longitudinally aligned PLC
nanofibers promoted HUVEC adhesion and proliferation over randomly aligned PCL fibers.
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Figure 10. (A) Electrospinning schematic used by Tan et al. (B) Electrospun PCL nanofibers
were collected between two parallel rods and (C, D) collected on a mandrel resulting in
longitudinally aligned fibers. (E) PCL and PEG were co-electrospun to create the outer layer and
(F) finished scaffold [159]. Reproduced with permission of Elsevier.

One method for altering the mechanical behavior of an electrospun scaffold is to alter the
shape of the mandrel. Of particular interest is grafts with a wavy cross section that allow
circumferential expansion of the graft to better replicate the nonlinear mechanical behavior of
native vessels. In the simplest form a mandrel with a wavy cross section has been utilized with
PU fibers being collected directly on the mandrel forming a dense electrospun wall. The wavy
shape was maintained after removal from the mandrel through subsequent cyclic loading (100
cycles). The stress-strain curve displayed nonlinear behavior reminiscent of native vessels [114].
In a novel approach, Yu et al. and Mi et al. [148, 149] both used a round mandrel surrounded by
thin (0.8 mm diameter) rods (Figure 11). At sufficient rotational speed, the thin rods flexed in a
manner analogous to a jump rope. As nanofibers were collected on the satellite rods, they would
become constrained and shrink back against the mandrel resulting in a wavy structure. As an
added benefit, the satellite rods facilitated the removal of the graft from the mandrel without
damaging the graft. A flat, dense region was present in areas in contact with outermost area of
the rods while a looser, wavy region was found in areas between the rods. The choice of polymer
blend and concentration aided in the formation of the wavy structure. Both used elastic PU due
to its ability to mimic the behavior of elastin. In order to mimic the stiffer collagen Yu et al. used
SF and Mi et al. used PCL. In both cases an intermediate blend of the elastic and stiff polymers

49

best held the wavy shape with pure stiff polymer unable to contract the satellite rods and pure
elastic polymer contracting to a round shape after removal of the mandrel.

Figure 11. Schematic used by Mi et al. The set up composed of a hollow metal mandrel
surrounded by satellite rods. When rotating the metal rods deform and fibers are collected. As
the fibers are deposited the rods contract with the fibers forming a wavy structure [148].
Reproduced with permission of Elsevier.

4.9.3. Increasing Porosity
One major limitation of electrospinning in tissue engineering is the inherently small pore size
and porosity as electrospun scaffolds are essentially 2D mats. The lack of porosity hinders
cellular infiltration of the grafts, which limits remodeling and integration of the graft into native
tissue, as well as the exchange of nutrients and waste products. Porosity can be changed by
adjusting the electrospinning parameters including voltage, flow rate, distance to collector, and
rotational speed [166]. Thicker fibers are also associated with larger pore size and increased
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porosity. Wang et al. [167] obtained thicker PCL fibers by increasing PCL concentration while
using a higher flow rate and reducing the voltage and collector distance. The thick fibers were
5.59 ± 0.67 𝜇m in diameter compared to 0.69 ± 0.54 𝜇m for the thinner fibers. This resulted in a
nearly 8-fold increase in pore size and marked increase in porosity. The increased porosity
influenced macrophage polarization and allowed for the remodeling of the grafts and the
formation of a tunica media after 100 days in vivo. Using a novel electrospinning technique, Yin
et al. [168] used a porous mandrel through which pressurized air was pumped. Termed airimpedance electrospinning, the pressurized air impeded the deposition of PLCL/SF nanofibers
resulting in larger pore sizes. Interfiber distance was largest at 50 kPa and decreased with higher
pressures. However, cell infiltration depth was still high at 200 and 300 kPa. This was
hypothesized to be caused by increased fiber alignment at higher pressures, which resulted in
VSMCs assuming a more spindle-like shape and thus could migrate through the smaller gaps
between fibers.
Another common approach to increase scaffold porosity is to utilize sacrificial fibers.
With this technique, a soluble polymer such as non-crosslinked gelatin [155], polyvinyl alcohol
(PVA) [169], polyethylene glycol (PEG) [170], or PEO [171–174] is co-electrospun with a nonsoluble polymer. In a three-layer graft, Han F. et al. [155] co-electrospun non-crosslinked gelatin
with an inner PLCL layer, middle PLGA layer, and outer PCL layer. The loss of the gelatin
nanofibers in the outer two layers would function to increase pore size and allow VSMC
infiltration while the gelatin in the inner layer was primarily used to promote early EC adhesion
on the lumen. Within several days the gelatin was completely degraded and in vivo results in
New Zealand white rabbits showed VSMCs migrating into the middle layer and forming a thick
layer. Tan et al. [169] co-electrospun PVA with a PCL/gelatin blend. After electrospinning, the
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PVA was removed by rinsing with phosphate buffer saline (PBS) for 24 h at 37º C. The PVA
containing grafts had an 8% increase in porosity without a detrimental decrease in mechanical
properties compared to the PCL/gelatin only graft. The grafts were implanted subcutaneously in
rats and after 8 weeks cells infiltrated much deeper (about 300 𝜇m) compared to the PCL/gelatin
only grafts (about 100 𝜇m). In a different method, Hodge and Quint [174] electrosprayed PEO
nanoparticles while simultaneously electrospinning PGA, PCL, or PLGA. Electrospraying is a
process similar to electrospinning except the voltage used is high enough to overcome the
viscosity of the solution resulting in the formation of particles rather than fibers. After the grafts
were constructed, PEO was removed by rinsing with a series of ethanol solutions of decreasing
concentration for 1 h each. The PGA/PEO graft had similar mechanical properties but faster
degradation compared to the PGA graft while the PLC/PEO and PLGA/PEO graft saw a
decrease in mechanical properties, but similar degradation times compared to their respective
single polymer grafts. The porous PEO grafts did allow for significantly increased infiltration
and proliferation of human dermal fibroblasts after 3 and 7 days of culture.
Composite grafts utilizing electrospinning and another method of graft formation have
also been used to generate porous grafts. In these grafts the electrospun layer typically provides
increased mechanical support that the porous polymer structure is unable to provide. The
simplest method to produce a porous scaffold is freeze drying a hydrogel which leaves behind a
highly porous scaffold. In an early study, Jeong et al. [175] created a porous jellyfish collagen
layer by casting the hydrogel in a mold with a mandrel in the center followed by lyophilization
and crosslinking. A layer of PLGA nanofibers was then collected on the outer surface via
electrospinning to reinforce and improve the mechanical properties of the graft. Under pulsative
perfusion, the grafts supported the survival and proliferation of VSMCs and ECs, which was
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enhanced compared to a static culture. In a more recent study, Norouzi and Shamloo [176] coelectrospun a PCL/gelatin inner layer around which a gelatin hydrogel was cast. After freeze
drying and crosslinking with glutaraldehyde a porous outer layer was generated (Figure 12). The
graft displayed good mechanical properties due to the PCL nanofibers. VSMC proliferation was
supported by the outer porous layer while the inner electrospun PCL/gelatin layer successfully
allowed adhesion and proliferation of VSMCs. Another method to create a porous layer is
thermally induced phase separation (TIPS). During the TIPS process, hot polymer is poured in a
mold and rapidly cooled to -80º C. The solvent crystals are then leached out from the scaffold
and freeze-dried leaving behind a porous scaffold. Solenti et al. [177] used TIPS to create a
porous poly(ester-urethane)urea (PEUU) inner layer enveloped by electrospun PEUU layer. The
TIPS/electrospun grafts showed sufficient burst pressure and suture retention strength to
withstand the arterial environment while the mechanical properties were similar to native
vessels. Under dynamic culture conditions the grafts supported muscle derived stem cells though
decrease in cell number was found between day 0 and day 3, attributed to the high initial seeding
density which saturated pore space and limited proliferation.
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Figure 12. Schematic used by Norouzi and Shamloo. A crosslinked gelatin hydrogel was cast
around an inner electrospun PCL/gelatin layer. After freeze drying, the hydrogel formed a porous
outer layer [176]. Reproduced with permission of Elsevier.

4.10. Reducing Thrombogenicity by Including an Anticoagulant Molecule.
One of the main causes of vascular graft failure is thrombosis. This is attributed to the inherent
thrombogenicity of the graft itself, causing failure shortly after implantation, or the failure to
develop a confluent endothelium covering the lumen of the graft, which affects long-term
patency. From a processing perspective, fiber diameter has been shown to influence the
thrombogenicity of electrospun grafts with larger fibers (2-3 µm) inducing platelet adhesion and
activation of the coagulation cascade [178]. A common method to address acute thrombosis and
reduce the thrombogenicity of the TEVG is to include an anticoagulant molecule into the graft,
either by direct mixing into the polymer or post hoc modification of the lumen surface. By far the
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most commonly used and highly effective drugs for this are heparins. Heparins are highly
sulfated glycosaminoglycans that inhibit the action of thrombin and clotting factor FXa [179].
Commonly used methods for incorporating heparin into vascular grafts are immobilization [146,
180–183], plasma treatment [182, 184, 185], and coaxial electrospinning [186, 187].
Additionally, emulsion electrospinning has been utilized to incorporate heparin directly into the
fibers of the graft. In emulsion electrospinning, two or more immiscible solutions (generally a
water-soluble drug and a synthetic polymer) are mixed together with the aid of a surfactant
resulting in microscopic droplets of the drug being dispersed throughout the polymer [188].
Emulsion electrospinning can take advantage of the drug release kinematics of different
polymers to time release of heparin [176].
Immobilization of heparin involves directly linking heparin to the graft surface. Some
polymers such as chitosan allow for heparin immobilization without the need for further
processing. Yao et al. [146] showed that increasing the mass ratio of chitosan in a PCL/chitosan
blend greatly increased the amount of heparin immobilized on the graft surface, improving the
anticoagulant properties and reducing platelet adhesion while having no significant effect on the
mechanical strength of the graft. In order to immobilize heparin onto the surface of synthetic
polymers the surface must first be functionalized through the addition of amine groups. Several
groups have successfully utilized modified PEG as a linker, using PEG bis(amine) to
functionalize ester and urethane linkages in PLA and PU, respectively, and isocyanate linked
PEG on PU, which convert to amine groups in the presence of water [181, 183]. Heparin can
then be bound to the amine group with the use of activators such as 1-(3-dimethylaminopropyl)3-ethylcarbodiimide hydrochloride (EDC) and hydroxysulfosuccinimide (NHS). In a recent
study, Kuang et al. [189] immobilized heparin onto mesoporous silica nanoparticles (MSN)

55

using PEG as the linker. The MSN-PEG-heparin nanoparticles were then dispersed into a
PLGA/collagen solution for electrospinning. With the MSN-PEG-heparin nanoparticles
dispersed throughout the fibers, the nanoparticles would be exposed gradually as the fibers
degraded, increasing the duration of heparin’s effect as opposed to directly grafting to the
surface. In vivo studies demonstrated the nanoparticle containing grafts remained patent up to 8
weeks.
Another common method surface modification of a vascular graft is plasma treatment.
Plasma treatment uses inert gases such as argon to create radicals on the graft surface allowing
heparin to bind to the surface [184]. Other gases can be used to graft functional groups onto the
graft surface. Li et al. [185] used NH3 plasma treatment to graft amine groups to polycarbonate
polyurethane (PCU) and subsequently graft heparin to the surface. In a comparison of the
efficacy of heparin grafting techniques, Qui et al. [182] used two immobilization techniques:
aminolysis with a PEG amine linker and a polydopamine (PDA) coating for the absorption of
heparin; and compared them to an allyl-amine plasma treatment on a PCU graft. The plasma
treated grafts had a higher amine group density than either the aminolysis or PDA coated grafts
and resulted in a higher heparin density. In addition, the heparin-plasma treated grafts also
showed greater heparin activity after 7 days in vitro compared to the aminolysis and PDA coated
grafts, sustaining the same level of activity seen on day 0.
Several groups have explored alternatives to heparin to improve the antithrombogenicity
of electrospun vascular grafts. Liu et al. [190] generated sulfated SF by treating SF with
chlorosulphonic acid. The sulfated SF was hypothesized to imitate the highly sulfated structure
of heparin. The sulfated SF grafts had greatly improved anticoagulant behavior while also
increasing the proliferation of ECs and VSMCs and maintaining higher expression of phenotypic
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markers. Eldurini et al. [191] constructed a novel electrospun mat using a PCL-wintergreen oil
polymer solution. Wintergreen oil significantly improved the blood clotting tendency of PCL and
the addition of a PEO coating further improved the anticoagulant effect. An increase in
hemolysis seen with the wintergreen oil was reduced with the addition of heparin to the graft.
Furthermore, the wintergreen oil had antioxidant activity over the course of 32 hours, which
could be a favorable behavior. However, the amount of wintergreen oil must be carefully
managed due to its potential toxicity and the hemolytic activity of pure wintergreen oil.
Conjugated linoleic acid (CLA) has also demonstrated potential as an antithrombosis agent. As a
smaller molecule compared to heparin, CLA has the potential to be easier to graft to polymers
due to its lower steric hinderance. Tran et al. [192] grafted CLA to a PU/PCL graft via plasma
treatment. Despite not changing the hydrophobicity of the PU/PCL, CLA significantly increased
clotting time and saw reductions in platelet adhesion and activation. Furthermore, CLA improved
proliferation of fibroblasts and especially ECs although there appeared to be an optimal density
of CLA above which proliferation was consistently, but not significantly slowed. Salicin, a
compound extracted from white willow Salix alba, has anticoagulant and anti-inflammatory
properties. When incorporated in to an extruded ePTFE-SF graft, salicin significantly reduced
platelet adhesion and increased clotting time, demonstrating its anticoagulant effect. In addition,
the ePTFE-SF-salicin material had greatly improved HUVEC adhesion and proliferation
compared to neat ePTFE [193].
4.11. Improving Endothelialization by Incorporating Endothelial Growth Compounds.
Although various compounds have demonstrated anticoagulant activity in vascular grafts, the
key to long-term thrombosis prevention is regeneration of the endothelium. The endothelium
lining of blood vessels plays a critical role in the function of the cardiovascular system,
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providing a smooth, antithrombogenic surface for blood flow and regulating vascular tone
through the release of NO among other functions. Inducing rapid and successful
endothelialization is an essential step to generating a viable TEVG. A number of proteins, small
peptides, and various drugs have incorporated into vascular grafts to promote endothelialization
and we will highlight a few of them here.
One popular growth factor used to improve endothelialization is vascular endothelial
growth factor (VEGF). VEGF binds to tyrosine kinase cell receptors and has an important role in
vasculogenesis and angiogenesis and mainly targets ECs, promoting proliferation and migration
among other things [194, 195]. VEGF and heparin immobilized via a PDA coating have been
shown to greatly improve the hydrophilicity of PU, attributed to the abundant hydrophilic groups
in the coatings. In combination, heparin and VEGF showed the greatest HUVEC adhesion,
spreading, and proliferation, better than either alone [196]. Sevostyanova et al. [197]
incorporated VEGF into a PCL tubular scaffold using emulsion electrospinning. The diameter of
the PCL fibers decreased with the addition of VEGF, which could help improve cell adhesion. In
Wistar rats, the VEGF/PCL improved patency after 1 and 3 months. The improved patency
coincided with faster endothelialization and the appearance of a mature, functional endothelium
after 6 months which was not apparent on the PCL grafts. Emechebe et al. [198] adhered VEGF
to a PDA coated co-spun polydioxanone (PDO)/PCL+dipyridamole (DY) (PDO/PCL+DY)
vascular graft. Fibrinogen absorption, which has been shown to increase platelet adhesion and
activation, was significantly decreased with the addition of VEGF to the graft and more
inactivated platelets were found adhered to the PDO/PCL+DY and PDO/PCL+DY+PDA+VEGF
grafts. Increasing VEGF concentration increased HUVEC adhesion and proliferation over the
course of 5 days, with 3350 ng mL-1 VEGF showing the highest proliferation and confocal
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microscopy showed nearly continuous EC coverage after 7 days. In a porcine model, the
PDO/PCL+DY+PDA+VEGF grafts had the lowest thrombosis formation and had confluent ECs
orientated with blood flow. However, patency and thrombosis formation were only monitored for
two weeks so longer-term studies are needed to better evaluate the efficacy of the graft.
Oxidative stress induced by cardiovascular diseases are known to induce EC and EPC apoptosis.
Dai et al. [199] sought to limit oxidative stress-induced apoptosis and improve the efficacy of
VEGF by incorporating PEG-coated cerium oxide nanoparticles (CNPs-PEG) into an electrospun
PU scaffold. CNPs have antioxidant properties and the ability to decompose H 2O2 into O2 and
H2O. The PEG coating on the CNPs reduced their cytotoxicity and did not limit the growth of
EPCs over 3 days in culture. The CNP-PEGs reduced H2O2-induced EPC apoptosis and
maintained their antioxidant function after electrospinning. In vitro, the CNP-PEGs enhanced the
effects of VEGF resulting in increased number of migrating EPCs and promoting increased
differentiation of EPCs with high mRNA and protein expression of several EC markers.
Stromal cell-derived factor (SDF) 1α is a CXC chemokine that binds to CXC chemokine
receptor type-4 (CXCR-4). SDF1α is a chemoattractant that recruits hematopoietic stem cells
(HSCs) and EPCs. EPCs circulate in the blood and have the capacity to regenerate the
endothelium making them a promising source for in situ endothelialization [200, 201]. In one
study, CD34+ and CD117+ cells were recruited to vessel grafts with a fibronectin (FN)-SDF-1α
coating at a significantly higher level compared to controls and resulted in nearly twice the
endothelium coverage 3 months after implantation in sheep [202]. SDF1α experiences a strong
electrostatic interaction with heparin and this can be used to immobilize SDF1α. In a recent
study, a heparin-SDF1α coating was used in a TIPS vascular graft. In addition to the
anticoagulant activity of the heparin, SDF1α enhanced the recruitment of EPCs after 24 h in vitro
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while also stimulating HUVEC migration proliferation. Heparin upregulated the expression of
endothelial functional genes CD144 and endothelial nitric oxide synthase (eNOS), with the
addition of SDF1α resulting in further upregulation of the genes [203]. Moreover, the technique
used to generate the heparin-SDF1α could easily be applied to electrospun grafts. In a canine
study, Guo et al. [204] transplanted VEGF/ SDF1α PU electrospun grafts into the femoral
arteries. The VEGF/ SDF1α grafts had higher patency than the neat PU graft after 6 months (5/8
vs 0/8, respectively). Explanted VEGF/ SDF1α grafts showed a continuous neointima composed
of ECs while a neointima was absent on the neat PU grafts, making VEGF/ SDF1α
functionalized grafts a promising candidate for a TEVG.
One major challenge with the use of SDF1α is its short plasma half-life, measured at 25.8
± 4.6 min, due to its cleavage by dipeptidyl peptidase-4 and MMPs [205, 206]. To improve
SDF1α release dynamics, Lee et al. [207] created a charge-based self-assembled SDF-1α
coacervate with heparin and poly(ethylene argininylaspartate diglyceride) and coated a porous
poly(glycerol sebacate) (PGS) scaffold with it. The SDF-1α coacervate limited the initial burst
release and showed a sustained release over the course of 28 days under flow conditions. EPCs
and mesenchymal progenitor cells (MPCs) were shown to migrate upwards through a fibrin gel
toward the SDF-1α coacervate-laden scaffolds. When seeded on top of the SDF-1α coacervate
scaffold, EPCs and MPCs both penetrated deeper into the scaffold and had higher proliferation at
days 7 and 10 compared to control and free SDF-1α. This system is versatile, designed to load
any heparin-binding growth factor and could be used on electrospun grafts. In a more recent
study, Muylaert et al. [208] synthesized SDF-1α-derived peptides containing the CXCR-4
binding domain with and without the MMP2 cleavage site to limit rapid proteolytic degradation.
The SDF-1α-derived peptides were modified with ureidopyrimidinone (UPy) and mixed with
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chain-extended UPy-PLCL for electrospinning. Both the proteolytic resistant (UPy-SDF1α(R))
and non-resistant (UPy-SDF1α(NR)) peptides attracted and increased adhesion of peripheral
blood mononuclear cells (PBMCs) and reduced expression of proinflammatory proteins. The
latter effect was greater on the UPy-SDF1α(R), providing some evidence of increased longevity,
though longer-term studies are needed. Likewise, in vivo results showed greater cellularity and
penetration with both SDF-1α-derived proteins and an increase in CD68+ macrophages compared
to control.
The use of small peptides represents another method used to improve endothelialization.
Generally, the small peptides consist of a few amino acids that correspond to cell attachment
domains of ECM proteins and seek to improve EC adhesion. The Arg-Gly-Asp (RGD) sequence
is present in many ECM proteins and a number of integrins recognize this domain making it an
important recognition site for cell adhesion [209]. A number of studies have demonstrated the
ability of RGD to promote endothelialization of vascular grafts [210–213]. RGD also has been
shown to have equal efficiency at improving primary patency and endothelialization as VEGF
[214]. Zheng et al. [212] fabricated tubular RGD containing PCL grafts. To overcome the
inherent difficulty in directly immobilizing RGD to PCL, a molecule containing RGD and
naphthalene groups (Nap-FFGRGD) was used, which is capable of self-assembly on the PCL
surface. The RGD surface greatly reduced platelet adhesion, reducing the risk of thrombosis. In
New Zealand white rabbits, the RGD-PCL grafts maintained 100% patency after 4 weeks and
showed greater endothelialization compared to PCL grafts (51.1 ± 6.4% vs 11.5 ± 3.2%,
respectively). Kuwabara et al. [215] reported on a promising Cys-Ala-Gly (CAG) sequence
derived from collagen type IV with a high affinity for ECs and a low affinity for VSMCs.
Although the patency of CAG-PCL grafts in rats was not significantly different from PCL grafts,
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the CAG grafts did have a higher endothelialization ratio at 1, 2, and 6 weeks. Expression of
eNOS was significantly higher in CAG grafts, indicative of more functional ECs. The function of
CAG peptides can be improved with the addition of the antithrombogenic peptide
LTFPRIVFVLG (ACH11). CAG and ACH11 have a synergistic effect, outperforming their single
peptide counterparts in thrombogenicity, HUVEC proliferation and migration, and NO
production. In New Zealand white rabbits, the CAG-AHC11 grafts remained patent and had much
improved endothelialization after 6 weeks compared to neat PLCL scaffolds [216].
4.12. Modulation of the VSMC Layer Formation on TEVG by VSMC Regulating Compounds
The formation of a VSMC layer is critical to the overall function of a vascular graft. A mature
VSMC layer helps to stabilize the endothelium, preventing EC apoptosis and promoting its longterm survival, without which the endothelium could degenerate [217, 218]. However, the
proliferation of VSMCs must be carefully managed to avoid neointima hyperplasia and stenosis,
which reduces the patency of the vessel graft and can lead to graft failure. VSMCs maintain one
of two phenotypes: a synthetic phenotype with the capacity for migration, proliferation, and
ECM secretion and a quiescent contractile phenotype. Ideally, early migration and proliferation
of VSMCs with the synthetic phenotype into the graft would give rise to predominantly
contractile VSMCs with a few synthetic VSMCs to maintain homeostasis [219]. Heparin has
been noted as having inhibitory effects on VSMC proliferation in several papers [146, 181, 203,
220, 221]. This effect is similar to that seen in native vessels where the mature endothelium
releases heparin-like substances that maintain VSMCs in a contractile state [219]. Furthermore,
heparin has been shown to stimulate elastogenesis and elastic fiber formation from VSMCs on
SF films while simultaneously inhibiting VSMC proliferation and may help promote vascular
remodeling [220]. Elastin, one of the primary constituents of the vessel wall ECM, may help
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promote VSMC adhesion and function. Recombinant elastin-like polypeptide-4 (ELP4), which
mimics the structure of tropoelastin, was crosslinked to the surface of aligned nanofiber PCNU
and flat PCNU films. On the electrospun scaffolds, VSMCs exhibited high viability, alignment,
and F-actin organization. Interestingly on flat films, ELP4 substantially improved viability and
had cell alignment and F-actin organization comparable to the electrospun scaffolds. Moreover,
ELP4 increased smooth muscle myosin heavy chain (SM-MHC) expression on electrospun
scaffolds and displayed a marked increase on the flat films compared to tissue culture plates.
Since proliferation was limited (i.e. cell number was maintained) on the electrospun and flat
films compared tissue culture plats and in light of the increased SM-MHC expression, ELP4 may
help to maintain VSMCs in a contractile phenotype [222]. Other ECM-like peptides may also
help modulate VSMC behavior and formation of a medial layer. The peptide RGD, distributed in
many ECM proteins, promoted the formation of VSMC layer in rabbits as identified by α-SMA
and SM-MHC staining [212]. On the other hand, CAG, the peptide sequence found in collagen
type-4 which forms the elastic lamina that separates the intima from the media, has been
demonstrated to limit VSMC adhesion and has the potential to inhibit intimal hyperplasia [215,
216]. Thus, careful consideration of the placement of ECM protein-like peptides in the design of
an electrospun TEVG may be a viable option to form a functional VSMC layer.
Other peptides have been developed to deliver microRNAs (miRNAs) to VSMCs. Wen et
al. [223] developed a Val-Ala-Pro-Gly (VAPG) peptide-modified trimethyl chitosan-g-PEG
(TPV) for the targeted delivery of miRNA-145 and incorporated it into electrospun PLCL.
miRNA-145 can regulate contractile VSMCs and avoid excessive proliferation and intimal
hyperplasia. The TPV was able to release miRNA-145 over the course of 56 days, avoiding the
usual quick degradation of miRNAs. TPV/miRNA-145 was able to limit the proliferation of
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VSMCs for 56 days while maintaining contractile phenotype, evidenced by morphology and αSMA expression.
The combination of the growth factors VEGF and PDGF have been identified to assist
neovasculature formation and maturation [218]. As discussed in a previous section, Han F. et al.
[155] devised a multilayered electrospun graft to generate a spatio-temporal delivery of VEGF
and PDGF. PDGF alone stimulated the adhesion and proliferation of VSMCs but also restenosis
in rabbits. However, with the quick release of VEGF and slow release of PDGF, VSMC
proliferation was slowed and generated a VSMC layer 8 weeks after implantation and had the
best results in comparison to grafts loaded with a single growth factor.
Rapamycin (RM) is an effective inhibitor of VSMC migration and proliferation and is
used to prevent restenosis. As a hydrophobic drug it can be readily electrospun in a variety of
synthetic polymers. Han J. et al. [224] electrospun RM in PU at different weight ratios and with
different concentrations of RM or RM powder added to 5% PU. After an initial burst release,
RM had a sustained release over the course of 77 days. At 10% RM/PU (w/w%) and above,
VSMC proliferation was inhibited after 5 days. The 20% RM/PU from powder had a high
encapsulation efficiency (>94%) and was still able to inhibit VSMC proliferation after 77 days of
release. Yang Y. et al. [225] incorporated RM into an electrospun PCL layer a top an inner
decellularized rat aorta layer. After 12 weeks, the RM containing grafts were able to significantly
reduce neointima hyperplasia without inhibiting endothelialization or M2 macrophage
polarization. One issue with the use of RM is that the dosage must be carefully controlled to not
prevent vascular remodeling as high RM concentrations can kill VSMCs. Another drug with
VSMC modulation potential is the antithrombogenic DY. At concentrations of 5 and 10% in
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polyurethane urea, DY has been shown to limit VSMC proliferation and maintain cell number
over 7 days in vitro [226].
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5. Main Goal, Specific Aims, and Hypotheses
The main goals of this dissertation are twofold. First is to assess the biomechanics of VSMCs in
an in vitro environment mimicking the atherosclerotic plaque and the biomechanics of
atherosclerotic VSMCs themselves to better understand the role of VSMCs in disease
progression. The second goal is to develop an electrospun tissue engineered scaffold suitable for
VSMC growth and proliferation. These goals were achieved with the following specific aims:
Specific Aim 1: To develop a model to mimic the different microenvironments seen in
atherosclerotic plaques in order to assess VSMC migration and cytoskeletal dynamics.
Hypothesis: Substrate stiffness and ECM proteins will coordinate to regulate VSMC migration
and cytoskeletal organization.
Specific Aim 2: Investigate the differences in biomechanics between atherosclerotic
ApoE-/- and wild type VSMCs.
Hypothesis: ApoE-/- VSMCs will display altered biomechanics that are further influence by
changes to substrate stiffness.
Specific Aim 3: Develop a SF-PCL based electrospun scaffold for vascular tissue
engineering.
Hypothesis: SF-PCL based scaffolds will have suitable mechanical properties for use in vascular
tissue engineering and promote VSMC proliferation and differentiation.
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Chapter 2: Extracellular Matrix Proteins and Substrate Stiffness Synergistically Regulate
Vascular Smooth Muscle Cell Migration and Cortical Cytoskeleton Organization
Abstract
Vascular smooth muscle cell (VSMC) migration is a critical step in the progression of
cardiovascular disease and aging. Migrating VSMCs encounter a highly heterogeneous
environment with varying extracellular matrix (ECM) composition due to the differential
synthesis of collagen and fibronectin (FN) in different regions and greatly changing stiffness,
ranging from the soft necrotic core of plaques to hard calcifications within blood vessel walls. In
this study, we demonstrate an application of a 2D model consisting of an elastically tunable
polyacrylamide gel of varying stiffness and ECM protein coating to study VSMC migration. This
model mimics the in vivo microenvironment that VSMCs experience within the blood vessel
wall, which may help identify potential therapeutic targets for the treatment of atherosclerosis.
We found that substrate stiffness had differential effects on VSMC migration on type 1 collagen
(COL1) and FN-coated substrates. VSMCs on COL1-coated substrates showed significantly
diminished migration distance on stiffer substrates while on FN-coated substrates VSMCs had
significantly increased migration distance. In addition, cortical stress fiber orientation increased
in VSMCs cultured on more rigid COL1-coated substrates, while decreasing on stiffer FN-coated
substrates. On both proteins, a more disorganized cytoskeletal architecture was associated with
faster migration. Overall, these results demonstrate that different ECM proteins can cause
substrate stiffness to have differential effects on VSMC migration in the progression of
cardiovascular diseases and aging.
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1. Introduction
Vascular smooth muscle cells (VSMCs) are the primary cellular constituent of the medial layer
of arteries, contributing to vascular tone and blood pressure regulation. It has long been known
that VSMCs undergo phenotypic switching from a quiescent contractile phenotype to a synthetic
phenotype with ageing and cardiovascular diseases such as atherosclerosis [12, 227, 228]. With
the synthetic phenotype, VSMCs acquire an increased capacity for proliferation, migration, and
extracellular matrix (ECM) protein secretion [12]. VSMC migration and proliferation are critical
to the formation of the fibrous cap in atherosclerotic plaques and intimal thickening that occurs
with age [12, 229]. In addition, VSMCs have been found to make up a large portion of the
necrotic plaque core. The core of a plaque is occupied by lipid-laden macrophages known as
foam cells. However, VSMC-derived foam cells have been found to comprise up to 40% of the
total foam cells [15]
Migrating VSMCs encounter a broad range of microenvironments as the ECM varies widely
within atherosclerotic plaques and with aging, both in composition and stiffness. Tracqui et al.
used atomic force microscopy (AFM) to measure the stiffness of different regions of plaques in
apolipoprotein E-deficient (ApoE) mice, finding stiffness varied from a low average of 5.5 kPa
in lipid-rich regions to an average of 59 kPa with high values of 250 kPa in areas of hypocellular
fibrosis [230]. Calcifications, another key feature of advanced plaques, especially in older
patients, are considerably stiffer, reaching the GPa range [229, 229, 231]. Elsewhere, stiffer
ECMs have been shown to promote angiogenesis [232, 233]. It has been well established that
stiffening of arteries also occurs with age, due in large part to a change in ECM composition and
in particular an increased collagen to elastin ratio [227, 229]. It has also been reported that
increased transforming growth factor-β1 expression in aged rat aortas resulted in increased
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expression of fibronectin (FN), type I collagen (COL1), and type III collagen [234, 235]. Within
an atherosclerotic plaque, a varied ECM composition occurs in different regions. COL1 is highly
prevalent within the fibrous cap but nearly absent from the lipid-rich core and increased FN
deposition has been associated with early atherosclerotic lesions and VSMC remodeling [20].
Furthermore, migrating cells have been shown to actively modify the ECM, promoting FN fibril
formation, collagen deposition, and strain stiffening of the ECM [236–238]. Given the widely
varied ECM environments potentially experienced by migrating VSMCs, deciphering the
interplay of ECM stiffness and composition is critical to further understanding of atherosclerosis
progression. Previous studies comparing FN and laminin-coated substrates have shown
differential responses to substrate stiffness with FN showing enhanced responses and laminin
showing depressed responses [239–242]
Cells are able to sense forces from their surrounding environment and translate mechanical
signals into biochemical responses, a process known as mechanotransduction [34]. Binding to
the ECM occurs through focal adhesion complexes (FAs), mainly consisting of integrins, which
bind directly to the ECM and various intracellular proteins [34]. FAs connect to and transduce
mechanical signals to the actin cytoskeleton through mechnosensitive proteins such as talin and
vinculin [32, 34]. Known as the molecular clutch, the proteins connecting the ECM-bound
integrins to actin filaments harness the retrograde motion of actin to generate tension along the
substrate to induce movement. This system is sensitive to ECM stiffness as talin unfolding only
occurs on stiff substrates allowing the recruitment of vinculin and higher force transmission [32].
Ample previous studies have demonstrated the ability of the ECM to alter cell fate and function
[81, 141, 243, 244]. In addition, the transduction of forces to the actin cytoskeleton can induce
cytoskeletal remodeling in response to ECM stiffness changes [27, 245].
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The stiffness and composition of the ECM are known to affect VSMC migration during
atherosclerosis and aging as well as the actin cytoskeleton. However, the combinatorial effect of
ECM stiffness and composition is worth further investigation given the varied
microenvironments seen in atherosclerosis, especially how they affect migration dynamics and
actin cytoskeleton orientation. In this study, we investigated the influence of ECM stiffness and
composition on VSMC migration using elastically tunable polyacrylamide (PA) gels coated with
COL1 or FN, as well as a novel analysis of migration dynamics. The combinatorial effect of
ECM stiffness and composition on cytoskeleton orientation was also studied using confocal
microscopy and AFM.

2. Materials and Methods
2.1. Vascular Smooth Muscle Cell Isolation
Animals used in this study were kept in accordance with the NIH guidelines (8th Edition of the
Guide for the Care and Use of Laboratory Animals), and the animal use protocol was approved
by the Laboratory Animal Use Committee of the University of South Dakota (#13-09-15-18C)
and Sanford Institutional Care and Use Committee (#153-03-21C). VSMCs were enzymatically
isolated from the descending thoracic aorta of euthanized male Sprague-Dawley rats using
carbon dioxide (CO2) asphyxiation and seeded onto 60 mm plastic dishes (Corning, Corning,
NY, USA). Cells were maintained in DMEM-F12 (Invitrogen) medium supplemented with 10%
fetal bovine serum (FBS, ATLANTA Biologicals, Lawrenceville, GA) in a humidified incubator
with 5% CO2 at 37°C [246].
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2.2. ECM Protein-Coated Polyacrylamide Gel Substrate Preparation
PA gel substrates were prepared according to the protocol adapted from Fisher et al. [247].
Briefly 50 mm glass bottom dishes (MatTek Corporation, Ashland, MA, USA) were activated by
drying a small amount of 0.1 N sodium hydroxide at 37°C, followed by grafting a single layer of
(3-aminopropyl) triethoxysilane (Sigma, St Louis, MO, USA). The aminated surface was then
coated with 0.5% glutaraldehyde to serve as a crosslinker for the PA gel. PA solutions were
prepared using 40% acrylamide (ACR), 2% Bis-ACR solution, 10% tetramethylethylenediamine
(TEMED), and 10% ammonium persulfate (APS, Sigma; ACR, Bis-ACR, and TEMED from
BIO-RAD, USA) such that the resulting gels were 3.5 kPa (5% acrylamide (ACR), 1%
Bis/ACR), 28 kPa (15% ACR, 2.5% Bis/ACR), and 103 kPa (15% ACR, 3.5% Bis/ACR). PA
gel polymerization was catalyzed with 0.05% APS and 0.1% TEMED. Coverslips were
deactivated using a small volume of dimethyldichlorosilane (Sigma, St. Louis, MO, USA). The
PA solution was pipetted onto the activated glass bottom dishes, covered with a deactivated
coverslip, and allowed to polymerize under vacuum for 30 min. The resulting PA gels were then
washed several times with 50 mM 4-(2-hydroxyethy)-1-peperazineethanesulfonic acid buffer
(HEPES, ThermoFisher Scientific, Waltham, MA, USA) to remove unreacted monomer. The PA
gel surface was coated with1 mM sulfosuccinimidyl 6-(4’-azido-2’-nitrophenylamion) hexanoate
(ThermoFisher Scientific, Waltham, MA, USA) in HEPES and activated under 20 min of UV
light and served as the crosslinker between the PA gel and ECM proteins. After quick washes
with HEPES, the gel surface was then grafted with one layer of either COL1 (Sigma, St. Louis,
MO, USA) (0.15 mg/mL) or FN (Invitrogen, Carlsbad, CA, USA) (0.15 mg/mL). The ECM
protein-coatings were evaluated by immunostaining and imaging on a confocal microscope
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(Figure 9). PA gel stiffness was determined by AFM indentation as previously described [27,
248]
2.3. ECM Protein Coating Evaluation
The protein coatings were verified using immunostaining. Following protein coating the PA gels
were blocked for 30 minutes with 3% bovine serum albumin (Sigma, St. Louis, MO, USA). The
gels were then stained with the following mouse anti-rat antibodies: anti-fibronectin (1:50) and
anti-collagen type-1 (1:25) (Santa Cruz, Dallas, TX, USA) at 4°C overnight, respectively. After
rinsing three times with PBS, gels were incubated with FITC-conjugated goat anti-mouse IgG
(Invitrogen, Carlsbad, CA, USA) at room temperature for 1 h. Samples were visualized under a
confocal microscope and fluorescent intensity was analyzed using Fluoview 4.2 (Olympus Life
Science, USA). The coatings appeared consistent and uniform across the different proteincoatings for each substrate (Figure 9A). No significant difference in intensity was observed
across the different substrate stiffnesses for both COL1 and FN-coated substrates (Figure 9B and
C)
2.4. Cell Migration Studies
At 70% confluency, P0 cells were trypsinized and seeded onto COL1 or FN coated gel substrates
at a density of 10000 cells/cm2. Cells were allowed to plate in serum free media for 2 h in a
humidified incubator with 5% CO2 at 37°C. Cell migration studies were carried out using a JuLI
™ Stage Real-Time Cell History Recorder (NanoEnTek Inc., Seoul, Korea) maintained in a
humidified incubator with 5% CO2 at 37°C. Regions of interest with a sufficient number of nontouching cells were preselected and imaged with a 4x or 10x objective at 10 to 15 minute
intervals over the course of 24 hours. Image stacks were processed using FIJI (FIJI is Just
ImageJ). The plugin StackReg (Biomedical Imaging Group, Swiss Federal Institute of
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Technology Lausanne) was used to align image stacks and cell tracking was done manually
using the built-in MtrackJ plugin. Position data was processed using MATLAB and any tracked
cell with a final displacement less than 10 μm was eliminated from analysis (R2016a,
MathWorks Inc. Natick, MA, USA). The random motility coefficient (RMC) was calculated by a
linear curve fit of mean square displacement (MSD) vs. time using eq. 1
𝑀𝑆𝐷 = 4𝜇𝑡

(1)

where μ is the RMC [249]

2.5. Confocal Imaging and Image Processing
Primary VSMCs were seeded onto PA gels at a density of 10000 cells/cm2. At 60 to 80%
confluency, VSMCs were fixed using 4% paraformaldehyde solution in PBS (Affymetrix, CA,
USA) for 20 min at room temperature and rinsed with PBS. Cells were permeablized with 0.1%
Triton X-100 in PBS for 5 min followed by two rinses with PBS. A 1:1000 dilution of phalloidin
(Phalloidin-iFluor 488, Abcam, Cambridge, UK) in 1% bovine serum albumin/PBS was used to
stain the F-actin cytoskeleton for 20 min. Following two more washes with PBS, the nucleus was
counterstained using a 1:1000 dilution of Hoechst 33342 (BD Biosciences, San Jose, CA, USA)
dissolved in PBS for 10 min. VSMCs were imaged using a laser scanning confocal microscope
(Olympus IX83 FV1200, Olympus Life Science, USA) at a 1024x1024 pixel resolution and zheight of 0.38 μm. Z-stacks were flatten and manually segmented by tracing VSMCs in contact
with at least one other cell. As previously described a series of elongated Laplacian-of-Gaussian
(eLoG) filters were used to convolve flattened z-stacks to detect total cellular cytoskeletal fibers
orientation [27, 246]
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2.6. Live VSMCs AFM Imaging and Cytoskeletal Orientation Processing.
Contact mode live AFM imaging (MFP-3D-BIO, Asylum Research, Santa Barbara, CA, USA)
was used to study live VSMCs topography. A 30 × 30 μm area of the cell surface was scanned at
a digital density of 512 × 512 pixels using a stylus AFM probe (model MLCT-C, k=15 pN/nm,
Bruker, Santa Barbara, CA, USA). The cell surface scanning frequency was 0.3 Hz. All
experiments were conducted in CO2 independent medium at room temperature for a period of 12 hours [27, 248]. AFM height images were used to compute actin stress fiber density (Figure
10). AFM deflection images were used to compute VSMCs cortical actin stress fibers orientation
using a modified method of Karlon et al (Figure 11) [250]

2.6. Statistical Analysis.
Statistically significant differences between substrates of differing stiffness were determined
using a one-way analysis of variance (ANOVA) on Origin Pro 8.1 (OriginLab Corporation,
Northampton, MA, USA). Significant differences in stress fiber orientation were assessed using
Student’s t-test on the circular variance of each experimental group of VSMCs. A value of
*P≤0.05, **P≤0.01, and ***P≤0.001 was considered statistically significant. All data were
reported as mean ± SEM.

3. Results
3.1. Effect of Substrate Stiffness and Extracellular Matrix Proteins on Vascular Smooth
Muscle Cell Migration Distance.
An overview schematic showing the methodology for the migration experiments can be seen in
Figure 1A. Using the manually tracked positions of the nuclei, cell tracks for each gel were
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mapped to a common origin (Figure 1B). Qualitatively, VSMCs on the FN-coated 103 kPa gel
had the greatest migration distance overall, with the FN-coated gels appearing to show an
increase in migration as stiffness increased. Furthermore, the Gaussian curve fit of the migration
histograms showed the peak shifting to the left as stiffness increased on COL1-coated gels
indicating that cells traversed a shorted distance (Figure 2A-C).
The opposite effect was observed on the FN-coated gels with the peak shifting to the right as
stiffness increased, indicative of a greater migration distance (Figure 2D-F). The 103 kPa COL1
and 3.5 kPa FN, which were the substrates that exhibited the lowest migration distance, also had
the narrowest peak, whereas peaks were broader for the substrates with higher migration
distances. The average distance vs. time plots also showed this trend with the migration distance
increasing as substrate stiffness decreased for COL1 and the inverse trend for FN (Figure 3A-B).
Statistical testing with one-way ANOVA showed substrate stiffness had a significant effect on
migration distance on both COL1 and FN-coated substrates (P<0.05) (Figure 3C-D).

3.2. Effect of Substrate Stiffness and Extracellular Matrix Proteins on Vascular Smooth
Muscle Cell Migration Dynamics
VSMC migration dynamics were characterized by analyzing migration speed and stoppages.
From the distance vs. time graphs for individual cells, a stepwise migratory behavior was noted,
where there would be rapid increases in distance traveled followed by a much slower increase of
complete stops (representative plot in Figure 4A). The derivative of this plot confirmed this
behavior with the number of local speed peaks observed at regular intervals, demonstrating an
oscillatory migration behavior (Figure 4B). Average migration speed for COL1 (Figure 4C) was
found to significantly decrease with increasing stiffness while FN-coated substrates (Figure 4F)
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showed the opposite trend with average speed increasing with increasing stiffness, matching the
migration distance results. The migration stops were also analyzed for each cell. The number of
stops was counted, and consecutive stops were merged together. COL1-coated substrates had the
greatest number of stops on 103 kPa substrate, and stiffness was found to have a significant
effect on the number of stops, with an increasing trend seen with increasing stiffness (Figure
4D). The opposite trend was seen with FN-coated substrates. The 3.5 kPa substrate had the
highest number of stops and a significant downward trend in the number of stops was seen with
increasing stiffness (Figure 4G). For the resting time (total time stopped), the lengths of all stops
were added together. Substrate stiffness was also shown to have a significant effect on the resting
time for both proteins, following the same trend as migration distance with total resting time
increasing on COL1-coated substrates (Figure 4E) and decreasing on FN-coated substrates with
increasing substrate stiffness (Figure 4H).
From the displacement data, the MSD was calculated for each time point and averaged
across all cells. On COL1-coated gels, the average MSD for both 3.5 and 28 kPa substrate
tracked almost identically, while for the 103 kPa substrate, the MSD was consistently higher
although error bars still overlapped (Figure 5A). This result stands in contrast to migration
distance for COL1 as the 103 kPa substrate had the lowest average distance. For FN, the 28 kPa
substrate initially had a higher MSD than the 3.5 kPa substrate but the difference ended after
about 800 min (Figure 5B). VSMCs cultured on the 103 kPa FN-coated substrates maintained
the highest MSD among all three substrates. From the MSD, the RMC was calculated, and
substrate stiffness had a significant effect on the RMC for FN-coated substrates (Figure 5D) but
not for COL1-coated substrates (Figure 5C).
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3.3. ECM Composition did not Alter Global VSMC Cytoskeletal Architecture in Response to
Changes in Substrate Stiffness
To test whether overall cytoskeletal architecture was altered in response to ECM composition
and substrate stiffness, fluorescent images of the actin cytoskeleton were obtained using confocal
microscopy. Representative z-stack images of actin stress fibers are shown in Figure 6 (top rows,
panels A and B) for COL1 and FN-coated gel substrates with an E-modulus of 3.5 kPa (left), 28
kPa (middle) and 103 kPa (right). The corresponding stress fiber orientation color maps (Figure
6A and B, bottom rows) were computed using a proprietary MATLAB software. VSMCs on the
28 and 103 kPa substrates showed a fairly consistent mix of colors for each cell for a given ECM
coating, indicating substrate stiffness had little or no effect on global cytoskeletal arrangement.
However, a potential effect was observed with VSMCs on the COL1-coated 3.5 kPa substrate,
with the cells displaying more varied colors. F-actin orientation was quantitatively analyzed and
plotted in histograms. The results confirmed our qualitative assessment of the color maps that
substrate stiffness had an effect on cytoskeletal architecture on COL1-coated substrates but not
the FN coated substrates (Figure 6C and D, respectively). In addition, VSMCs on the FN-coated
substrates did show a more dispersed F-actin orientation than those on the COL1-coated
substrates. The quantified group data showed a significant difference in global actin stress fiber
alignment along the dominant orientation angle (-10° ~ 10°) between the COL1-coated
substrates, with VSMCs on the 3.5 kPa showing a more dispersed orientation while no
significant difference was observed on the FN-coated substrates (Figure 6E and F, respectively).
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3.4. Live AFM imaging Revealed ECM Composition Induces Differential Effects of Substrate
Stiffness on VSMC Cytoskeletal Orientation.
In order to examine if the observed changes in VSMC migration on COL1 and FN coated PA
gels were correlated with differences in the cortical cytoskeletal architecture, live cell AFM
imaging was used. As opposed to confocal microscopy which shows the whole actin
cytoskeleton, AFM contact mode scans only the outermost cortical stress fibers [27, 246, 248].
Representative AFM height images of stress fibers are shown in Figure 7 for VSMCs cultured on
COL1 (top rows of panel A) and FN (top rows of panel B) coated substrates. The bottom row of
each panel shows the stress fiber area fraction of each image, with the red representing the area
occupied by stress fibers and the blue representing the background. No significant difference in
stress fiber area fraction between the different substrate stiffnesses for both COL1-coated (Figure
7C) and FN-coated gel substrates was found, indicating the amount of stress fibers did not vary
(Figure 7D). In addition, no significant difference in average roughness was seen between the 28
and 103 kPa substrates for both COL1 and FN (Figure 7E and F, respectively).
Representative AFM deflection images were presented in Figure 8 for the cells cultured on
the COL1 (Panel A, top row) and FN-coated (Panel B, top row) substrate, respectively. The
corresponding circular histogram for each deflection image was displayed in the bottom row.
Stress fiber orientation angles were normalized along the most dominant orientation angle
frequency to allow for comparison across groups. The COL1-coated 28 kPa substrate shows a
much broader variety of fiber orientation angles (panel A, bottom left) compared to the tight
grouping seen on the 103 kPa substrate (panel A, bottom right), indicating an increase in stress
fiber orientation for the stiffer substrate. Qualitatively, for FN-coated substrates, the 103 kPa
substrate (Figure 8B, bottom left) shows a more dispersed angle grouping compared to the 28
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kPa substrate (Figure 8B, bottom right), indicating a more disorganized stress fiber architecture.
The summarized stress fiber orientation corroborated the qualitative analysis of the deflection
images, showing a clear increase in stress fiber alignment with increased stiffness for the COL1coated substrate (Figure 8C) and a clear decrease for the FN-coated substrate (Figure 8D). From
the summarized percent frequency of the stress fibers with dominant orientation angle (-20° ~
20°), increasing substrate stiffness was found to significantly increase stress fiber alignment for
the COL1-coated substrate (Figure 8E) and conversely result in a significant stress fiber
dispersion for the FN-coated substrate (Figure 8F).

4. Discussion
Cell migration is a well-studied phenomenon and the importance of ECM stiffness and
composition has been known for a long time [251, 252]. However, reported effects were highly
variable, even contradictory, depending on the cell type used. Bangasser et al. reported that U251
glioma cells exhibited a peak RMC on a 100 kPa COL1-coated substrate [249]. Others have
reported lower migration of MDA-MB-231 cells on irradiated collagen substrates with reduced
stiffness [253]. Meanwhile, human keratinocytes have been found to have a higher migration
velocity on a 1.2 kPA digested COL1-coated substrate than on a 24 kPa substrate [254].
Differences were also observed for FN-coated substrates where no changes in migration were
found for mouse enteric neural crest cells on substrates with stiffness ranging from 1.5 kPa to
GPa [255], while both fibroblasts and neutrophils exhibited lower migration distances with
increasing stiffness [251, 256]. Others have shown an increased migration speed of human
adipose-derived stem cells with increasing substrate stiffness [257]. Interestingly, in the
aforementioned study with neutrophils, Oakes et al. reported that although migration velocity

79

decreased with increasing stiffness, neutrophils on stiff substrates had a higher MSD indicating
they migrated with greater persistence [256]. In this study, we provide further insight on the
effects of substrate stiffness and composition on cell migration specifically with VSMCs by
mimicking atherosclerotic microenvironments.
We found that the migration distance and speed on COL1-coated substrates decreased with
increasing substrate stiffness, with other dynamical properties behaving as would be expected for
the observed decrease in migration (Figures 3 and 4). Interestingly, although not significant, the
103 kPa COL1-coated substrate did exhibit the highest MSD and RMC, indicating that despite
migrating slower, VSMCs on the stiff substrate did migrate with greater persistence, as was
reported on FN-coated substrates (Figure 5) [256]. In addition, an oscillatory-like behavior was
seen in the migration speed (Figure 4), potentially relating to oscillations in cell stiffness we have
previously found [248]. Spontaneous oscillations in cell elasticity have been linked to myosin II
activity, which plays a critical role in the contraction of the cell during migration [32, 258]. The
decrease in migration distance on the stiffer COL1-coated substrates correlates well with the
behavior of VSCMs during atherogenesis, where VSMCs migrate from the less stiff media to the
stiffer fibrous cap. During the formation of the fibrous cap in the middle stages of atherogenesis,
VSMCs secrete abundant amounts of fibrous COL1, which stabilizes the fibrous cap and has
been shown to downregulate migration related genes [8, 17, 24, 259, 260]. Our results
demonstrate that simultaneous stiffening of the cap during these stages may contribute to a
decrease in VSMC migration and help to stabilize the plaque. As the plaque progresses to a latestage atheroma, macrophages accumulate in the shoulder regions of the plaque, secreting MMPs
[24, 259]. MMPs degrade the COL1-rich ECM and along with the loss of VSMCs, cause the
fibrous cap to thin and become prone to rupture in late-stage atherosclerosis [8, 260]. Monomeric
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and fragmented COL1 resulting from the degradation of the fibrous cap have been shown to
stimulate VSMC migration [24]. Apoptosis has been identified as a primary cause of VSMC loss
within the fibrous cap due to the activity of activated inflammatory cells [261]. However, based
on our results the degradation of COL1 would lower the stiffness of ECM and could further
stimulate VSMC migration toward regions of greater stiffness and thus also contribute to fibrous
cap thinning and subsequent plaque rupture. Migration on FN-coated substrates was found to be
similar to some previously reported results, with migration distance and speed increasing with
increasing stiffness (Figures 3 and 4) [257]. Large amounts of FN have been previously noted in
the fatty streaks of early atherosclerosis [262, 263]. The increased FN has been shown to be vital
not only for further atherosclerotic progress but also in the formation of the fibrous cap, despite
being nearly absent within the fibrous cap [21]. FN-rich COL1-poor deposits have been found in
some plaques with subendothelial cells being concentrated to these areas [263]. The ECM of
atherosclerotic arteries have also been found to contain abundant deposits of FN with extra
domain A that has been shown to promote atherosclerosis [264]. Based on our results, these FN
deposits along with the increased stiffness of atherosclerotic arteries may contribute to the
VSMC migration seen in the progression of atherosclerosis. In addition, both MSD and RMC
increased with increasing stiffness, indicating that VSMCs not only migrated a greater distance
but also had greater persistence (Figure 5). Meanwhile, the number of stops and resting time
decreased with increasing stiffness as anticipated for the increase in migration distance on stiffer
substrates (Figure 4G-4H). It should be noted that although the PA gels were coated with equal
concentrations of COL1 and FN, cells have been shown to exhibit different migratory responses
to the same level of different proteins [265–268]. In particular human smooth muscle cells
displayed peak migration on FN at a coating concentration around 20 μg/mL and lower
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migration at higher concentrations [265] while 3T3 fibroblast migration peaked at a COL1
coating concentration of 0.15 mg/mL [266]. Furthermore, substrate stiffness and ECM protein
density has been shown to modulate mechanotransduction, with behavior varying by ECM
protein [269]. Thus, the observed differences could be due in part to the amount of protein
present and further studies varying the protein-coating concentration are required to examine this
question.
Our results indicate how VSMCs respond to environments of different stiffness may depend
on the ECM protein present. Numerous studies have shown migration behavior may depend on
ECM proteins [239–241]. Recently, we have also shown VSMCs cultured on COL1 and FN have
different responses to fluvastatin, which was linked to integrin adhesion and expression [28]. It is
widely known that cells bind to different ECM proteins through different integrins [270]. These
integrin-ECM protein binding pairs are known to vary in binding strength and dynamics [268,
271]. Talin has been shown to be critical to integrin adhesion function by binding directly to
actin, inducing integrin activation, and is mechanosensing, unfolding in response to large enough
forces enabling the recruitment of other proteins such as vinculin [272]. Some evidence suggests
that some integrins may be mechanosensitive [273]. Thus, it is possible that different integrins
binding to different ECM proteins could have varied mechanosensitivity and thus exhibit
different responses to substrate stiffness. It is also not clear what effect COL1 and FN together
would have on VSMC migration as other studies have shown that one ECM protein can
completely mask the effect of another [240, 241].
Cytoskeletal remodeling in response to changes in substrate stiffness and membrane
cholesterol manipulation has been reported [27]. Thus, we thought that cytoskeletal remodeling
could also be linked to ECM composition, which may influence VSMC migration. Global stress
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fiber orientation was first analyzed using confocal microscopy. Substrate stiffness was shown to
have no effect on actin stress fiber alignment for the FN-coatings while a significant effect was
observed on the COL1-coated substrates. In addition, VSMCs on FN-coated substrates did have
a notably more dispersed actin alignment compared to those on COL1 (Figure 6). To more
closely analyze only the cortical actin stress fibers, AFM contact mode imaging was employed.
Since the AFM tip is only able to indent several nanometers into the cell surface, it is able to
detect only the stress fibers closest to the surface. These fibers hold the most relevance for cell
migration as they are linked to focal adhesion through the proteins vinculin and talin [32, 34].
Our results demonstrate that substrate stiffness had a significant effect on cortical VSMC stress
fiber orientation for both COL1 and FN-coated substrates (Figure 8). However, VSMCs cultured
on COL1 had an increase in stress fiber orientation on the stiffer substrate while those cultured
on FN displayed a decrease in organization, similar to previously reported results [27, 251].
Furthermore, for both COL1 and FN, VSMCs with the more disorganized stress fiber orientation
exhibited a higher migration distance. It is plausible that increased F-actin polymerization at the
leading edge of faster VSMCs leads to a decrease in stress fiber orientation [27]. The observed
difference in global and cortical stress fiber architecture could be due to the linkage of cortical Factin to mechanosensing integrins via talin in FAs, which have been shown to co-align with Factin and grow parallel to strain [274].

5. Conclusion
In summary, we found that VSMC migration was dependent on both substrate stiffness and ECM
protein composition. Higher migration distance was also linked to a more disorganized actin
cytoskeleton architecture. These results support our hypothesis that ECM stiffness and
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composition coordinate to regulate cell migration dynamics and cytoskeleton architecture. Our
results also provide further insight into the effects of the heterogeneous microenvironments seen
in aging and atherosclerotic plaques on disease progression. In future studies, we aim to also
study the effect of cholesterol on VSMC migration in conjunction with ECM stiffness and
composition potentially using ApoE-/- mice or manipulating cholesterol using statins and
oxidized low-density lipoprotein while also employing a three-dimensional model to better
mimic atherosclerotic microenvironments.
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Figures
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Figure 1. VSMC migration on the different ECM protein-coated gel substrates with varying
stiffness. (A) Schematic of VSMC migration experiments. The descending thoracic aorta was
harvested from 8-week-old male Sprague-Dawley rats and VSMCs were enzymatically isolated.
After 6-10 days of culture, VSMCs were trypsinized and seeded on ECM protein-coated PA gels
for 24 h imaging and VSMC positions were tracked. Distance (in red) covers the path the cell
took. Displacement (yellow) is the straight-line path from the start point to the end point. Mean
Square Displacement (MSD, cyan) is the square of the displacement, essentially a box covering
the area traversed by the cell. (B) Position plot of VSMC nucleus mapped to a common origin.
Top Row: VSMCs on COL1-coated substrates displayed little visual change in migration.
Bottom Row: VSMCs on FN-coated substrates show an apparent increase in migration with
increasing substrate stiffness. For each stiffness and protein combination, 30 to 50 cells were
tracked per independent trial, with three independent replicates.
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Figure 2. Distribution of the VSMC migration distance on different ECM proteins coated gel
substrates with varying stiffness. (A-C) VSMCs on the COL1-coated gel substrates. 103 kPa
substrate histogram had a left-shifted, narrower peak than those on the 3.5 and 28 kPa substrates,
indicating lower migration distance. (D-F) VSMCs on the FN-coated gel substrates. VSMC
migration distances became more dispersed on the stiffer substrates, with the peak shifting to the
right indicating a higher average migration distance.
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Figure 3. Substrate stiffness and ECM composition alter VSMC migration. (A, B) Migration
distance vs. time plots demonstrated VSMC migration distance decreased on COL1-coated gels
as stiffness increased, while migration distance increased on FN-coated gels with increasing
stiffness. (C) Increasing substrate stiffness resulted in a significant decrease in migration distance
for COL1-coated substrates. (D) FN-coated substrate showed a significant increase in migration
distance with increasing substrate stiffness. Data in panels A and B are presented as mean
migration distance (mid-line) at each time point ± SEM. Data were presented in panels C and D
as mean migration distance at end point ± SEM. **P ≤ 0.01 and ***P ≤ 0.001.
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Figure 4. The combinatorial effect of ECM proteins and substrate stiffness on VSMC migration
dynamics. (A) A representative migration distance vs. time plot shows an apparent stepwise
migration behavior. (B) Instantaneous migration speeds were determined by the first derivative
of the migration distance at each time point. A clear pattern of speed peaks and stops was seen in
migration speed vs. time plot. (C, F) VSMC migration speed significantly decreased on COL1
(C) with increasing substrate stiffness. VSMCs on 103 kPa FN-coated (F) substrates displayed
significantly higher migration speed than the 28 kPa and 3.5 kPa FN-coated substrates. (D, G)
The number of migration stops significantly increased on COL1-coated (D) substrates with
increasing substrate stiffness. On FN-coated substrates (G), VSMCs experienced significantly
fewer stops on the stiffer gels. (E, H) VSMCs on stiffer COL1-coated substrates (E) stopped for
a longer resting time. Conversely, the total resting time significantly decreased on the stiffer FNcoated substrates (H). Data were presented as mean ± SEM. **P ≤ 0.01 and ***P ≤ 0.001.
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Figure 5. The combinatorial effect of ECM proteins and substrate stiffness on VSMC migration
displacement. (A) Despite having the lowest migration distance, VSMCs on the 103 kPa COL1coated substrate had the highest MSD across all time points, indicating a more persistent
migration. (B) VSMCs on the 103 kPa FN-coated substrate also had the highest MSD. (C)
Substrate stiffness had no significant effect on the RMC of VSMCs on COL1-coated substrate.
However, VSMCs on the 103 kPa substrate did have the highest RMC. (D) On FN-coated
substrate, substrate stiffness was found to have a significant effect on the RMC. Data were
presented as mean ± SEM. **P ≤ 0.01.
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Figure 6. Confocal images of VSMC actin cytoskeleton. (A, B) The top row of each panel shows
a representative confocal image of VSMCs actin fibers culture on the 3.5 kPa (left), 28 kPa
(middle) and 103 kPa (right) substrates for COL1 and FN-coatings, respectively. The bottom row
of each panel shows the corresponding color map of stress fiber orientation computed from the
confocal images. (C, D) Stress fiber orientation histograms for COL1 and FN-coating
respectively, where the dominant orientation angle was normalized to zero for each cell. (E, F) A
significant difference in the frequency of the dominant orientation angle (−10° ~ +10°) was
observed for COL1-coated PA gels, with VSMCs on the 3.5 kPa substrate having a more
disorganized actin cytoskeleton. No significant difference in the dominant orientation was
observed for VSMCs cultured on the FN-coatings. Actin (green) was stained with phalloidin and
the nuclei (blue) were counterstained with Hoechst. At least 20 confocal images were analyzed
for each condition. Data were presented as mean ± SEM.

93

Figure 7. AFM height images of the cortical cytoskeleton and the area fraction of cortical stress
fiber. (A, B) Representative AFM height images for VSMCs cultured on COL1 and FN-coated
28 kPa (left) and 103 kPa (right) substrates (top row of panel A and B, respectively). The color
changes from blue to red indicate the increasing height of the stress fibers. The bottom row of
each panel shows the threshold applied to the height image to separate the areas occupied by
stress fibers (red) from the empty background (blue). (C, D) Substrate stiffness did not have a
significant effect on the area occupied by stress fibers for the cells cultured on the COL1 or FNcoated substrate. (E, F) Substrate stiffness did not have a significant effect on the average
roughness of cell surface cultured on COL1 or FN-coated substrate. For AFM imaging, 20 cells
cultured on COL1 for each stiffness and 14 cells on FN for each stiffness were imaged. Data
were presented as mean ± SEM.
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Figure 8. Substrate stiffness and ECM coating alter VSMC’s cytoskeleton organization. (A, B)
Representative 30 μm × 30 μm AFM deflection images for VSMCs cultured on 28 kPa (left) and
103 kPa (right) are seen in the top row of each panel. The bottom row of each panel displays
circular histogram showing the normalized stress fiber orientation of each corresponding
deflection image. (C) The VSMCs cultured on the 103 kPa COL1-coated substrate displayed a
more aligned stress fiber organization than those on the 28 kPa substrate. (D) On FN-coated
substrates, VSMCs on the softer 28 kPa substrate displayed the more aligned stress fiber
architecture. (E) Summarized percent frequency of dominant fiber orientation (-20 ~ 20) showed
a significantly more orientated stress fiber architecture on the 103 kPa COL1-coated substrate.
(F) The summarized percentage frequency of dominant fiber orientation (-20 ~ 20) showed the
opposite trend for FN-coated substrate, with VSMCs on the 28 kPa substrate having a more
aligned stress fiber orientation. Data were presented as mean ± SEM. *P ≤ 0.05.
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Figure 9. ECM protein-coated gels. (A) Protein-coatings appeared visually uniform for COL1
(top row) and FN (bottom row) for the 3.5 kPa (left), 28 kPa (middle), and 103 kPa (right)
substrates. (B, C) Intensity quantification showed no significant difference in coating on the
substrate of different stiffness for both COL1 and FN-coated substrates. Images were taken of
three different spots on each gel with three replicates for each group.
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Figure 10: AFM height image flattening. (A) A representative raw AFM height image of cortical
cytoskeleton. (B) Representative flattened AFM height image. A higher contrast between the
stress fiber and the background is visualized in the flattened height image.
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Figure 11: Calculation of x- and y-gradients of the AFM deflection image. (A) Representative
raw AFM deflection image of cortical cytoskeleton (same cell as Figure 10). (B, C) x- and ygradients calculated by convolving of x- and y- directional masks with the original AFM
deflection image, respectively.
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Chapter 3: Exploring the difference in the mechanics of vascular smooth muscle cells from
wild type and apolipoprotein-E knockout mice
Abstract
Atherosclerosis-related cardiovascular diseases are a leading cause of mortality worldwide.
Vascular smooth muscle cells (VSMCs) comprise the medial layer of the arterial wall and
undergo phenotypic switching during atherosclerosis to a synthetic phenotype capable of
proliferation and migration. The surrounding environment undergoes alterations in extracellular
matrix (ECM) stiffness and composition in addition to an increase in cholesterol content. Using
an atherosclerotic murine model, we analyzed how the mechanics of VSMCs isolated from
western diet fed apolipoprotein-E knockout (ApoE-/-) and wild type (WT) mice were altered
during atherosclerosis. Increased stiffness of ApoE-/- VSMCs correlated with a greater degree of
stress fiber alignment as evidenced by atomic force microscopy (AFM)-generated force maps
and stress fiber topography images. On type-1 collagen (COL1)-coated polyacrylamide (PA) gels
of varying stiffness, ApoE-/- VSMCs had lower adhesion forces to N-Cadherin (N-Cad) and
COL1. ApoE-/- VSMC stiffness was significantly greater than WT cells and cell stiffness
increased with increasing substrate stiffness for both ApoE-/- and WT VSMCs. In addition,
ApoE-/- VSMCs showed an enhanced migration capability on COL1-coated substrates
correlating with the lower adhesion forces as compared to WT VSMCs. Altogether, these results
demonstrate the potential contribution of the alteration in VSMC mechanics in the development
of atherosclerosis.
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1. Introduction
Despite strides of progress, cardiovascular disease has become the world’s leading cause of
mortality and atherosclerosis is a major contributor to this global epidemic [275]. Atherosclerosis
is a complex disease that has been described as a chronic state of inflammation resulting in the
formation of arterial plaques filled with lipid and cellular debris. Atherosclerotic plaque
instability, fibrous cap thinning, and rupture cause a plethora of cardiovascular diseases such as
heart attack, stroke, and peripheral vascular disease [276, 277].
Vascular smooth muscle cells (VSMCs) are present in the medial layer of the vasculature
providing arterial contraction and extracellular matrix (ECM) production to maintain optimal
hemodynamic conditions [278]. During the progression of atherosclerosis, VSMCs “respond to
injury” and shift from a contractile to a synthetic phenotype to stabilize the plaque and form a
fibrous cap. The VSMC phenotypic shift entails the reduction of contractile protein expression
and the upregulation of cell proliferation, migration, and secretion of ECM proteins [12, 279].
VSMCs detach from neighboring cells and the surrounding ECM to migrate towards the intima
during the development of atherosclerosis. Migrating VSMCs experience a wide range of
microenvironments as the ECM within the plaque varies in composition and stiffness [280].
Type-1 collagen (COL1) was shown to be abundant near the stiffer fibrous cap but nearly absent
within the softer, lipid rich necrotic core [20, 230]. In addition, migrating VSMCs actively
modify ECM composition and stiffness through COL1 and fibronectin (FN) deposition [236,
238].
Mechanotransduction at the cell-matrix interface plays a critical role in regulating cell
adhesion to the ECM and cell migration [244, 257, 281–284]. ECM stiffness has emerged as a
prominent mechanical cue that precedes disease and drives its progression, by altering cellular
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behaviors such as phenotypic shifting [285] and aberrant cell migration in response to disease
development [249, 257]. Cell-matrix mechanotransduction is regulated by factors including
integrin expression and activity [286], and ECM composition; the latter has been demonstrated to
be a critical determinant of cell behaviors [240, 287, 288]. In our recent study, ECM proteins and
substrate stiffness were found to synergistically regulate VSMC migration and cortical
cytoskeleton organization [289]. Moreover, VSMCs from apolipoprotein-E knockout (ApoE-/-)
mice were shown to constitute 30-70% of macrophage marker-positive (CD68) cells [290] and
foam cells [291]. In humans approximately 30-40% of CD68 positive cells and 50% of foam
cells are of VSMC origin [15, 290]. VSMCs from ApoE-/- were shown to have altered structural
and functional properties [292–295]. Moreover, phenotypically altered VSMCs were shown to
metabolize lipids differently to contractile VSMCs, partly due to the reduced cholesterol efflux
mediated by ATP-binding cassette transporters and the decreased expression of cholesterol
esterase, facilitating foam cell formation [15, 296]. Collectively, membrane cholesterol and
substrate stiffness were proved to coordinate and induce VSMC cytoskeleton remodeling and
alteration of biomechanics [27].
This study aims to investigate the difference in the mechanics of VSMCs isolated from
ApoE-/- and wild type (WT) mice. Atomic force microscope (AFM) was employed to study Ncadherin (N-Cad) mediated cell-cell adhesion, integrin mediated cell-ECM adhesion forces, and
stiffness of VSMCs cultured on elastically tunable substrates. AFM was also used to examine
live VSMC submembranous cytoskeleton architecture. In addition, we inspected VSMC
migration dynamics and global cytoskeleton organization on elastically tunable COL1 coated
substrates, mimicking the variation in environmental stiffness VSMCs experience in

103

atherosclerosis. Our results demonstrated a significant difference in cell mechanics, cytoskeletal
organization, and migratory behavior of VSMCs isolated from WT and ApoE-/- mice.

2. Materials and Methods
2.1. Mouse vascular smooth muscle cell isolation
The mice used in this study were kept in accordance with the NIH guidelines (8th Edition of the
Guide for the Care and Use of Laboratory Animals), and the animal use protocol was approved
by the Laboratory Animal Use Committee of the University of South Dakota (#13-09-15-18C)
and Sanford Institutional Care and Use Committee (#153-03-21C). For this study, male ApoE-/(B6.129P2-Apoetm1Unc /J, Jackson Laboratory) and male WT (C57BL/6J, Jackson
Laboratory) mice were subjected to 10 weeks of western diet after reaching 8 weeks of age. To
discern the influence of the western diet on cell mechanics, additional ApoE-/- and WT mice
were fed normal chow for 18 weeks and only used for stiffness measurements on plastic. Mice
were euthanized using carbon dioxide (CO2) asphyxiation and VSMCs were enzymatically
isolated from the descending thoracic aorta and seeded onto 60 mm plastic dishes (Corning,
Corning, NY). Cells were maintained in a DMEM-F12 (Invitrogen) medium supplemented with
10% fetal bovine serum (FBS, ATLANTA Biologicals, Lawrenceville, GA) in a humidified
incubator with 5% CO2 at 37 °C [246, 246, 289].

2.2. Elastically tunable ECM protein coated polyacrylamide gel preparation
Elastically tunable COL1 coated PA gels preparation was described in detail in our previous
studies [27, 248, 289]. Briefly, either 50mm glass bottom dishes (MatTek, Ashland, MA, USA)
or glass-bottom 6-well plates (Cellvis, Mountain View, CA, USA) were activated using 0.1N
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sodium hydroxide at 37 °C and grafted with one layer of (3-aminopropyl) triethoxysilane (APTS,
Sigma, St. Louis, MO, USA). The aminated glass surface was then grafted with a 25 mm
diameter PA gel using 0.5% glutaraldehyde (Sigma, St. Louis, MO, USA) as a crosslinker
between the PA gel and aminated glass surface. The PA substrate was washed with 50 mM 4-(2hydroxyethy)-1-peperazineethanesulfonic acid buffer (ThermoFisher Scientific, Waltham, MA,
USA) to remove the unreacted monomer. The PA gel surface was coated with 300 µL of 1mM
sulfosuccinimidyl 6-(4’-azido-2’-nitrophenylamion) hexanoate (sulfo-SANPAH, ThermoFisher
Scientific, Waltham, MA, USA), activated for 10 min under UV light, and quickly washed with
phosphate-buffered saline (PBS). This step was repeated to ensure sufficient coating of the
crosslinker. After quick washes with PBS, one layer of COL1 (Sigma, St. Louis, MO, USA)
(0.15mg/mL) was grafted to the PA surface. The different elasticities of the gels were previously
determined using AFM indentation [248].

2.3. Cell migration studies
Cells were trypsinized, counted, and plated on elastically tunable COL1-coated PA gels at a
density of 2500 cells/cm2. Cells were allowed to attach to the plate in serum-free medium in a
humidified incubator with 5% CO2 at 37°C for 2 h. Afterwards, migration experiments were
performed using a JuLI Stage Microscope (NanoEnTek Inc, South Korea). For each PA gel, five
to ten regions of interest were chosen and imaged with a 10x objective every 10 min for 24 h.
FIJI (FIJI is Just Image J) (NIH, Bethesda, MD, USA) was used to analyze image stacks. Timelapse image stacks were aligned using the plugin StackReg (Biomedical Imaging Group, Swiss
Federal Institute of Technology Lausanne). Manual cell tracking was completed by tracing the
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position of the cell nucleus with the MtrackJ plugin. For each experiment, 90 cells were tracked
from at least 3 replicates [28, 289].

2.4. VSMC biomechanical characterization using AFM
VSMC stiffness, cell-cell, and cell-ECM adhesion were assessed in real time using an Asylum
AFM System (Model MFP-3D-BIO, Asylum Research, Santa Barbara, CA) mounted on an
inverted microscope (Model IX81, Olympus America Inc.). A 5 μm diameter glass microbead
was glued to an AFM probe (MLCT-O10-D, Santa Barbara, CA; Bruker Corp.) and used for
Young’s modulus (E-modulus) measurement. Cell surface areas of 30 × 30 μm were
automatically scanned and indented at 6×6 positions with a 0.5 Hz indentation frequency and
1µm/s approach/retraction velocity. A parabolic Hertz equation was used to estimate VSMC
stiffness [248, 297]. For adhesion force measurement, cell surfaces were probed at a 0.05 Hz
indentation frequency and 0.1µm/s approach/retraction velocity using an AFM probe (MLCT,
Santa Barbara, CA; Bruker Corp.) functionalized with N-cadherin (Human N-Cad R&D
Systems, Minneapolis, MN) (10µg/ml) or COL1 (1mg/ml). The AFM force curves were
analyzed using a proprietary MATLAB program (R2016a, Mathworks). The product of the AFM
probe spring constant and the height of ruptures (adhesion events) on a retraction force curve
were identified and used to compute adhesion forces. The total average adhesion force is the
product of average adhesion force and number of ruptures. Adhesion and stiffness testing of
VSMCs cultured on elastically tunable PA gels were limited to measuring a single position.
Primary VSMCs attached to at least two other cells were selected and indented at a site between
the cell edge and their nucleus. The thermal noise amplitude method was used to calibrate each
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AFM probe after each adhesion measurement and before each stiffness measurement experiment,
respectively [298, 299].
2.5. VSMC adhesion rate using MTT assay
MTT assay was used to assess the rate of VSMC adhesion to plastic and COL1-coated surfaces.
For COL1 coated surfaces, 96 well plates were coated with 100 µg mL-1 COL1 in PBS. VSMCs
were trypsinized and seeded at a density of 3000 to 8000 cells per well at allowed to plate. At 15,
30, and 60 min the media was aspirated to remove any nonadherent cells and fresh media was
added. Cells were allowed to fully plate overnight. MTT assay (Abcam, Cambridge, UK) was
performed according to manufacturer’s instructions and cell count was calculated from a
standard curve. Counts at the various timepoints were then compared to a control group where
the cells were allowed to plate without removing the media.
2.6. VSMC adhesion rate using manual cell count
MTT assay results were verified by cell counting. For COL1 coated surfaces, 6 well plates were
coated with 100 µg mL-1 COL1 in PBS. VSMCs were trypsinized and seeded at a density of
6000 cells per well. At 30 min the media was aspirated to remove nonadherent cells. VSMCs
were allowed to plate overnight. The live cell nuclei were then stained with a 1:1000 dilution of
Hoechst 33342 (BD Biosciences, San Jose, CA). The whole well surface was imaged with an
Olympus IX83 inverted fluorescent microscope (Olympus Corporation, Central Valley, PA,
USA) using a 10x objective. Adaptive thresholding and cell counting were then performed using
FIJI (FIJI is Just Image J) (NIH, Bethesda, MD, USA).
2.7. Real time VSMC cytoskeletal imaging using AFM and image processing
Contact mode AFM imaging was employed to assess VSMC cytoskeleton architecture in real
time. Using an AFM stylus probe (model MLCT-C, k = 15 pN/nm, Bruker, Santa Barbara, CA,
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USA), a 30 × 30 μm cell surface area was imaged with the digital density of 512 × 512 pixels.
The scanning frequency was 0.3 Hz. The obtained height and deflection images were analyzed
using a proprietary MATLAB program to analyze cell fiber orientation and density as described
in our previous work [27, 28, 289]. Stress fiber area fraction is defined as the ratio of the whole
cell surface area compared to that covered by stress fibers. The area fraction was computed from
AFM height images post flattening and background noise elimination to improve the contrast
between the background (non-stress fiber area) and the foreground (stress fibers). AFM
deflection images were utilized to determine cytoskeletal stress fiber orientation. Finally, cell
surface roughness was determined from height images using the built-in function of the AFM
Asylum Research software.
2.8. Confocal Imaging and Image Processing
VSMCs were passaged and seeded onto COL1-coated PA gels at a density of 10,000 cells/cm2.
Cells were fixed at 60-80% confluency with 4% paraformaldehyde in phosphate-buffered saline
(PBS) (Affymetrix, CA) for 20 min at room temperature followed by several rinses with PBS.
VSMCs were permeabilized with 0.1% Triton X-100 in PBS for 5 min and rinsed with PBS. Factin cytoskeleton was stained with a 1:1000 dilution of phalloidin (Phalloidin-iFluor 488,
Abcam, Cambridge, U.K.) in 1% bovine serum albumin/PBS for 20 min and rinsed with PBS.
The nuclei were counterstained with a 1:1000 dilution of Hoechst 33342 (BD Biosciences, San
Jose, CA) dissolved in PBS for 10 min followed by a final rinse with PBS. VSMCs were imaged
using a laser scanning confocal microscope (Olympus IX83 FV1200, Olympus Life Science) at a
1024 × 1024-pixel resolution and z-height of 0.38 μm. Z-stacks were flattened and manually
segmented by tracing VSMCs in contact with at least one other cell. As previously described, a
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series of elongated Laplacian-of- Gaussian (eLoG) filters were used to convolve flattened zstacks to detect total cellular cytoskeletal fiber orientation [246, 289].

2.8. Statistical testing
One-way ANOVA with Tukey’s post hoc test was used to infer statistical significance for all
experiments. A value of *P ≤ 0.05 was considered statistically significant. All data were reported
as the mean ± standard error of the mean (SEM).

3. Results
3.1. ApoE-/- and WT VSMCs stiffness and submembranous stress fibers orientation
measurement using AFM
Using a 5 μm diameter glass microbead glued to an AFM probe, 30 × 30 μm cell surface areas
were automatically scanned and indented at 6×6 positions (Figure 1A). Normal diet fed ApoE-/and WT mice had no significant difference in cell stiffness (Figure 1B). Stiffness maps for
Western diet fed ApoE-/- and WT VSMCs are presented in Figure 1 C and D, respectively.
Western diet fed ApoE-/- VSMCs cultured on a plastic plate were significantly stiffer compared
to WT VSMCs (Figure 1E). Submembranous stress fiber topography was acquired by scanning a
30 × 30 μm area in contact mode (Figure 2A). Figure 2B and 2C are representative threedimensional 30 × 30 μm cell surface area stress fiber topography of a ApoE-/- and WT VSMC,
respectively. The stress fiber area fraction was unchanged for both cell types suggesting similar
stress fiber area coverage within the cell body (Figure 2D). The normalized percentage circular
histograms along the dominant orientation (Figure 2E and F) shows a clear difference in stress
fiber orientation between ApoE-/- and WT VSMCs. Figure 2G illustrates the percent frequency of
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average stress fiber orientation for ApoE-/- and WT VSMCs groups plotted in a percentage
frequency histogram, with the stress fiber angles were normalized along the dominant orientation
and fitted with a first order Gaussian function. The summarized percent frequency of the stress
fibers orientated around the dominant angle (±20°) indicates that ApoE-/- VSMCs have
significantly greater stress fiber alignment as compared to WT (Figure 2H). The surface
roughness average (the absolute difference in the peak and valley value of measured microscopic
surface peaks and valleys of VSMC topographical images) of ApoE-/- VSMCs was significantly
greater than WT VSMCs (Figure 2I).

3.2. Stiffness, cell-cell adhesion, and cell-ECM adhesion of WT and ApoE-/- VSMCs on COL1coated gel substrates.
ApoE-/- and WT VSMCs were cultured on elastically tunable COL1-coated gels and probed with
the AFM to measure stiffness (Figure 3A). The stiffness of these substrates was previously
measured with AFM and determined to be 28 and 103 kPa [248]. ApoE-/- VSMCs cultured on 28
and 103 kPa substrates had a significantly higher elastic modulus (E-modulus) compared to WT
VSMCs and those cultured on the stiffer substrate had a higher E-modulus for both ApoE-/- and
WT VSMCs (Figure 3B).
Cell- ECM adhesion was investigated with a COL1-coated stylus probe (Figure 4A).
Average adhesion force of ApoE-/- VSMCs on the 28 and 103 kPa substrates was significantly
lower compared to WT, with both ApoE-/- and WT VSMCs exhibiting slightly reduced adhesion
force on the 103 kPa substrate (Figure 4B). Cell-cell adhesion was measured using an AFM
stylus probe coated with N-Cad (Figure 4A). ApoE-/- VSMCs had a significantly lower adhesion
force to N-Cad compared to WT VSMCs on the 28 and 103 kPa substrates. The average
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adhesion force increased slightly with increased substrate stiffness for both ApoE-/- and WT
VSMCs (Figure 4C). MTT assay showed there was no difference in the rate of cell adhesion to
plastic and COL1 coated surfaces between ApoE-/- and WT VSMCs (Figure 5A and B). Cell
counting of VSMC nuclei further verified this result with no significant difference between
ApoE-/- and WT after allowing to plate for 30 min (Figure 5C).

3.3. ApoE-/- and WT VSMC migration dynamics on COL1-coated gel substrates.
ApoE-/- and WT VSMC migration were measured on 28 and 103 kPa COL1-coated PA gels
(Figure 6A). The average migration distance over time was significantly greater for ApoE-/VSMCs compared to WT on both the 28 and 103 kPa substrates (Figure 6D). With increasing
substrate stiffness, migration distance appeared to increase for ApoE-/- VSMCs and slightly
decrease for WT VSMCs (Figure 6B and C), consistent with our previously reported results in
rat VSMCs [289]. However, substrate stiffness did not have a statistically significant effect on
migration for both ApoE-/- and WT VSMCs (Figure 6D).

3.4. ApoE-/- and WT VSMC global cytoskeleton architecture
Global cytoskeleton architecture was characterized through the study of stress fiber orientation in
ApoE-/- and WT VSMCs on the 28 and 103 kPa COL1-coated gels imaged using confocal
microscopy. Fluorescent actin cytoskeleton z-stack images represented in Figure 6 for ApoE-/and WT VSMCs on the 28 kPa substrate and 103 kPa substrates (Figure 7A, B, C, and D,
respectively), were used to generate the corresponding segmented stress fiber orientation color
maps (Figure 7E, F, G, and H) using a proprietary MATLAB program. On both the 28 and 103
kPa COL1-coated substrates, ApoE-/- VSMCs exhibit a high degree of intracellular color map
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uniformity indicating a close alignment of actin filaments, while the more varied coloration
within WT VSMCs indicates greater dispersion of actin filaments (Figure 7E, F, G, and H). This
observation was consistent with qualitative analysis of F-actin orientation, illustrated by circular
histograms with a tighter grouping around the dominant orientation angle for ApoE-/- VSMCs on
both substrates compared to WT VSMCs, especially on the 103 kPa substrate (Figure 7I, J, K,
and L). Normalized fiber orientation histograms confirm increased frequency of fiber orientation
about the dominant angle for ApoE-/- VSMCs compared to WT, with a slightly higher peak on
the 28 kPa substrate and a more pronounced peak on the 103 kPa substrate (Figure 7M and O,
respectively). ApoE-/- VSMC global stress fiber alignment around the dominant orientation angle
was significantly greater than WT on the 103 kPa substrate, with the ApoE-/- VSMC cytoskeleton
showing a more orientated structure and the WT a more dispersed (Figure 7P). No significant
difference in stress fiber orientation was seen on the 28 kPa substrate, though ApoE-/- orientation
had a slightly higher average (Figure 7N).

3.5. Statistical testing
One-way ANOVA with Tukey’s post hoc test was used to infer statistical significance for all
experiments. A value of *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001 was considered statistically
significant. All data were reported as the mean ± standard error of the mean (SEM).

4. Discussion
We have previously demonstrated the effects of cholesterol and substrate stiffness on VSMC
biomechanics including changes in cytoskeletal organization, cellular stiffness, adhesion forces,
migration, and vasoactivity through in vitro manipulation of cholesterol using methyl-𝛽-
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cyclodextrin and statins in rat VSMCs [27, 28, 289]. We sought to expand these studies and
utilize a murine atherosclerosis model. ApoE-/- mice exhibit hypercholesterolemia and
spontaneous development of atherosclerosis with a Western diet [300]. Hypercholesterolemia
from the Western diet significantly altered VSMC biomechanics as normal diet ApoE-/- and WT
VSMCs had no significant difference in elastic modulus whereas VSMCs isolated from ApoE-/mice fed a Western diet exhibited a higher elastic modulus compared to WT, an effect that was
also seen with increased substrate stiffness [27]. ApoE-/- VSMCs had a more aligned
arrangement of cortical actin as well as lowered adhesion for both N-Cad and COL1 compared to
WT. In addition, ApoE-/- VSMCs migrated further than the WT VSMCs on both the 28 kPa and
103 kPa substrates and exhibited greater cytoskeleton alignment, particularly on the stiffer
substrate.
These results largely corroborate our previously reported results, providing further insight
into VSMC behavior during the progression of atherosclerosis. ApoE-/- VSMCs were stiffer than
WT VSMCs which is consistent with the enhanced alignment of cytoskeletal stress fiber
orientation. The cytoskeleton has been shown to be a major contributor of cell stiffness and actin
disruption resulted in decreased stiffness [301]. Furthermore, several studies in erythrocytes have
shown that increased cholesterol promotes tighter membrane cytoskeleton linkage and increase
resistance to cell lysis [302–304]. Other studies have implicated ezrin, radixin, and moesin
(ERM), which link the membrane to the actin cytoskeleton, to influence cytoskeletal architecture
and stiffness, though their exact function has yet to be elucidated in VSMCs as ERM function
appears to differ between cell types [305]. However, cholesterol has been shown to regulate
ERM proteins. During adipogenic differentiation, cholesterol enrichment upregulated
phosphorylated moesin and downregulated phosphorylated ezrin, decreasing stiffness, while
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cholesterol depletion had the opposite affect [306]. In addition, the cytoskeleton is connected to
the ECM through focal adhesions that physically couple cells to the matrix [307]. In our previous
work, we showed that both membrane cholesterol and substrate stiffness co-ordinate to induce
the remodeling of the cytoskeleton and alter VSMC integrin mediated biomechanics [27]. Thus,
the increased VSMC stiffness with increased substrate stiffness could be attributed in part to an
enhanced transduction of tension from substrates to the cell surface and VSMC cholesterol
content.
ApoE-/- VSMCs had a significantly greater migration distance compared to WT VSMCs
on each of the different substrate stiffnesses. This behavior aligns with VSMCs demonstrating
enhanced proliferation and migration with the progression of atherosclerosis following the
switch from a contractile to a synthetic phenotype. Enhanced cell migration distance is likely the
result of a combination of changing adhesion forces and cytoskeleton dynamics. Increased
plasma membrane cholesterol content has been associated with a reduction in maximum
protrusion force and subsequent increase in protrusion length in human embryonic kidney cells
during optical tweezer manipulation [301]. As the formation of filopodia and lamellipodia drives
cell migration, the ability to easily form longer protrusions could partially explain ApoE-/VSMC behavior. Ezrin has also been demonstrated to influence migration and cytoskeleton
stiffness with a constitutively activated ezrin resulting in greater migration and cytoskeleton
stiffness [48]. Adhesion to the ECM through focal adhesion complexes is another critical
component to cell migration. A significant reduction in adhesion forces to N-Cad and COL1 was
observed in ApoE-/- VSMCs for each substrate stiffness compared to WT VSMCs. However, no
change in adhesion rate to plastic and COL1 coated surfaces was observed between ApoE-/- and
WT VSMCs. Although not significant, we observed an increase trend in cell adhesion force to

114

N-Cad with increased substrate stiffness for both ApoE-/- and WT VSMCs. ApoE-/- VSMCs
exhibited reduced N-Cad adhesion force and greater migration compared to WT VSMCs,
consistent with chemotaxis migration assays that suggest N-Cad has an anti-migratory effect and
that downregulation of N-Cad promotes cell migration [308, 309]. Alternatively, ApoE-/VSMCs exhibited lower COL1 adhesion force and increased migration compared to WT
VSMCs. With increased substrate stiffness from 28 kPa to 103 kPa, ApoE-/- VSMC migration
increased while COL1 adhesion was reduced. Bangasser et al. proposed a model of cell
migration wherein substrate stiffness modulates cell migration dependent upon the number of
motors and clutches, for which an optimal range promotes fast migration and by nonlinear trends
[249].

5. Conclusion
In summary, hypercholesterolemia from the Western diet likely had a significant causal effect on
the observed differences in biomechanics. ApoE-/- VSMCs had a higher stiffness compared to
WT VSMCs as a result of greater cytoskeleton stress fiber alignment. Increasing substrate
stiffness had a synergistic affect, increasing cell stiffness for both ApoE-/- and WT VSMCs,
though to a greater degree for ApoE-/- VSMCs, and increasing cytoskeleton stress fiber
alignment in ApoE-/- VSMCs. Adhesion forces to N-Cad and COL1 were lower for ApoE-/VSMCs compared to WT VSMCs, associated with increased migration for ApoE-/- VSMCs
compared to WT. These results support our hypothesis that atherosclerosis alters the mechanical
properties of VSMCs and provide insight into the underlying mechanisms that may lead to future
novel therapeutic approaches.
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Figures

Figure 1. Live WT and ApoE-/- VSMC stiffness maps. (A) 30 × 30 μm cell surface areas were
automatically scanned and indented at 6×6 positions with a glass bead. Created with
Biorender.com. (B) Average stiffness for normal diet fed ApoE-/- and WT VSMCs. (C, D)
Stiffness force maps for WT and ApoE-/- VSMCs, respectively. (E) Average stiffness for
Western diet fed WT and ApoE-/- VSMCs. No significant difference in E-modulus was observed
between normal diet fed ApoE-/- and WT VSMCs. Western diet fed ApoE-/- VSMCs had a
significantly higher E-modulus compared to WT VSMCs. All data are presented as the mean ±
SEM (n ≥ 60 cells across six different mice). Scale bar in lower right corner represents 10 μm.
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Figure 2. Live WT and ApoE-/- VSMC submembranous stress fibers orientation measurement.
(A) 30 × 30μm areas were scanned for overall VSMCs stiffness measurement. Created with
Biorender.com. (B, C) Representative 30 × 30 μm three-dimensional stress fiber topography of a
WT and ApoE-/- VSMC used for live VSMCs stress fiber orientation and area fraction analysis.
(D) Average area fraction of VSMC submembranous actin stress fibers. (E, F) Circular
histogram, showing the normalized stress fiber orientation of WT and ApoE-/- deflection images,
respectively. (G) The average stress fiber orientation percentage histogram for WT and ApoE -/VSMCs, in which the dominant stress fiber orientation angle was set as zero degrees for each
cell. (H) The summarized percentage frequency of dominant fiber orientation (−20°~+20°). (I)
Average stress fiber surface roughness average. ApoE-/- VSMCs have significantly greater stress
fiber alignment and surface roughness compared to WT VSMCs. All data are presented as the
mean ± SEM (n= 16 cells for imaging both across 6 different mice).
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Figure 3. Measuring stiffness of WT and ApoE-/- VSMCs on COL1-coated gel substrates. (A)
WT or ApoE-/- VSMCs were cultured on elastically tunable COL1-coated PA gels and indented
with a glass bead at a single point. Created with Biorender.com (B) Average VSMC E-modulus
on 28 and 103 kPa substrates. ApoE-/- VSMCs cultured on 28 and 103 kPa substrates had a
significantly higher E-modulus compared to WT VSMCs and demonstrated an increase Emodulus when cultured on stiffer substrates. All data are presented as the mean ± SEM (n ≥ 60
cells across 6 different mice for each group.)
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Figure 4. Measuring cell-cell adhesion and cell-ECM adhesion of WT and ApoE-/- VSMC on
COL1-coated gel substrates. (A) AFM tips were coated in ECM proteins or cadherin and used to
measure adhesion forces. Created with Biorender.com. (B) Total average adhesion force to cellECM adhesion protein COL1. (C) Average adhesion force to N-cadherin. ApoE-/- VSMCs
demonstrated a significant lower adhesion force to COL1 and N-Cad compared to WT cells.
Interestingly, a slight decreasing trend of adhesion force was observed for both WT and ApoE-/cells on the 103 kPa compared to the 28 kPa substrate. All data are presented as the mean ± SEM
(n ≥ 60 cells across 6 different mice for each group).
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Figure 5. Measuring cell adhesion of ApoE-/- and WT VSMCs to plastic and COL1-coated
surfaces. (A, B) MTT assay measuring percent cell count relative to control at three different
time points on plastic and COL1 coated surfaces, respectively. (C) Manual cell count of ApoE-/and WT cells at 30 minutes on plastic and COL1 coated surfaces. No statistical significance
between ApoE-/- and WT cell counts were observed from either the MTT assay or manual cell
count. All data are presented as the mean ± SEM (n ≥ 3 different mice).

121

Figure 6. WT and ApoE-/- VSMCs migration dynamics on COL1-coated gel substrates. (A)
VSMCs isolated from WT and ApoE-/- mice were seeded onto COL1-coated PA gel to track cell
migration. (B, C) Average distance vs time for WT and ApoE-/- VSMCs on the 28 and 103 kPa
COL1-coated substrates, respectively. (D) Migration distance of VSMCs on different substrate
stiffnesses. ApoE-/- VSMCs demonstrated a higher migration capacity compared to WT cells. All
data are presented as the mean ± SEM (n = 90 cells across 3 different mice for each group).
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Figure 7. Confocal imaging of WT and ApoE-/- VSMC cytoskeleton orientation. (A, B, C, D)
Representative fluorescent z-stack images of the actin cytoskeleton for WT and ApoE-/- VSMCs
on the 28 and 103 kPa COL1-coated substrates. (E, F, G, H) The corresponding segmented color
maps showing cytoskeleton orientation computed from the confocal images. (I, J, K, L)
Corresponding circular histograms showing the normalized F-actin fiber orientation. (M, O)
Average normalized fiber orientation where the dominant angle is set as zero degrees on the 28
and 103 kPa substrate, respectively. (N, P) Summarized percentage frequency of fibers
orientated around the dominant angle. ApoE-/- VSMCs on the 103 kPa substrate demonstrated a
greater cytoskeletal alignment compared to WT cells. All data are presented as the mean ± SEM
(n > 60 cells from at least 25 images across 3 different mice for each group). Scale bars in lower
right corner represent 50 μm.
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Chapter 4: Electrospun Nanofiber Scaffold for Vascular Tissue Engineering
Abstract
Due to the prevalence of cardiovascular diseases, there is a large need for small diameter
vascular grafts that cannot be fulfilled using autologous vessels. Electrospinning is a promising
technique for producing nanofibrous scaffolds that mimic the ECM. Both PCL and SF are well
known for their biocompatibility use in biomedical applications. Here we offer a preliminary
assessment of the suitability of electrospun PCL-SF nanofibrous scaffolds for vascular tissue
engineering. Scanning electron microscopy was used to evaluate fiber morphology and
mechanical testing was done to characterize the scaffolds. The addition of SF to the scaffolds
resulted in a significantly more elastic scaffold and thicker nanofibers. Expression of myosin
heavy chain, calponin, and smoothelin indicated PCL-SF scaffolds supported TGF𝛽-1 induced
differentiation of mesenchymal stem cells. Scaffolds containing 1-2% SF also appeared to direct
stem cell differentiation to VSMC-like cells without TGF𝛽-1. While electrospun PCL-SF does
show some promise as a scaffold for vascular tissue engineering, more research characterizing
the properties of scaffold, cytocompatibility, and stem cell differentiation potential needs to be
completed to fully evaluate its potential.
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1. Introduction
In total nearly 200 million people have CHD and 113 million people suffer from peripheral
artery disease (PAD) [58]. In the United States, an estimated 20 million people suffer from CHD
and 6.5 million people have PAD, with 365,000 people dying from CHD and 70,000 from PAD
in 2018 [59]. Graft bypass surgery is one of the most common treatments for CHD with an
estimated 371,000 surgeries performed in 2014 in the United States [59]. Open revascularization
surgery for the treatment of PAD is needed in cases of critical limb ischemia or where
endovascular intervention is unsuitable [60, 61]. The rise of these diseases has created an everpresent demand for suitable vascular grafts. There are synthetic grafts available for medium to
large diameter vessels. However, for small diameter vessels (<6 mm in diameter), these synthetic
grafts are prone to failure due to rapid occlusion and acute thrombogenicity. This has been
attributed to a mismatch of mechanical properties and poor endothelialization [73, 74]. An ideal
tissue engineered vascular graft should be nonimmunogenic, biocompatible, have suitable
mechanical properties, elicit the proper wound healing response, and be able to be used in
surgery [73]. Electrospinning, a technique that uses high voltage to stretch a polymer solution
into nanofibers creating a nanofibrous scaffold that mimics the structure of native ECM, is a
promising method to create such a graft.
Silk is renowned for its strength and elasticity, often exceeding those of synthetic
polymers, making it of particular interest in the field of tissue engineering [128]. The most
extensively used silk in tissue engineering comes from the domesticated silkworm Bombyx mori
and is composed of sericin and silk fibroin (SF), the latter of which is of particular interest in
tissue engineering applications. SF has hydrophobic domains formed from crystalline 𝛽-sheets
interspersed with hydrophilic, semi-amorphous regions. The crystalline 𝛽-sheets give SF its
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strength and stiffness while the semi-amorphous region lend SF its extensibility and toughness
[130]. The mechanical properties and degradation of SF is tunable, particularly by modulating
the formation of 𝛽-sheets via heating or solvent exposure which essentially renders SF immune
to degradation in water [131].
PCL is renowned for its excellent biocompatibility, biodegradability, and nontoxicity
making it a promising biomaterial for use in tissue engineering, drug delivery, surgical sutures,
and wound dressings [96]. PCL has a semi-crystalline structure and a low melting point at about
60°C and a glass transition temperature at about -60°C. Therefore, under physiological
conditions, it has great mechanical properties such as high toughness, strength, and elasticity
[106]. However, PCL is limited by its hydrophobicity, which can limit cell attachment, and
mechanical properties that do not match well with native arteries [108]. Blending PCL with other
materials such as SF has the potential to overcome these drawbacks.
In this study several blends of PCL and SF were used to electrospin nanofibrous scaffolds
and evaluated for their potential in tissue engineered vascular grafts. The effect of increasing SF
concentration on mechanical properties and fiber morphology was analyzed. The ability of the
PCL-SF scaffolds to support differentiation of mesenchymal stem cells (MSCs) into VSMC-like
cells was evaluated using immunocytochemistry and compared to MSCs and human aortic
smooth muscle cells cultured on the scaffolds.
2. Materials and Methods
2.1. Silk Fibroin Extraction
SF was purified from Bombyx mori cocoons (The Yarn Tree, Roanoke, VA, USA)
according to the protocol published by Rockwood et al. [129]. Briefly, the dried silkworms were
removed from the cocoons and empty cocoons were cut into approximately dime sized pieces. 5
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g of silk cocoon pieces were added to 2 L of 0.2 M Na2CO3 solution and boiled for 30 min to
dissolve the sericin. The SF fibers were then removed, quickly rinsed, and cooled in ultrapure
water to prevent degradation of fibers. Fibers were then rinsed three times in ultrapure water for
20 min with stirring and dried overnight. Dried silk was weighed and a sufficient volume of 9.3
M LiBr (Sigma Aldrich, St. Louis, MO) was prepared to 20 w/v% solution of SF. The SF was
then tightly packed into a small beaker, the LiBr solution was added on top such that the silk was
covered, and then allowed to dissolve at 60ºC for 4 h. The SF solution was then loaded into 3500
molecular weight cutoff dialysis cassettes (ThermoFisher Scientific, Waltham, MA, USA) and
dialyzed against ultrapure water with gentle stirring. Water was changed six times during the 48
h dialysis to prevent gelation of the SF. The SF solution was then transferred to 50 mL conical
tubes and centrifuged twice at 3000 rcf at 4˚C for 30 min to remove impurities. The solution was
then frozen at -80˚C overnight and lyophilized for 2 days until all the water was removed.

2.2. Electrospinning
PCL and SF were mixed with 1,1,1,6,6,6-hexafluoroisopropanol (Sigma Aldrich, St.
Louis, MO, USA) and allowed to dissolve overnight with gentle stirring. The following polymersolvent w/w% solutions were prepared: 10% PCL, 10% PCL 1% SF, 10% PCL 2% SF, and 10%
PCL 3% SF. After mixing, the solutions were loaded into a 20 mL plastic syringe with a 22gauge blunt tip needle. Fibers were collected on a rotating mandrel collector (Spinbox Systems,
Valencia, Spain) using an aluminum foil wrapped 1.5 cm diameter mandrel rotating at 1020 rpm.
Electrospinning parameters for each of the blends is shown in Table 1. After spinning, scaffolds
were removed from the mandrel and allowed to dry overnight before removing them from the
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aluminum foil. The SF blends were soaked in ethanol (Decon Labs, King of Prussia, PA, USA)
for 30 min then dried and stored.
2.3. Mechanical Testing
Scaffolds were cut into 1 cm wide strips and soaked in PBS prior to mechanical testing. The
thickness of each sample was measure using a micrometer. Mechanical testing was carried out
using an MTS Insight 1kN mechanical tester with a 100 N load cell (MTS, Eden Prairie, MN,
USA). Samples were stretched at a rate of 10 mm min-1 until fracture occurred. Data was
collected using Testworks 4.12 (MTS, Eden Prairie, MN, USA).
2.4. Scanning Electron Microscopy
Fiber morphology and diameter were assessed using a Quanta 450 scanning electron microscope
(SEM) (FEI, Hillsboro, OR, USA). Samples were gold coated prior with an amperage of 0.1 mA
for 60 s. Fiber diameter was measured on images taken at 20,000x using the built-in
measurement tool in the SEM software. Images were taken for 3 different samples for each
polymer blend with at least 10 fibers measured per image.
2.5. Cell Culture
Primary human aortic smooth muscle cells (VSMCs), bone marrow-derived mesenchymal stem
cells (MSCs), and their respective basal media and growth kits were purchased from ATCC
(Manassas, VA, USA). VSMCs and MSCs were cultured in T-75s using vascular cell basal
medium supplemented with VSMC growth kit (complete VSMC medium) and MSC basal
medium supplemented with low serum MSC growth kit (complete MSC medium) in a 5% CO 2
humidified incubator at 37ºC. Cells were subcultured at 90% confluency. Media was changed
every 48 hr.
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2.6. VSMC Differentiation
Scaffolds were first cut into disks to fit a 24 well plate and placed under a germicidal UV lamp
for 1 hr for each side of the scaffold. Scaffolds were then soaked in 70% ethanol for 30 min
followed by three washes with PBS. Complete media with 1:100 penicillin/streptomycin was
then added to the well to sterilize and equilibrate the scaffolds overnight. VSMCs and MSCs
between passages 3 and 6 were seeded onto the scaffolds at a density of 40,000 cells per
scaffold. MSCs cultured in complete MSC medium were defined as the MSC control group.
MSCs cultured in complete MSC medium with 10 ng mL-1 transforming growth factor-beta 1
(TGFβ-1) (Invitrogen, Carlsbad, CA, USA) were defined as the VSMC differentiation group.
VSMCs cultured in complete VSMC medium were defined as the VSMC control group. Cells
were grown on the scaffolds for 14 days.
2.7. Confocal Imaging
Cells were fixed after 14 days of culture with 4% paraformaldehyde in PBS (Affymetrix, CA,
USA) for 20 min at room temperature followed by several rinses with PBS. Cells were
permeabilized with 0.1% Triton X-100 in PBS for 10 min and rinsed with PBS three times. Cells
were blocked with 1% bovine serum albumin/PBS + 0.1% Tween 20 (PBSTS) for 30 min.
Scaffolds were then stained with the following mouse anti-human antibodies (1:200 in PBSTS):
anti-myosin heavy chain (MHC), anti-smoothelin, and anti-calponin and incubated for 4 hr at
room temperature. Except for anti-smoothelin which was purchased from Abcam (Cambridge,
MA, USA), all other antibodies were purchased from Sigma (St. Louis, MO, USA). The primary
antibody solution was then aspirated, and scaffolds were rinsed three times in PBS. After rinsing,
cells were incubated with FITC-conjugated goat anti-mouse IgG (Invitrogen, Carlsbad, CA,
USA), covered in foil for 1 hr at room temperature, rinsed well with PBS, and counterstained
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with DAPI (BD Biosciences, Franklin Lakes, NJ, USA). Samples were mounted on glass slides
and observed under a laser scanning confocal microscope (Olympus IX83 FV1200, Olympus
Life Science).
2.8. Statistical Analysis
One-way ANOVA with Tukey’s post hoc test was used to infer statistical significance for all
experiments. A p-value of *P ≤ 0.05 was considered statistically significant. All data were
reported as the mean ± standard error of the mean.

3. Results
3.1. Scaffold Characterization
PCL-SF nanofibers were successfully electrospun. The results of mechanical testing are given in
Figure 1 and Table 2. The neat PCL nanofiber scaffolds had the highest elastic modulus (17.6 ±
2.2 MPa) and ultimate tensile strength (13.1 ± 1.9 MPa) which was significantly higher than the
10% PCL 1% SF (6.2 ± 0.2 MPa and 2.7 ± 0.2 MPa, respectively), 10% PCL 2% SF (6.2 ± 0.6
MPa and 2.4 ± 0.1 MPa, respectively), and 10% PCL 3% SF (2.7 ± 0.1 MPa and 1.3 ± 0.02 MPa,
respectively). While the addition of SF to PCL lowered the elastic modulus and ultimate tensile
strength, higher concentrations of SF had no significant effect on the mechanical properties of
the scaffolds. The SF blends were also much more elastic compared to neat PCL with the 10%
PCL scaffold having a significantly lower percent elongation at 125 ± 4.7% compared to 625 ±
43%, 608 ± 45%, and 513 ± 25% for 10% PCL 1% SF, 10% PCL 2% SF, and 10% PCL 3% SF,
respectively. Interestingly, for the three mechanical properties tested, the 2% and 3% SF blends
had nearly identical properties.
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The fiber morphology and diameter were assessed using SEM. Relatively bead-free fibers
were produced, particularly for the scaffolds containing 1% and 2% SF (Figure 2A, top row).
More numerous and larger beads were noted on the neat PCL as well as the 3% SF blend. In
addition, larger agglomerations and/or tangles of fibers were present to some degree on every
scaffold but again to a greater degree on the neat PCL and 10% PCL 3% SF blend. At higher
magnification, the nanofibers appeared smooth with no major apparent defects (Figure 2A,
bottom row). The 10% PCL 3% SF showed notable conglutination with several crossing fibers
appearing to have merged with other fibers. Fiber diameters were measured from the 20000x
images. Fiber diameters are present in Figure 2C and Table 2. The 10% PCL scaffold showed a
significant reduction in fiber diameter with an average diameter of 256.4 ± 14.6 nm. 10% PCL
3% SF scaffold had the highest fiber diameter (765.6 ± 46.9 nm) while fiber diameter on the
10% PCL 1% SF and 10% PCL 2% SF were once again similar (625 ± 43 nm and 608 ± 45 nm,
respectively.
3.2. VSMC Marker Expression
The ability of scaffolds to support VSMCs and promote the differentiation of MSCs to VSMCs
was qualitatively examined using immunocytochemistry. MSCs and VSMCs were cultured on
the scaffolds for 14 days, fixed, and stained with antibodies for the VSMC markers MHC,
calponin, and smoothelin. All four scaffolds tested supported the growth and proliferation of
MSCs (Figures 3, 4, and 5). Based on observations of nuclear staining, fewer nuclei were present
in the VSMC control group compared to both the MSC control and VSMC differentiation
groups. The VSMC differentiation group appeared to have the highest expression of MHC and
smoothelin (Figures 3 and 5, bottom row) and VSMC control group had the lower expression of
these proteins (Figures 3 and 5, middle row). Interestingly, the MSC control group appeared to
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have smoothelin expression that was higher than the VSMC control group and had the highest
expression of calponin overall (Figures 3 and 4, top row). In general, expression of MHC,
calponin, and smoothelin appeared the highest on the scaffolds containing 1 and 2% SF for all
three groups.
4. Discussion
PCL and SF are popular polymers for tissue engineering research and as such several groups
have used them for neural [310], skin [311, 312], and vascular grafts [313, 314] with varying
degrees of success. Hong and Kim added small intestine submucosa to PCL/SF scaffolds to
improve their hydrophilicity and growth of PC-12 nerve cells [310] while Bajsić et al. found that
their electrospinning method resulted in hydrophilic PCL/SF scaffolds but resulted in poor
keratinocyte adhesion and proliferation [311]. This preliminary study of PCL/SF electrospun
scaffolds added more to this conundrum.
For our study, SF was chosen for its interesting mechanical properties and its potential to
help replicate the mechanical properties of native arteries. PCL was chosen with a larger scope in
mind for this study. One of the major drawbacks of electrospun scaffolds is that as-spun the
scaffolds are essentially 2D sheets with high porosity but few interconnected pore spaces, greatly
inhibiting the ability of cells to infiltrate the scaffold and for remodeling to occur [166]. This is a
major concern for vascular grafts because of the need for VSMCs to infiltrate the scaffold to
form a neomedia layer, which is critical to the function of the artery as well as supporting the
endothelium [217, 218]. One interesting method that has been utilized to form porous scaffolds
for bone tissue engineering is the thermally induced self-agglomeration (TISA) process [315]. In
the TISA process, electrospun scaffolds are mechanically ground into small fibers and pieces
before being suspended in a water:ethanol:gelatin solution. The suspension is then heated to just
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below the melting point of PCL causing the fibers to spontaneously condense and aggregate to
form a highly porous structure. These scaffolds are able to take on a variety of shapes including a
tubular scaffold that could have potential as a vascular graft [315, 316]. Thus, PCL was selected
for use in this study. Exploratory experiments were conducted using the PCL/SF blends, but a
number of issues arose. We had difficulty controlling the TISA process and scaffolds would
either end up as a solid mass or easily crumble. Furthermore, there would also be issues in
controlling pore size as well as concerns about the mechanical properties of finished graft, which
we planned to solve by adding additional electrospun layers as mechanical reinforcement.
However due to limited time, the TISA process was abandoned and we instead focused on
examining the mechanical and biological suitability of electrospun PCL/SF scaffolds.
The 10% PCL scaffold had the highest elastic modulus and ultimate tensile strength. The
addition of SF resulted in a significant reduction in both properties. Interestingly, the 10% PCL
1% SF and 10% PCL 2% SF scaffolds had nearly identical mechanical properties while the 10%
PCL 3% SF had the lowest. Natural SF has a high elastic modulus of 10-17 GPa and an ultimate
tensile strength of 300-740 MPa [130]. However, much of SF’s mechanical strength is lost
during the degumming and dissolution process which causes some degree of hydrolysis [130].
This makes SF somewhat better suited for vascular grafts as the mechanical properties of native
SF would result in an extreme mismatch of mechanical properties which would likely cause graft
failure similar to that seen with small diameter synthetic grafts composed of ePTFE and Dacron
[73, 74]. The internal mammary and femoral arteries are reported to have circumferential elastic
moduli of 8 and 9-12 MPa, respectively and an ultimate tensile strength of 4.1 and 1-2 MPa,
respectively [317]. The radial artery is reported to have an elastic modulus of 2.7-3.3 MPa [318].
These values are fairly similar to those of the 10% PCL 1% SF and 10% PCL 2% SF scaffolds,
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which had elastic moduli of 6.2±0.2 and 6.2±0.6 MPa, respectively, and ultimate tensile strength
of 2.7±0.2 and 2.4±0.1 MPa, respectively. The addition of SF also greatly enhanced the
extensibility of the scaffolds, with all three SF blends showing similar percent elongation. This is
likely due to the semi-amorphous regions of the SF [130].
Fiber diameter was significantly higher in all three scaffolds containing SF with the 10%
PCL 3% SF scaffold having the highest fiber diameter (765.6±46.9 nm). Fiber morphology
appeared the best on the 10% PCL 1% SF and 10% PCL 2% SF scaffolds with little beading or
other defects observed. The 10% PCL scaffold had the worst morphology with many beads as
well as tangles of fibers that appeared on the outer surface. There was also rather extreme
variability in fiber diameter with most fibers being up to a few hundred nanometers in diameter
and a few fibers with much larger diameters, approaching a micron in size. This morphology is
potentially from the use of HFIP as the solvent as adjusting other electrospinning parameters was
only able to moderately improve fiber morphology and our micrographs appeared remarkably
similar to those of McClure et al. who also used HFIP as the solvent [313]. The scaffolds
containing 1% and 2% SF had medium sized fibers around 600 nm in diameter, a size that has
been reported to show good retention of endothelial cells subjected to shear stress [163].
Since cytocompatibility and cellular interactions with biomaterials are critical for
biomedical applications, we examined the effects of SF on VSMC proliferation and MSC
differentiation using immunocytochemistry. VSMCs appeared to proliferate slower on the
scaffolds compared to the MSC groups based on the number of nuclei present, though cell size
could also affect this. The scaffolds containing 1% and 2% SF appeared to be the most
supportive of MSC differentiation into VSMC-like cells, with expression of MHC and
smoothelin appearing markedly higher on these scaffolds compared to the neat PCL scaffold.

135

The ability of pure SF to support MSC proliferation appears limited and mixing with other
natural polymers greatly improves MSC proliferation [319, 320], though others have shown that
SF hydrogels are able to support differentiation of MSCs into VSMC-like cells [321]. This may
explain the apparent decrease in nuclei and expression of calponin and smoothelin on the 10%
PCL 3% SF scaffolds. Interestingly, SF appeared to help stimulate MSC differentiation in the
absence of TGF𝛽-1 with expression of calponin and smoothelin appearing to be higher than the
VSMC control groups, particularly on the 10% PCL 1% SF and 10% PCL 2% SF scaffolds. In
addition to potential bioactivity of SF, this could be the result of scaffold stiffness as matrix
stiffness has been demonstrated to be a mediator of stem cell differentiation [322]. Probing the
mechanical properties of the scaffold at the cellular level using AFM and quantifying the
expression of VSMC markers through polymerase chain reaction (PCR) would be useful in
providing insights into this potential for the PCL/SF scaffolds.
5. Conclusion
This work focuses on a preliminary investigation into the suitability of electrospun PCL/SF as a
material for vascular tissue engineering. SF significantly reduced the elastic modulus and
ultimate tensile strength of the scaffolds with these properties being similar to that of native
arteries. Fiber morphology was also affected, with PCL/SF fibers appearing more uniform with
fewer beads as well as significantly increased fiber diameter compared to the pure PCL
scaffolds, which may assist in cell adhesion. Qualitative observations of immunostaining for
VSMC markers showed that the 1% SF and 2% SF scaffolds appeared to help stimulate MSC
differentiation with and without TGF𝛽-1. However more work is needed to fully evaluate the
potential of this material.
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Tables
Table 1. Electrospinning parameters for PCL-SF scaffolds.
Blend
Collector
Needle
Distance
Voltage (kV) Voltage (kV)
(cm)
10% PCL
10% PCL 1% SF
10% PCL 2% SF
10% PCL 3% SF

-1
-1
-1
-1

+24
+15
+16
+15

22
18
18
18
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Dispense Rate
(mL hr-1)
0.8
0.8
0.8
0.8

Rotational
Speed
(rpm)
1020
1020
1020
1020

Table 2. Mechanical testing results and fiber diameter.
Blend
Elastic
Ultimate
Modulus (MPa)
Tensile
Strength (MPa)
10% PCL
17.6 ± 2.2
13.1 ± 1.9
10% PCL 1% SF
6.2 ± 0.2
2.7 ± 0.2
10% PCL 2% SF
6.2 ± 0.6
2.4 ± 0.1
10% PCL 3% SF
2.7 ± 0.1
1.3 ± 0.02
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Elongation (%)

Fiber Diameter
(nm)

125 ± 4.7
625 ± 43
608 ± 45
513 ± 25

256.4 ± 14.6
657.5 ± 21.3
616.4 ± 19.5
765.6 ± 46.9

Figures
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Figure 1. Mechanical characterization of PCL-SF nanofibrous scaffolds. (A) 10% PCL scaffolds
had significantly higher elastic modulus compared to the PCL/SF blend scaffolds. (B) 10% PCL
scaffolds had significantly higher ultimate tensile strength compared to the PCL/SF blend
scaffolds. (C) 10% PCL scaffolds had significantly lower percent elongation compared to the
PCL/SF blend scaffolds. All data are presented as the mean ± SEM (n = 12 or 16 with
measurements taken on 3 or 4 samples from each polymer blend with 4 replicates per sample,
***P ≤ 0.001).
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Figure 2. SEM imaging of fiber morphology. (A) SEM images showing the microstructure of the
scaffolds (top row) and morphology of the nanofibers (bottom row). Scale indicated by the white
bar showing 100 µm for the 1000x images and 5 µm for the 20000x images. (B) 10% PCL
scaffolds had significantly smaller average fiber diameter. Data are presented as the mean ±
SEM (n ≥ 56 with measurements taken on 3 or 4 samples for each polymer blend, ***P ≤ 0.001).
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Figure 3. Immunostaining for VSMC marker MHC. Scale bar in the bottom right indicates 100
µm.
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Figure 4. Immunostaining for VSMC marker calponin. Scale bar in the bottom right indicates
100 µm.
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Figure 5. Immunostaining for VSMC marker smoothelin. Scale bar in the bottom right indicates
100 µm.
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Chapter 5: Overall Conclusions and Future Directions
1. Conclusions
In this dissertation, we aimed to study the biomechanics of VSMCs during atherosclerosis and
develop an electrospun scaffold for vascular tissue engineering. First, we sought to mimic the
heterogeneous microenvironments seen in atherosclerotic plaques by using tunable elastic
substrates to study the effect of stiffness and ECM proteins on VSMC migration and
cytoskeleton architecture. We showed that different ECM proteins help to regulate the VSMCs’
response to substrate stiffness and modulate migration. This response was also seen in
differential remodeling of cortical actin stress fibers. The differential migratory and cytoskeletal
response to COL1 and FN are interesting in the context of disease progression. Rich FN deposits
may help improve migration and the formation of the fibrous cap while stiff COL1 regions may
help reduce migration and promote fibrous integrity. Furthermore, the degradation of fibrous cap
may not be only due to the death of VSMCs but also migration, which could be a potential
therapeutic target.
Next, we explored changes to VSMC biomechanics during atherosclerosis by analyzing
the differences in mechanical behavior of ApoE-/- and WT VSMCs. We showed ApoE-/- VSMCs
had altered biomechanics compared to WT VSMCs including differences in stiffness,
cytoskeleton organization, adhesion forces, and migration. Increasing substrate stiffness had a
synergistic affect, increasing cell stiffness and stress fiber alignment in ApoE-/- VSMCs. These
results support our hypothesis that atherosclerosis alters the mechanical properties of VSMCs. In
turn this supports the idea that mechanics could be a potential target of novel therapeutics for
example those that target adhesion molecules such as N-Cad. Improving N-Cad adhesion may
help promote cell-cell adhesion in the fibrous cap and help to reduce the risk of plaque rupture.

145

Other potential targets include altering VSMC stiffness through the cytoskeleton which may help
reduce overall arterial stiffness and improve blood flow and overall function of VSMCs.
Finally, we aimed to conduct a preliminary assessment of the potential of PCL/SF
electrospun scaffolds for vascular tissue engineering. Electrospun PCL/SF scaffolds had
mechanical properties similar to that of native arteries. These scaffolds helped to support the
differentiation of MSCs into VSMC-like cells demonstrating their potential for vascular tissue
engineering. However, more work is needed to fully evaluate PCL/SF scaffolds.
In summary, in this dissertation we uncovered how atherosclerosis and its
microenvironments are able to alter VSMC biomechanics and investigated a promising material
for vascular tissue engineering.
2. Future Directions
The first two aims of this work demonstrated how different microenvironments and
atherosclerosis alters VSMC biomechanics. However, plenty of work is still needed to fully
elucidate how VSMC biomechanics change during atherosclerosis, the mechanisms underlying
these changes, and how they impact the contribution of VSMCs to atherosclerosis progression.
Under the first aim, a next step would be to analyze the effect of different ECM proteins
at different concentrations and combination of ECM proteins on cell migration and
biomechanics. The atherosclerotic plaque is a highly heterogeneous lesion with numerous
microenvironments that have varying stiffness and ECM proteins. Although parts of the plaque
can be enriched in particular ECM proteins, these are rarely the only ECM proteins present so
examining the combinatorial and/or any masking effect ECM proteins have on one another
would be more relevant to understanding the role of VSMCs in atherosclerosis progression.
Something similar could also be done with ApoE-/- and WT VSMCs to find any further
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differences in the behavior of atherosclerotic VSMCs. One interesting result from this work was
the finding that migration may be oscillatory. Previous work in our lab has demonstrated that
VSMC stiffness and adhesion forces are oscillatory [248]. To better analyze this, a shorter time
course with more frequent imaging would be needed. Realtime imaging of the cytoskeleton
could also be done by tagging the actin cytoskeleton with fluorescent probes to track if
cytoskeleton remodeling is also oscillatory. Advanced microscopy techniques such as total
internal reflection fluorescence (TIRF) microscopy could be utilized to monitor changes in
cortical actin. The most pressing work needed under aim two would be to investigate the
mechanism behind the differences found in ApoE-/- and WT VSMC biomechanics. This would
include probing the expression of various cytoskeleton linker proteins, FA proteins including the
various integrins, and signaling pathways such as the Rho/ROCK pathway using western blots,
PCR, and immunocytochemistry. These results could then be expanded by either knocking down
or silencing specific genes to provide further insights and open the pathway for any potentially
useful therapeutic targets.
As the work under aim three was largely a preliminary exploration, much more work is
needed to fully evaluate electrospun PCL/SF scaffolds for vascular tissue engineering. First off
would be characterizing more mechanical properties including compliance, burst pressure, and
suture retention strength. Dynamic mechanical testing would also be useful to better understand
long term changes in mechanical properties from cyclic loading such as creep. Quantifying the
cytocompatibility and differentiation capacity of the scaffolds is also needed. We attempted to
analyze VSMC proliferation using the MTT assay, but the scaffolds would react with or were
stained by the formazan crystals turning them purple and interfering with absorbance
measurements. Another assay such as a fluorescence or ATP based assay may work better in this
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regard. In this study we offered qualitative assessments of MSC differentiation so a quantitative
method using PCR is needed to make stronger conclusions. Expanding the scope of this project
would include culturing cells on tubular scaffolds in a bioreactor to better mimic the mechanical
forces experienced in vivo. Both the mechanical and biological properties of these scaffolds
could be improved upon by producing scaffolds with aligned fibers, surface modifications to
improve cell adhesion, and the addition of bioactive components to potentially help guide cell
growth and differentiation. It is also worth continuing explorations into making a multilayered
graft with a porous layer for VSMC growth and proliferation whether by continuing with the
TISA process or trying a different method.
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